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Abstract
The limited capacity of the kidney for regeneration and the scarcity of organs for 
transplantation have led to the search for alternative therapies to repair the 
damaged kidney before it becomes non-functional. One approach to regenerate 
damaged structures in the kidney would be to use stem cells. However, the 
existence of stem cells in mature kidneys is still controversial.
During the first part of this study the prevalence and location of renal stem cells 
during mouse development was established using Pax-2 immunostaining. Pax-2 
positive cells were found in the outer cortex and the papilla of neonatal mice. By 
week one Pax-2 positive cells were restricted to the papilla. This Pax-2 
expressing population, which remained in kidney after nephrogenesis was 
complete, may be similar to the precursor cells previously found in human 
kidney.
Pax-2 is expressed in both the nephrogenic metanephric mesenchyme (MM) and 
the non-nephrogenic ureteric bud, however, the marker WT1 is only expressed in 
MM. To determine the origin of Pax-2 positive cells, WTl-Cre/Rosa26R mice 
were used, in which cells expressing WT-1 also express Cre recombinase which 
irreversibly activates P-galactosidase. Day 7 mice were immunostained for Pax-2 
and P-galactosidase. When transgenic mice were analyzed, some Pax-2 positive 
cells in the papilla were found positive for p-galactosidase, suggesting that they 
were derived from metanephric mesenchyme.
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Magnetic cell sorting was the chosen technique to select Pax-2 positive cells in 
kidney, however, a cell surface marker was required to do so. A screening of 
twenty-one lectins showed that peanut agglutinin lectin (PNA) bound to the 
majority of Pax-2 positive in the papilla. PNA was then used for the isolation of 
the cell population of interest by immunomagnetic cell sorting.
However, expansion of disaggregated cells from mouse kidney under the optimal 
culture conditions proved to be equally effective to enrich the population of Pax-2 
positive cells or putative kidney stem cells (pKSC).
These expanded populations displayed some potential to integrate into new 
developing kidneys. It was possible to induce pKSC to differentiate into more 
specialized cell types, such as tubular epithelial cells, podocytes or mesangial 
cells, by changing the culture conditions. These cells also have high clonogenic 
potential, which is characteristic of stem cells.
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Glossary of common abbreviations
a-SMA Alpha smooth muscle actin




BMP-7 Bone morphogenic protein 7
BrdU Bromodeoxyuridin
BSA Bovine serum albumin
CD2AP CD2-asssociated protein
DAPI 4',6-diamidino-2-phenylindole, dihydrochloride
DMEM Dulbecco’s modified Eagle’s medium
DNase I Deoxyribonuclease I
dpKSC Differentiated putative stem cells
dSTO Sodium deoxycholate-treated STO
ECM Extracellular matrix
EDTA Ethylenediaminetetraacetic acid
EGF Epidermal growth factor
ESRF End stage renal failure
FACS Fluorescence-activated cell sorting
IX
FCS Fetal calf serum
FGF Fibroblast growth factor
FN Fibronectin
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
GBM Glomerular basement membrane
GDNF Glial cell-line derived neurotrophic factor
HBSS Hanks’ buffered saline solution
HGF Hepatocyte growth factor
KSC Kidney stem cells
Ksp-cadherin Kidney specific cadherin
LIF Leukemia inhibitory factor
LRC Low rate cycling cells
MACS Magnetic-activated cell sorting
MEF Mouse embryo fibroblasts
MEM Modified Eagle’s medium
MM Metanephric mesenchyme
NCAM Neural cell adhesion molecule
NT No template control
PBS Phosphate buffered saline
PCNA Proliferative cell nuclear antigen
PECAM Platelet endothelial cell adhesion molecule
x
PFA Paraformaldehyde
pKSC Putative kidney stem cells
Salll Sal like 1 gene
siRNA Small interfering RNA
SP Side population
STO Sandoz inbred mouse embryo-derived thioguanine and 
ouabain- resistant cells
STO-CM STO-conditioned media
TAE T ri s-acetate-EDT A
TBS Tris buffered saline
TGFa Transforming growth factor alpha
TGFP Transforming growth factor beta
THP Tamm-Horsfall protein
TIMP2 Tissue inhibitor of metalloproteinase 2
UB Ureteric bud
VEGF Vascular endothelial growth factor
vWF von Willebrand factor




Some organs in mammals have the ability to regenerate to compensate for 
damage; for example the liver is able to regenerate when a fraction is removed 
(Stanger et al., 2007). Other organs, such as skin or blood, also present an evident 
capacity for regeneration (Clark and Kamen, 1987; Li et al., 2004). However, 
most mature organs, such as pancreas, heart or kidney, have a very limited 
regenerative potential (Stanger et al., 2007). When extensive insult occurs in 
these organs, the damage is usually irreversible and leads to failure of the organ, 
in such cases transplantation is the chosen therapy (Schaubel et al., 2000; 
Schnuelle et al., 1998). Thousands of people die every year in Europe waiting for 
organ transplants (Ransford et al., 2000). The lack of available organs for 
transplant necessitates the search for alternative treatments.
During the last decade it has been suggested that repair or regeneration of 
damaged organs with stem cells might offer a suitable alternative to 
transplantation. There have been several successful attempts during the last few 
years in regenerative medicine. In 2006, Anthony Atala’s group from Wake 
Forest University (North Carolina) grew a whole bladder de novo using urothelial 
and smooth muscle cells isolated from the patient, and then successfully 
transplanted the bladder into the patient (Atala et al., 2006). Another exciting 
breakthrough was achieved when Macchiarini et al. (2008) in Spain managed to 
reconstruct and replace a bronchus using bone marrow stem cells from the 
patient.
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The kidney is one of the organs that have a limited regeneration potential in 
mammals (Drummond, 2003). When the kidney is injured and loss of renal 
function occurs, the outcome may be endstage renal failure (ESRF) (Schnuelle et 
a l, 1998). While dialysis provides a means of replacing the loss of kidney 
function for patients in ESRF the only current means of permanently treating 
ESRF is transplant (Schnuelle et a l, 1998).
There is severe lack of kidneys available for transplantation requiring many 
patients be treated with dialysis. Furthermore, dialysis requires expensive 
machinery, severely reduces the patient’s quality of life, and, most importantly, 
has significant side effects for the patient including osteoporosis (Barreto et al., 
2006). These considerations have led to the search for potential regenerative 
treatments.
One proposal is that it might be feasible to repair or replace damaged nephrons in 
patients suffering chronic renal failure before the kidney becomes non-functional 
using adult stem cells from the patient. This approach would have the advantage 
that no rejection would occur when transplanted. However, the existence of stem 
cells in mature kidneys is still controversial.
The kidney is a highly complex organ and in order to develop a therapy using 
stem cells to repair or regenerate injured kidney, it is very important to 
understand both the anatomy of the fully mature kidney and how the kidney 
develops.
13
1.1 Anatomy of the Kidney
The kidneys are bean-shaped organs located in the retroperitoneal space (Figure
1-1) and are covered by a layer of connective tissue called the capsule, the main
components of which are fibroblasts, myofibroblasts and collagen fibers (Martini
and Bartholomew, 1997).
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Figure 1-1 Diagram showing gross structures of a human kidney (From Piotr Michai 
Jaworski with permission under the terms of the GNU Free Documentation License, 
http://commons.wikimedia.0rg/wiki/File:Kidney_PioM.png)
The nephron is the basic structural and functional unit of the kidney and is 
formed by the renal corpuscle (Bowman’s capsule and glomerulus) and the renal 
tubule (Figure 1-2) (Georgas et al., 2008; Vize et al., 2003). The renal corpuscle 
is responsible for the filtration of blood, which generates an ultrafiltrate 
(Junqueira et al., 1977). The tubular portions are then responsible for altering the 
concentrations of ions and other chemicals in the ultrafiltrate to produce dilute
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urine. This process is essential not only for waste excretion but also for 
maintaining the appropriate ion balance in the body.
The Bowman’s capsule is the initial portion of the nephron and it is invaded by 
the vascular tuft, which is the glomerulus. The renal corpuscle contains the 
filtration apparatus of the kidney, which comprises three components: a vascular 
endothelial cell layer, an outer epithelial cell layer that contains specialised cells
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Figure 1-2 Diagram showing the structures of the nephron (Gray, 1918). This image is in the 
public domain because its copyright has expired obtained from 
http://commons.wikimedia.Org/wiki/File:Grayll28.png reproduced from 20th U.S. edition of 
Grays Anatomy of the Human Body (1918).
called podocytes, and an intermediate layer of basement membrane called 
glomerular basement membrane (GBM) (Vaughan and Quaggin, 2008).
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The structural support that the GBM contributes to the glomerulus is responsible 
for its characteristic spherical morphology (Gundersen and Osterby, 1980). 
Glomerular endothelial cells and mesangial cells are located inside the GBM, 
while podocyte cells lie outside(Smoyer and Mundel, 1998).
The kidney can be divided into three different regions that are clearly 
distinguishable by the naked eye, given the differences in blood supply within the 
organ. The outer part of the kidney is the cortex, which receives 90-95% of the 
blood passing through the kidney and therefore has a characteristic intense red 
colour (Regan et al., 1995). The cortex contains the renal corpuscles with the 
convoluted and straight tubules of the nephron as well as collecting tubules and 
collecting ducts (Vize et al., 2003).
The renal medulla forms the inner part of the kidney and can be divided into the 
outer and inner medulla, based on which portions of the renal tubules are more 
abundant (Liu et al., 2001; Terada and Knepper, 1989). The outer medulla can 
also be divided into two: the outer and the inner stripe. The outer stripe of the 
outer medulla contains the straight part of the proximal and distal tubules, the 
thick ascending limb of the loop of Henle and the collecting ducts (Vize et al., 
2003). The inner stripe of the outer medulla contains the thin descending limbs of 
the loop of Henle, the collecting ducts and the thick ascending limbs. The inner 
medulla contains the thin descending and ascending limbs and large collecting 
ducts, which empty into the renal calyx (Vize et al., 2003).
The tubules in the renal medulla are arranged in a morphology that resembles a 
cone and they are referred to as the renal pyramids. The apical portion of the
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renal pyramids, known as the papilla, is where the collecting ducts open into the 
minor calyces (Martini and Bartholomew, 1997). The minor calyces then open 
into the major calyces, which are in turn subdivisions of the renal pelvis (Martini 
and Bartholomew, 1997; Yize et al., 2003).
The juxtaglomerular apparatus can be found next to the vascular pole of the 
glomerulus and adjacent to the efferent and afferent arterioles. The 
juxtaglomerular apparatus is composed of extraglomerular mesangial cells, 
juxtaglomerular cells and the macula densa. The macula densa are specialised 
tubular cells from a fraction of the distal convoluted tubule (Martini and 
Bartholomew, 1997). The macula densa measures the ionic concentration of fluid 
in the distal convoluted tubule and controls the release of renin by the 
juxtaglomerular cells. This is a crucial component in the regulation of blood 
volume and pressure via the renin-angiotensin-aldosterone system.
1.1.1 Major cell types of the nephron and their markers
The nephron can be divided into the renal corpuscle, comprising the Bowman’s
capsule and glomerulus, and the different tubular fractions (Georgas et al., 2008). 
Each portion of the nerphron is characterised by highly specialized epithelial cells 
with specific functions. The different functions of the cell types leads them to 
express specific proteins depending on their position on the nephron. (Vize et al., 
2003). These proteins can be used as markers to identify different cell types from 
the nephron (Yize et al., 2003).
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Podocyte cells
The epithelial podocytes lie on the outer layer of glomerular capillaries (Figure 
1-3), and are derived from the metanephric mesenchyme (MM), one of two 
embryonic tissues responsible for kidney development (see Kidney Development 
page 30). Podocytes can be divided into three structural and functional segments: 
the cell body, major processes, and foot processes (Smoyer and Mundel, 1998). 
The cell bodies and major processes of podocytes float in the filtrate within the 
Bowman’s capsule, whereas the foot processes are in direct contact with the 
GBM and interdigitate closely with foot processes from other podocytes (Smoyer 
and Mundel, 1998; Vize et al., 2003). Filtration slits are present between the foot 
processes, which are bridged by the slit diaphragm (Smoyer and Mundel, 1998).
The slit diaphragm is a thin structure that connects the foot processes of the 
podocytes and plays a crucial role in glomerular filtration. The slit diaphragm is 
involved in size selectivity and is responsible for restricting protein passage 
through the glomerular filtration barrier (Miner, 2002; Reiser et al., 2000).
1 Basement membrane
2 Bowman's capsule - parietal layer
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Figure 1-3 Diagram showing detailed histological structure of the glomerulus (from Michal 
Komorniczak with permission under the terms of the Creative Commons Attribution 
Sharealike 3.0 license, http://en.wikipedia.0rg/wiki/File:Renal_c0rpuscle.svg).
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Podocytes are highly specialized cells that perform a variety of glomerular 
functions such as GBM turnover, maintenance of the glomerular filtration barrier, 
support of the capillary tuft, and regulation of glomerular filtration (Mundel and 
Kriz, 1995).
Above the slit diaphragm of the podocytes lies the glycocalyx, a layer of 
negatively charged glycoproteins that repulse negatively charged proteins in the 
glomerular capillary (Smoyer and Mundel, 1998). As a result of these repulsions, 
there is less filtration of these negatively charged proteins than uncharged 
proteins of the same size (Smoyer and Mundel, 1998). The glycocalyx is also 
essential for maintaining the structure of the foot processes (Smoyer and Mundel, 
1998). The transmembrane sialoprotein podocalyxin is one of the major proteins 
of the glycocalyx, and helps to maintain structure and function of the podocyte 
foot processes (Vize et al., 2003). Differentiating podocytes synthesize 
podocalyxin (Schnabel et al., 1989) and its expression is restricted to the apical 
surface of foot processes (Schnabel et al., 1989; Vize et al., 2003).
During the early stages of nephron development the developing podocytes are 
present as a simple layer of cuboidal or columnar epithelium. As the nephrons 
mature, intercellular junctional complexes migrate basolaterally where they are 
eliminated or substituted by slit diaphragms which bridge the filtration slits 
between foot processes (Schnabel et al., 1990; Vize et al., 2003).
The tight junction protein, zonula occludens-1 (ZO-1), is expressed in all the 
portions of the renal tubules at the tight junctions in the junctional complexes, but 
is most abundant in glomeruli where it is concentrated at the point where the slit
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diaphragms insert into the plasmalemma of the foot processes (Schnabel et al., 
1990). It seems that slit diaphragms are derived from tight junctions and their 
functional property is to define the boundary between plasmalemmal domains 
(Schnabel et al., 1990).
Other proteins that are required for normal development of the foot processes 
include nephl, nephrin and CD2-associated protein (CD2AP). Nephl is a slit 
diaphragm protein that forms a protein complex with nephrin, a transmembrane 
receptor that is present at the intercellular junctions of the foot process (Barletta 
et al., 2003). Deletion of nephl or nephrin results in abnormal development of 
foot process junction formation (Garg et al., 2007; Georgas et al., 2008). CD2AP 
is another protein of the slit diaphragm that is critical for glomerular integrity. 
Mice lacking this protein develop abnormal foot processes, and die of renal 
failure six to seven weeks after birth (Shih et al., 1999).
Other proteins have also been proposed as differentiated podocyte markers such 
as WT1, vimentin, and synaptopodin (Shankland et al., 2007; Vize et al., 2003). 
The expression pattern of the transcription factor WT1 in glomerular podocytes 
during mouse adulthood indicates a possible role in maintaining functional 
podocytes (Mundlos et al., 1993). Point mutations in the WT1 gene in humans 
are associated with impaired podocyte function leading to damage in the 
glomerulus (Mundlos et al., 1993). WT1 expression is also crucial in controlling 
various stages of nephrogensis as described below in Kidney Development (page 
30).
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The intermediate filament protein, vimentin, is highly expressed in podocytes and 
vasculature. Vimentin does not appear to have an essential role in the kidney 
under normal physiological conditions, but following induced renal injury in 
mice, vimentin-null mice rapidly developed ESRF whereas wild-type mice 
recovered (Terzi et al., 1997). During kidney development vimentin expression is 
first seen in undifferentiated metanephric mesenchyme. As nephrogenesis 
progresses, vimentin is only expressed in the differentiating podocytes of the 
nephrons. In mature nephrons, vimentin expression is restricted to podocytes; 
however, it is only observed in cell bodies and major processes and it is absent in 
foot processes (Oosterwijk et al., 1990; Vize et al., 2003).
Synaptopodin is an actin associated protein that is specifically expressed in post­
mitotic differentiated podocytes and absent in immature podocytes and 
progenitors (Mundel et al., 1997a; Shankland et al., 2007). Synaptopodin is 
present in the foot processes of podocytes where its association with actin 
microfilaments is involved in the formation of the characteristic long unbranched 
actin filaments that can be observed in differentiated podocytes (Asanuma et al., 
2005).
The capacity of podocytes to repair or regenerate after injury is very limited 
(Mathieson, 2003). Under normal circumstances podocytes do not have the 
ability to proliferate and repopulate denuded areas (Barisoni and Mundel, 2003). 
The inability to repair podocyte injury means that damage to the glomerulus 
eventually leads to loss of glomerular function resulting in progressive 
glomerular disease (Barisoni and Mundel, 2003).
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Mesangial cells are glomerular intercapillary cells that occupy a central position 
in the glomerulus (Figure 1-3) (Schlondorff, 1987; Vize et al., 2003). Mesangial 
cells, like podocytes, are derived from MM. Mesangial cells have characteristics 
of modified smooth muscle cells, and are therefore able to contract and relax in 
response to vasoactive agents in order to modify glomerular filtration locally 
(Schlondorff, 1987). In addition to expressing a-smooth muscle actin (aSMA) 
(Skalli et al., 1989; Stephenson et al., 1998), mesangial cells also express the 
intermediate filament protein desmin (Georgas et al., 2008). Desmin is highly 
expressed in skeletal and cardiac muscle, therefore its presence in mesangial cells 
is probably related to the contractile function of these cells (Georgas et al., 2008).
Mesangial cells play various important roles in the kidney. As well as helping to 
maintain GBM and glomerular integrity, they are also responsible for 
phagocytosis of macromolecules trapped in the GBM, and secretion of 
prostaglandins and cytokines (Vize et al., 2003).
Endothelial cells
During nephron formation endothelial precursors invade the developing 
glomerulus at the distal portion. The vascular portions of the glomerulus develop 
from these invading endothelial cells.
The formation process of new blood vessels can take place in two different steps, 
one is vasculogenesis, or the formation of new blood vessels, and the other is 
angiogenesis, where new capillaries sprout from pre-existing vessels (Risau,
Mesangial cells
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1998). Both processes contribute to the formation of new vessels in the kidney 
(Vize et al., 2003).
Vascular endothelial growth factor (VEGF) is required for vasculogenesis and 
angiogenesis (Risau, 1998). VEGF, with its receptors flk-1 and flt-1, take part in 
the process of migration, proliferation and differentiation of the renal vasculature 
(Vize et al., 2003).
Endothelial cells express other endothelial markers such as Platelet endothelial 
cell adhesion molecule (PECAM) and von Willebrand factor (vWF). PECAM, 
which is widely used murine endothelial marker, is a member of the 
immunoglobulin superfamily. PECAM is located in the cell-cell borders of 
vascular endothelial cells and during inflammatory processes is responsible for 
the migration of monocytes and neutrophils out of the blood vessels (Redick and 
Bautch, 1999). vWF is a glycoprotein that mediates platelet adhesion to 
subendothelium where vascular injury has occurred (Pusztaszeri et al., 2006). 
Like PECAM, vWF is commonly used as an immunohistochemical marker for 
endothelial cells (Pusztaszeri et al., 2006).
1.1.2 Tubular markers 
Proximal tubular cells
A sudden change in epithelial morphology occurs at the urinary pole of the 
Bowman’s capsule, which demarcates the beginning of the proximal tubules. At 
this point it is possible to appreciate the transition from simple squamous to 
simple cuboidal epithelium (Vize et al., 2003). The epithelial cells forming the 
proximal tubules present a dense brush border of microvilli that enlarge the
23
absortion area. This large absortion area allows the cells to modify the ultrafiltrate 
with the resorption of numerous compounds, including proteins, aminoacids, 
glucose, and creatinine, but mainly water. The brush border of these cells is rich 
in water channels (Vize et al., 2003) such as channel aquaporin-1 (AQP1), which 
is expressed in renal proximal tubular cells and the thin descending limb of the 
loop of Henle (Georgas et al., 2008; Jenq et al., 1999).
Proximal tubular cells play an important role in reabsorption of fluids filtered by 
the glomerulus as well as most of the filtered glucose, amino acids and 
bicarbonate (Schnermann et al., 1998). AQP1 null mice present decreased water 
permeability in the proximal tubule, and defective fluid absorption (Schnermann 
et al., 1998).
Another protein that is important for the correct functioning of the proximal 
tubules is the 600-kDa transmembrane glycoprotein, megalin, which belongs to 
the low-density lipoprotein receptor family (Christensen and Verroust, 2002; 
Verroust and Christensen, 2002). Megalin is expressed in proximal tubular cells 
and is highly expressed at the apical surface of the cells. Megalin is able to bind a 
large number of plasma proteins such as albumin, insulin, prolactin and many 
others; megalin therefore plays an important role in protein reabsorption in 
proximal tubules (Christensen and Verroust, 2002; Verroust and Christensen, 
2002). Megalin-deficient mice present low molecular weight proteinuria and a 
deficiency in tubular resorption (Leheste et al., 1999).
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The brush border of proximal tubular cells contains membrane-bound enzymes 
such as alkaline phosphatase, the function of which is related to ion and solute 
transport (Taub et al., 2002; Vize et al., 2003).
The loop of Henle can be divided in three portions: the thin descending, thin 
ascending and thick ascending limbs. The thin descending limb is permeable to 
water and ions while the thin ascending limb is water-impermeable. Aquaporin-1 
is expressed in the thin descending limb but is absent in the thin ascending limb 
(Maunsbach et al., 1997).
Distal tubular cells
Two different portions, the convoluted and the straight, can be identified in distal 
tubules. Maintenance of the osmotic gradient in the renal medulla seems to be 
regulated by two tubular fractions: distal straight tubule and the thin ascending 
limb. Tamm-Horsfall (THP) protein is a 85-kDa glycoprotein localized in the 
thick ascending limb of the loop of Henle and the early distal convoluted tubule 
(Chakraborty et al., 2004). The pattern of expression of THP suggests that this 
protein might have a role in maintaining the medullary osmotic gradient (Kokot 
and Dulawa, 2000; Vize et al., 2003). THP null mice develop calcium crystal 
formation and are susceptible to urinary tract infections, suggesting that the 
specific kidney glycoprotein THP plays an essential role in defence against 
urinary tract infections and formation of renal stones (Mo et al., 2004).
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The collecting ducts are connected to the distal tubules through the connecting 
segment (Vize et al., 2003). As the collecting ducts approach the papilla they 
increase in size (Vize et al., 2003). Two main cells types are present in the 
collecting ducts: principal cells and intercalated cells (Vize et al., 2003). Principal 
cells are more numerous and are involved in water transport, expressing the water 
channel aquaporin-2 (AQP2), which is exclusively expressed in collecting ducts 
(Nielsen et al., 1995; Vize et al., 2003). The intercalated cells can be subdivided 
into type A, which are acid excreting cells, and type B cells, which secrete 
bicarbonate into the urine (Alper et al., 1989; Vize et al., 2003).
AQP2 is vasopressin-regulated water channel and has been proved to be essential 
for regulation of water balance in the kidney (Rojek et al., 2006). AQP2 null mice 
presented papillary atrophy and increased pelvic space (Ishibashi and Sasaki, 
1997; Rojek et al., 2006). These mice displayed severe defects in urine 
concentration and reduction of the extracellular fluid volume (Rojek et al., 2006). 
The mice failed to thrive and died before reaching two weeks old.
1.2 Kidney disease
Different insults can damage the kidney leading to acute or chronic renal failure. 
Poor renal perfusion, tubular damage and obstruction are the main causes of acute 
renal failure. When acute renal failure does not recover it leads to irreversible 
damage to the nephron and thus progresses to chronic renal failure. Chronic renal 
failure is the permanent loss of renal function, and, at some point, may lead to
Collecting duct cells
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endstage renal failure. Between 60-160 people per million of the population are 
affected by ESRF (Brewster et al, 2001).
1.2.1 Acute renal injury
The mammalian kidney has an extraordinary capacity to restore structure and 
function after toxic or ischaemic acute renal failure (Bacallao and Fine, 1989; 
Park et a l, 1997). After acute renal failure, tubular epithelial cells are 
desquamated and only the basement membrane remains. The presence of cells 
and debris causes blockade of the tubular lumen. In addition, the basement 
membrane itself can be tom, allowing the passage of molecules from bloodstream 
to the tubular lumen, for example fibronectin, which attachs to cells and debris in 
the lumen aggravating the obstruction (Bonventre, 2003).
After acute injury the kidney undergoes a repair process in order to repair the 
damage and restore functionality (Gupta and Rosenberg, 2008). New cells need to 
be recruited to replace the damaged cells (Gupta and Rosenberg, 2008). The most 
likely candidates responsible for tubular regeneration are undamaged 
neighbouring tubular cells, extrarenai cells, or resident kidney stem cells (Gupta 
and Rosenberg, 2008).
Different groups have shown that bone marrow cells have the potential to migrate 
and contribute to tubular repair after acute renal injury (Gupta et al, 2002; Gupta 
and Rosenberg, 2008; Kale et a l, 2003; Lin et a l, 2003). However, it has been 
demonstrated that most of the tubular repair occurs by proliferation of renal 
endogenous cells (Krause and Cantley, 2005; Lin et a l, 2005).
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Bonventre et al. (2003) and Humphreys et al. (2008) demonstrated that after 
acute kidney injury tubular epithelial cells that had survived the damage 
dedifferentiated, and started to proliferate in order to replace the damaged tubules 
and restore renal function (Bonventre, 2003). Under physiological circumstances, 
proximal tubular cells display a low proliferation activity, as shown by 
proliferative cell nuclear antigen (PCNA) and Ki-67 immunostaining (Bonventre, 
2003; Nadasdy et al., 1994). Under normal circumstances this tubular cell 
proliferation replaces tubular cells lost in urine (Bonventre, 2003). After an 
ischaemic injury, in which tubular cell death occurs, this proliferation activity 
dramatically increases in order to replace damaged cells (Bonventre, 2003). 
Humphreys et al. (2008) showed that intrinsic cells displaying epithelial markers 
are responsible for tubular repair after injury (Humphreys et al., 2008). This study 
does not exclude the possibility that stem cells play an important role in renal 
repair nor the possibility that the cells were renal stem cells expressing epithelial 
markers (Gupta and Rosenberg, 2008). Characteristic markers of undifferentiated 
renal cells such as vimentin and neural cell adhesion molecule (NCAM) are 
re-expressed in tubular cells approximately 5 days after injury (Bonventre, 2003). 
When acute damage is severe enough to require replacement therapies such as 
dialysis, in-hospital mortality is higher than 50% (Lameire et al., 2005). Acute 
renal failure seems to be reversible in 5% of cases, however, residual damage in 
children can cause renal failure in adolescence or adulthood (Lameire et al., 
2005).
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1.2.2 Chronic kidney disease
Some kidney diseases cause irreversible nephron degeneration. In chronic kidney 
disease there is a progressive loss of nephrons that results in a gradual loss of 
renal function (Kriz and LeHir, 2005). It has been shown that in humans and 
animal models, most of the diseases that progress to chronic renal failure start 
with glomerular damage. Independently of whether the original disease persists or 
not, there is a progressive loss of nephrons in chronic renal disease and loss of 
renal function as a consequence. In chronic renal disease, normal nephrons are 
usually found close to damaged nephrons. Two hypotheses have tried to explain 
how damaged nephrons affect surrounding healthy nephrons. Protein overload in 
a particular tubule causes a localized interstitial inflammation that damages the 
tubule and also the neighbouring ones. The second possibility is that as a 
consequence of nephron loss the remaining nephrons need to compensate for the 
lack of functionality. Compensatory mechanisms, such as hypertrophy, result in 
hyperfiltration and protein leakage leading to glomerular sclerosis. These 
nephrons do not appear to have any potential to recover and as a consequence are 
permanently lost (Kriz and LeHir, 2005).
Transplantation and dialysis are the only available treatments for ESRF, and 
without them ESRF would lead to death. However, the shortage of organs 
available for transplantation and the increasing number of patients on dialysis that 
need a new kidney make it necessary to search for novel alternatives to deal with 
renal failure (Brewster et a l, 2001; Brodie and Humes, 2005). The relatively long 
time window between the onset of symptoms of chronic renal failure and the
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progression of the disease to ESRF provides an ideal opportunity for intervention 
with a regenerative stem cell therapy.
1.3 Kidney development
1.3.1 Overview of mammalian kidney development: the 
pronephros, mesonephros and metanephros
The adult kidney is part of the urogenital system, which is mainly derived from 
the intermediate mesoderm of the mid-gestation mouse embryo (Saxen, 1987; 
Torres et al., 1995). The intermediate mesoderm is located between the paraxial 
mesoderm and the lateral plate mesoderm.
The coordinated differentiation of two different tissues derived from intermediate 
mesoderm gives rise to the urogenital system. One of these tissues is the ductal 
epithelium, which is responsible for generating the genital tracts, ureters and renal 
collecting duct system, and the other is the nephrogenic mesenchyme, which 
forms the nephrons of the mesonephric and metanephric kidney (Torres et al., 
1995).
The formation of the nephric duct is the first epithelial conversion that takes place 
during kidney development (Vize et al., 2003). The nephric duct, also called 
Wolffian or mesonephric duct, extends towards the caudal portion of the embryo 
bilaterally until it reaches the cloaca (Lanza et al., 2006). As the nephric duct 
extends caudally, the three embryonic kidneys, the pronephros, mesonephros and 
metanephros, develop sequentially (Figure 1-4) (Saxen, 1987; Torres et al., 
1995).
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The pronephros develops along the anterior part of the nephric duct and is 
comprised of a linear array of tubules that empty into the Wolffian duct (Saxen, 
1987; Torres et al., 1995). The pronephros is the most primitive of the three 
kidneys and in mammals the pronephric tubules are very rudimentary (Saxen, 
1987; Vize et al., 2003). Fish, including all teleosts, such as zebrafish (Danio 
rerio), and more primitive groups, such as lampreys and hagfish, and amphibians 
have well developed pronephroi that are only functional in larval stages and are 
replaced by the mesonephros in adult stages (Saxen, 1987; Vize et al., 2003).
In mammals, the mesonephros is the second kidney to form during development. 
The number of mesonephric tubules in mammals varies from 30 to 50 depending 
on the species (Saxen, 1987). Mesonephric nephron formation starts with the 
development of a mesenchymal condensate giving rise later on to renal vesicles 
and S-shaped bodies that connect with the Wolffian duct (Saxen, 1987). Different 
portions of the mesonephric nephron can be distinguished, such as the 
mesonephric corpuscle, proximal tubule, distal tubule, and collecting tubule. The 
maturation of the mesonephric nephrons closely resembles the maturation of 
nephrons in permanent kidneys. However, there are some noticeable differences; 
for instance the mesonephric nephrons lack a juxtaglomerular apparatus, the 
fenestration of capillaries is poor, and the glomerular basement membrane is 
















Figure 1-4 Diagram of the development of the vertebrate kidney showing (a) pronephros, (b) 
mesonephros and (c) metanephros (from Ashley Sawle with permission under the terms of 
the Creative Commons Attribution Sharealike 3.0 license, http://en.wikipedia.org/ 
wiki/File:Development_of_embyonic_nephrons.png).
The pronephros and mesonephros are transient structures in mammals that are 
later replaced by the metanephros, or adult kidney, which develops at the caudal 
end of the nephric duct (Lanza et al., 2006). Before birth, the embryonic kidneys 
and the adult kidneys are not essential for survival in many mammals, as has been 
proved by the live birth of many humans completely lacking kidneys (Vize et al.,
2003).
The adult kidney starts to form when a population of cells known as metanephric 
mesenchyme (MM) becomes demarcated in the caudal part of the intermediate 
mesoderm. MM is situated about 1-200 pm from the Wolffian duct and its
32
demarcation takes place at embryonic day 10 (E10) in mice and E30 in humans 
(Vize et al., 2003). The MM secretes some growth factors, such as GDNF and 
HGF, that induce the Wolffian duct to sprout and form the ureteric bud (UB), 
which elongates and invades the nearby MM (Saxen, 1987).
1.3.2 Ureteric bud development
After the UB invades the MM at E ll in mouse, the ends of the bud undergo a 
series of terminal bifurcations. During the first bifurcation, the UB divides into 
two branches that grow in opposite directions with an angle of approximately 
180°, giving rise to a T-shape structure. The process of branching continues with 
gradually decreasing angles (Lanza et al., 2006; Saxen, 1987). The pelvis and 
calyces are formed by remodelling of the first 6 to 10 branch generations of the 
UB while the final 6 to 10 form the collecting ducts (Woolf et al., 2004).
1.3.3 Nephron formation
The nephron is the basic functional unit of the kidney (Vize et al., 2003). Signals 
required for ureteric bud growth and branching are secreted by MM, while the 
UB provides the MM with the essential signals to condense around the ureteric 
bud tips and differentiate into the epithelium of the developing nephrons (Figure 
1-5) (Vize et al., 2003).
Cells from metanephric mesenchyme condense around the tips of the ureteric bud 
and differentiate to a polarized epithelium forming the renal vesicle. The renal 
vesicle elongates and forms the comma- and then the S-shaped body. In the S- 
shaped body, the most distal portion from the UB forms the glomerular
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epithelium comprised of visceral epithelium and the parietal epithelium of the 
Bowman’s capsule. Endothelial precursors invade this distal portion of the 
S-shaped body. The proximal end of the S-shaped body fuses with the ureteric 
bud and forms the distal tubule. The proximal tubule precursors are located 
between the proximal and distal parts of the S-shaped body. As the immature 
nephron continues to develop, the proximal tubules form a convoluted mass of 
epithelium which grows into the medullary area giving rise to the descending and 
ascending limbs of Henle’s loop (Vize et al., 2003). Finally the cells of the 
visceral epithelium, also known as podocytes, and the endothelial cells interact to 
form the filtration unit of the nephron. The capillary tuft is formed by the 
endothelial cells forming the capillaries and the mesangial cells that are highly 
specialized smooth muscle cells (Lanza et al., 2006).
1.3.4 Genes involved in kidney development
Metanephric kidney formation starts when MM demarcates in the intermediate 
mesoderm approximately at E10 (times given are for mouse development). MM 
expresses Pax-2 and WT1, two transcription factors that play an important role in 
kidney development. Another gene expressed in metanephric mesenchyme that 
has proved to be essential for ureteric bud invasion is Salll (Nishinakamura et al., 
2001).
Metanephric mesenchyme secretes glial-derived neural growth factor (GDNF) 
that interacts with the nearby Wolffian duct, which expresses the GDNF receptor 
c-Ret and its co-receptor GFR-la (Pachnis et al., 1993). As a result of these 
interactions the ureteric bud is induced to sprout at about E10.5; it then grows and
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Figure 1-5 Diagram showing reciprocal induction of metanephric mesenchyme and ureteric 
bud during kidney development, (a) MM demarcation, (b-c) Condensation of MM around UB 
tips. Mesenchymal to epithelial transition, (d-e) Formation of comma shaped body and S-shaped 
body formation, (f) Tubule maturation. Nephron and convoluted tubule formation. Reprinted by 
permission from Macmillan Publishers Ltd: Nature Reviews Cancer (Rivera and Haber, 2005), 
copyright (2005)
invades the metanephric mesenchyme at approximately El 1 (Vize et al., 2003). 
GDNF/c-Ret signaling is required for growth and branching of the UB within the 
MM, so it continues to be expressed once the ureteric bud has invaded the 
metanephric mesenchyme (Davies and Fisher, 2002; Pachnis et al., 1993). The 
transcription factor Emx-2 is required for the UB to continue expressing c-Ret 
after metanephric mesenchyme invasion (Pachnis et al., 1993).
As the ureteric bud grows and branches, it secretes some factors such as TGFa, 
TIMP-2, EGF and FGF-2 that prevent the metanephric mesenchyme cells from 
undergoing apoptosis (Coles et al., 1993).
35
Nephron formation starts approximately at El 1.5-12 when groups of cells in the 
metanephric mesenchyme expressing Pax-2, WT1, NCAM and other proteins 
condense around the tips of the ureteric bud (Vize et al., 2003).
The ureteric bud induces surrounding mesenchyme to form nephrons. Many 
different signals secreted by UB seem to induce the metanephric mesenchyme to 
undergo nephrogenesis.
Perantoni et al. (1995) showed that FGF-2 can mimic early events in nephron 
formation, inducing MM to condensate in the absence of an inductor tissue, 
however, no epithelial conversion was achieved. Another factor that seems to be 
relevant in nephrogenesis is leukemia inhibitory factor (LIF). LIF is secreted by 
UB, and in combination with FGF-2 induces nephron formation in 7 days 
(Barasch et al., 1999). A combination of FGF-2, LIF and TGF-0 induce nephron 
formation in isolated mesenchyme in 72 hours as in vivo (Plisov et al., 2001). 
When cells from metanephric mesenchyme condense around the tips of the 
ureteric bud they express Wnt4 (Kispert et al., 1998). Wnt4 expression is required 
for mesenchymal to epithelial transition of metanephric mesenchyme, and is 
therefore necessary for nephrogenesis to continue (Kispert et al., 1998; Stark et 
al., 1994).
Another important molecule in controlling morphogenesis of the kidney is bone 
morphogenic protein 7 (BMP-7). This morphogenic protein is secreted by 
metanephric mesenchyme and ureteric bud during kidney development 
(Vukicevic et al., 1996). The effect of BMP-7 in nephrogenesis seems to be dose 
dependent. Low concentrations of BMP-7 seem to promote ureteric bud
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branching whereas high concentrations seem to inhibit it. This may be a 
mechanism for balancing branching and nephrogenesis during development 
(Vukicevic et al., 1996).
1.3.5 Pax-2
Pax-2 encodes a paired box-containing transcription factor that plays an 
important role during kidney development (Dressier, 1996; Vize et al., 2003). 
Pax-2 expression in mouse is restricted to developing nervous and excretory 
systems (Nomes et al., 1990; Vize et al., 2003). During kidney development, 
Pax-2 is expressed in ductal epithelium and nephrogenic mesenchyme during 
development of the pronephros, mesonephros, and metanephros (Dressier et al., 
1990; Torres et al., 1995).
During renal development, Pax-2 is observed for the first time in the pronephric 
duct at about 12-13th somite, and as development progresses, Pax-2 is observed 
in Wolffian duct ~E9, and in the pronephric and mesonephric tubules (Dressier et 
al., 1990; Vize et al., 2003). Pax-2 is expressed in metanephric mesenchyme prior 
to ureteric bud invasion (Vize et al., 2003), and, as kidney development 
progresses, expression is up-regulated in condensed metanephric mesenchyme, 
renal vesicles, comma-shaped bodies, and the distal portion of the S-shaped body 
(Dressier, 1996; Dressier et al., 1990; Dressier and Douglass, 1992).
Homozygous Pax-2 mutant mice lack kidneys, ureters, and a genital tract (Torres 
et al., 1995). In these mutants, ureteric bud formation does not take place (Torres 
et al., 1995). These observations seem to show the crucial role of Pax-2 in early 
kidney development. Furthermore, Pax-2 expression seems to be essential for
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early epithelial differentiation as shown by its expression pattern during normal 
kidney development (Dressier, 1996; Rothenpieler and Dressier, 1993). Low 
Pax-2 protein levels lead to failure of the MM to aggregate and undergo 
morphological changes to nephron formation (Rothenpieler and Dressier, 1993).
Pax-2 is associated with cell proliferation and there is little expression observed 
in mature kidneys, with the exception of tubular regeneration as a consequence of 
kidney damage, or some renal tumors, such as renal cell carcinoma or Wilm’s 
tumor (Dressier and Douglass, 1992; Gnarra and Dressier, 1995; Imgrund et al., 
1999).
1.3.6 WT1
Wilms’ tumor suppression gene (WT1) encodes a zinc finger transcription factor 
(Yokoo et al., 2008). Initially WT1 was identified as the gene involved in Wilms’ 
tumor. Wilm’s tumor is an embryonic kidney neoplasia characterized by 
undifferentiated mesenchymal cells, poorly organized epithelium and surrounding 
stromal cells (Yize et al., 2003). Expression of WT1 in mouse embryo is first 
observed at E9.0 in the intermediate mesenchyme lateral to the coelomic cavity 
(Armstrong et al., 1993). A few hours later WT1 is expressed in differentiating 
heart mesothelium and in early mesonephric tubules (Armstrong et al., 1993). 
WT1 is expressed in uninduced MM approximately at El l ,  and by E l2.5 WT1 
expression is increased in the condensed MM of the developing metanephros 
(Armstrong et al., 1993). One day later, at about E13.5, WT1 is observed in 
nephrogenic condensations. As kidney development progresses at about E20
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WT1 is restricted to glomeruli (Armstrong et al., 1993). WT1 is not expressed in 
Wolffian duct or ureteric bud (Kreidberg et al., 1993).
It has been demonstrated that WT1 expression is essential for early kidney 
development. WT1 null mutant mice completely lack kidneys (Kreidberg et al., 
1993; Vize et al., 2003). In these mutants the ureteric bud never invades the 
metanephric mesenchyme, and without bud invasion MM quickly becomes 
apoptotic (Kreidberg et al., 1993; Vize et al., 2003).
Davies et al. (2003) showed that WT1 is not only required in early kidney 
development, but also plays an essential role in nephron formation. Davies et al. 
(2003) used small interfering RNA (siRNA) to suppress WT1 at different stages 
of kidney development, and showed that when WT1 is suppressed in MM at 
pre-epithelial stage, cells proliferate abnormally and do not differentiate into 
nephrons (Davies et al., 2003).
1.3.7 Comparison of Pax-2 and WT1 expression during kidney 
development
WT1 is expressed at low levels in uninduced metanephric mesenchyme where 
Pax-2 is also expressed (Ryan et al., 1995; Vize et al., 2003). By E12 when 
ureteric bud has invaded metanephric mesenchyme and has branched 4 to 8 times 
Pax-2 is highly expressed in condensed mesenchyme where WT1 is barely 
detected (Ryan et al., 1995). As nephrogenesis progresses, Pax-2 is maintained in 
condensing mesenchyme and comma-shaped bodies, and expression starts to 
decline in the proximal loop of the S-shaped bodies (Dressier and Douglass, 
1992; Ryan et al., 1995). As this happens, WT1 is expressed in the cells of the
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proximal portions of the S-shaped bodies where Pax-2 is downregulated. High 
levels of WT1 are present in the cells forming the glomerular epithelium (Ryan et 
al., 1995). High levels of Pax-2 and WT1 are not co-expressed during kidney 
development (Ryan et al., 1995).
1.3.8 Salll
Sal like 1 gene (Salll) is a mammalian homologue of the Drosophila 
region-specific homeotic gene spalt (sal) (Nishinakamura et al., 2001). During 
kidney development Salll is expressed in metanephric mesenchyme. 
Nishinakamura et al. (2001) showed that Salll expression in metanephric 
mesenchyme is required for ureteric bud invasion. As a result of homozygous 
deletion of Salll ureteric bud failed to invade the metanephric mesenchyme 
(Nishinakamura et al., 2001). Cells strongly expressing Salll have the potential to 
give rise to cell types in the nephron such as podocytes, and proximal and distal 
tubule cells (Osafune et al., 2006).
1.3.9 GDNF
Glial cell line-derived neurotrophic factor (GDNF) is a glycosylated, 
disulfide-bonded homodimer that is a distant member of the transforming growth 
factor-P (TGF-P) superfamily (Lin et al., 1993).
GDNF expression is first observed in nephrogenic cord in mouse embryos at E8.5 
(Sanchez et al., 1996). GDNF expression is later on restricted to metanephric 
mesenchyme approximately at E l0.5 (Sanchez et al., 1996).
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GDNF signal is transduced by a receptor complex formed by the GDNF receptor 
alpha (GDNFR-a) and the cRet receptor tyrosine kinase (Sainio et al., 1997; Vize 
et al., 2003). cRet is expressed in ureteric bud epithelium (Pachnis et a l, 1993) 
and is autophosphorilated once GDNF binds (Sainio et al., 1997).
GDNFR-a, one of the GDNF receptors, is expressed in metanephric mesenchyme 
and ureteric bud, however, it has been shown that GDNF binds exclusively to the 
tips of the ureteric bud branches where cRet receptor is expressed. In summary 
GDNF is involved in kidney development where it promotes ureteric bud 
outgrowth from Wolffian duct and is essential for ureteric bud branching (Sainio 
etal., 1997).
1.4 Stem cells in kidney repair
Stem cells are specialized cells with the ability of self-renewal. Self-renewing 
potential is the property of a cell to generate at least one daughter cell identical to 
the original cell (Lanza et al., 2006). Self-renewing allows stem cells to maintain 
the stem cell pool. Another property of stem cells is the potential to differentiate 
into a variety specialized cell types. Stem cells change to lineage commitment 
and give rise to progenitor, precursors and differentiated cells. When stem cells 
differentiate they acquire morphological, phenotypical, and functional 
characteristics of a specific cell type (Lanza et al., 2006).
Owing to their potential to give rise to specialized cell types, stem cells could be 
used to replace damaged tissues. According to Yokoo et al. (2008) two 
approaches could be used in order to repair kidney damage when renal structure
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is not completely lost. Resident stem cells in the kidney could be stimulated in 
order to make them differentiate to specific renal types and replace the lost tissue 
to restore functionality. A second approach could be to expand stem cells in vitro 
and differentiate them into the specialised cells required in the damaged kidney. 
However, if kidney structure has suffered extensive damage the whole kidney 
structure would need to be developed (Yokoo et al., 2008).
Different stem cells could be used to replace cells in damaged kidneys. It has 
been shown that stem cells from bone marrow have the potential to generate 
differentiated kidney cells such as mesangial cells (Imasawa et al., 2001), 
podocytes (Poulsom et al., 2001) and tubular cells (Gupta et al., 2002; Kale et al., 
2003).
Another approach for the stem cell therapy is the use of embryonic stem cells. 
Different groups have tried to generate kidney cells from embryonic stem cells 
(ES) (Bruce et al., 2007; Kim and Dressier, 2005; Vigneau et al., 2007). 
Embryonic stem cells are pluripotent cells, which mean that they have the 
potential to give rise to somatic cell lineages in the body (Lanza et al., 2006). It 
has been shown that mouse embryonic stem cells have the potential to generate 
cells expressing renal specific markers in vitro and in vivo (Bruce et al., 2007; 
Kim and Dressier, 2005; Vigneau et al., 2007). However, embryonic stem cells 
injected in vivo can generate tumours, which may limit their use in therapies to 
replace damaged tissues (Gomez and Thorgeirsson, 1998; Roufosse and Cook, 
2008).
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The third alternative to regenerate the tissue lost as a consequence of damage is 
the use of tissue specific stem cells (Ricardo and Deane, 2005). The advantage of 
using tissue stem cells is that they could be isolated from the patient, and 
therefore rejection would not be an issue when they were used later on to treat 
that patient. It is believed that tissue stem cells have some differentiation 
commitment, and that they may give rise to cells from their tissue of origin 
making the task of generating specific cell for that organ easier and avoiding 
formation of unwanted cells from other tissues (Bussolati et ah, 2008).
1.5 Evidence of tissue specific stem cells in adult kidney
Isolation of kidney stem cells has proved to be a difficult task due to the lack of a 
definitive marker characteristic of these tissue specific cells (Gupta and 
Rosenberg, 2008). A variety of different methods have been used in the attempt 
to isolate stem cells from kidneys in human and rodents including isolation using 
bromodeoxyuridine, identification of side populations by flow cytometry, 
selection using specific stem cell markers, and enrichment using selective culture 
conditions.
1.5.1 Bromodeoxyuridine labeling
Tissue stem cells in vivo present a low cycling rate. This property has been used 
to identify stem cells in kidney. When cells are labelled with bromodeoxyuridine 
(BrdU), it is incorporated into the DNA of the cells during DNA synthesis. Only 
slow cycling cells will retain the labelling.
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When Oliver et al. (2004) used this labelling technique to find kidney stem cells 
in rodents, they found a population of slowly cycling cells in the renal papilla 
retaining BrdU. These BrdU retaining cells disappeared from the papilla only 
after renal injury, suggesting a role in renal repair. In the papilla the majority of 
these BrdU retaining cells were located in the interstitium, but some were also 
located in the epithelium of tubules. Cells from the papilla were expanded in vitro 
and some of them, as previously described for metanephric mesenchyme cells 
(Oliver et al, 2002), were found to co-express epithelial and mesenchymal 
markers. Another interesting property of these papillary renal cells in culture was 
that they were able to form aggregates or spheres; this is a characteristic of 
embryonic stem cells and adult stem cells in culture. When the culture conditions 
of clones expanded from single cells were changed the cells changed phenotype. 
Cells expanded from single clones gave rise to a heterogenic population of cells 
and some of these cells expressed neuronal markers. These results suggested that 
renal papillary cells isolated by Oliver et al. (2004) were a pluripotent population 
able to generate different specialized cells.
Maeshima et al. (2006), on the other hand, described a population of low rate 
cycling cells (LRC) present mostly in proximal tubules, but also in distal tubules 
and collecting ducts, by BrdU labelling. They proposed that these low cycling 
cells present in the tubules, are an important contribution to regeneration after 
ischæmia.
Hoechst 33342 is fluorescent nuclear dye that is highly specific for thymine. In 
cells labelled with BrdU the thymidine has been substituted by the BrdU and thus
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these cells will only stain relatively weakly with Hoechst 33342. Maeshima et al. 
(2006) used this property to isolate the LRC population from adult kidney by 
fluorescence-activated cell sorting (FACS) and studied their properties 
(Maeshima et al., 2006). They were able to expand these cells in culture, and 
showed that their proliferation and differentiation properties were affected by 
factors present in conditioned media from a metanephric mesenchyme line. When 
the cells were grown in collagen they formed cysts and tubular structures. They 
also integrated into structures when injected in developing kidneys (Maeshima et 
al., 2006).
Although both experiments were done in rats, in the case of Maeshima et al. 
(2006; 2003) the low cycling cells were located in the tubules while the low cell 
cycling cells in the study of Oliver et al. were located in the interstitium of the 
papilla (Oliver et al., 2004). Maeshima et al. (Maeshima et al., 2006) proposed 
that these differences could be due to differences in the protocol followed for the 
BrdU labelling, and also the age of the animals used (Maeshima et al., 2003; 
Maeshima et al., 2006; Oliver et al., 2004).
1.5.2 Side populations
Goodell et al. (1996) proposed a new method for enriching hematopoietic stem 
cells from bone marrow. They stained murine bone marrow cells with 
Hoechst 33342 and identified a small cluster which displayed different staining 
patterns when analysed by FACS. This side population (SP) displayed phenotypic 
markers of hematopoietic stem cells.
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This approach has also been used to isolate kidney stem cells in rodents. Iwatani 
et al. (2004) isolated SP cells from adult rat kidneys. These cells did not seem to 
have any regenerative potential or engraftment when they were injected in rats 
with induced glomerulonephritis, nor did they demonstrate renal potential in 
vitro.
Hishikawa et al. (2005) isolated a side population in mouse kidney. The SP cells 
expressed musculin/MyoR, which was absent in the non-SP cells. These cells 
were located in the interstitial space. Injection of these cells to kidneys improved 
renal function in acute renal failure.
Challen et al. (2006) also isolated SP cells from adult mouse kidneys. These cells 
were located in proximal tubules and had the potential to differentiate in vitro to 
different lineages. The SP isolated in this study did not express musculin/MyoR. 
When these cells were injected after acute kidney injury, they seemed to improve 
renal function without significant tubular integration, suggesting that they may 
have a role in promoting repair (Challen et al., 2006).
1.5.3 Stem cells markers
Dekel et al. (2006) reported the existence in adult kidney of a population of non­
tubular cells expressing stem cell antigen-1 (Sca-1). Sca-1 is a cell surface marker 
for hematopoietic stem cells and tissue stem cells (Dekel et al., 2006; Kondo et 
al., 2003). Sca-1 positive cells were selected from the non-tubular fraction of 
adult mouse kidneys. Clones were derived from single cells and could be 
differentiated into myogenic, osteogenic, adipogenic, and neural cells. They also 
differentiated to a tubular phenotype when injected into renal parenchyma after
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acute renal injury (Dekel et al., 2006). These results suggested that a Sca-1 
population present in adult kidney may be multipotent stem cells (Dekel et al., 
2006).
1.5.4 Culture conditions
Another approach has been to isolate stem cells using selective culture conditions 
that favour the survival of stem cells over differentiated cells (Gupta et al., 2006). 
Gupta et al. (2006) plated disaggregated cells from rat kidney, and used 
expansion media that had previously been proved to support expansion of stem 
cells from human bone marrow (Jiang et al., 2002). They assumed that these 
culture media would promote expansion of potential stem cells present in rat 
kidney rather than differentiated cell types. These rat renal stem cells could self- 
renew, were clonogenic, and expressed undifferentiated markers, such as 
vimentin, Oct4, Pax-2 and CD90, but no differentiated markers. They could also 
differentiate in vitro to cells of all three germ layers, and could integrate and 
differentiate in vivo into renal tubules after acute renal damage.
A similar approach was used by Kitamura et al. (Kitamura et al., 2005), who 
dissected different portions of the nephrons from a rat kidney to find that the 
proximal tubules contained a fraction of the cells with high proliferation 
potential. Plating the cells at cloning density resulted in only a few cells forming 
colonies. From these cells they generated a cell line with high proliferation 
potential, potential to generate differentiated renal epithelial cells, and the ability 
to integrate in tubular epithelium after acute kidney damage.
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1.5.5 CD133 expressing cells in human kidney
Other evidence of the existence of renal resident stem cells in the adult human 
kidney was proposed by Sagrinati et al. (2006). They isolated another population 
of resident renal stem cells using CD133 and CD24 in the epithelium of the 
Bowman's capsule. These cells had properties of self-renewal and clonogenicity, 
and the capacity to differentiate in vitro into renal cells such as proximal and 
distal tubular cells, adipogenic and osteogenic cells, and neuronal cells. 
Intravenous injection of these cells into immunocompromised SCID mice that 
had acute renal failure resulted in regeneration of tubular structures (Sagrinati et 
al., 2006).
Bussolati et al. (2005) showed that the cortex of human adult kidney contained a 
population of cells that express CD 133 suggesting that they were renal stem cells. 
In a series of experiments they demonstrated that these cells were clonogenic and 
had the capability to self-renew and to differentiate in vitro into epithelial and 
endothelial lineages. This further reinforced the possibility that these cells 
represented an extant population of renal stem cells in adult kidney. These cells 
were also shown to co-express the transcription factor Pax-2, which plays a 
crucial role in urogenital development (Yize et al., 2003). Pax-2 is also highly 
expressed in the nephrogenic zone, but decreases when the cells begin to 
differentiate (Ryan et al., 1995).
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1.6 Animal model to study kidney stem cells
The fact that healthy human organs are used for transplantation makes it 
necessary to search for alternatives to study stem cells in organs. In humans 
nephrogenesis is complete before birth, by approximately during 38 week of 
gestation, however, in mice nephrogenesis continues after birth (Pierre et al., 
2008). This makes the mouse a convenient model for understanding the role of 
stem cells in forming nephrons. Furthermore, working with mice allows a 
complete study of the whole kidney, whereas working with human kidney is only 
possible with small biopsy samples made available for study.
1.7 Conditions to grow stem cells in vitro
Adhesion to an extracellular matrix is essential for the majority of the cells in 
order to survive and proliferate (Xu et al., 2001). Various studies have suggested 
that embryonic stem cells require fibroblast feeders in order to maintain their 
undifferentiated and pluripotent status in vitro (Thomson, 1998). However, 
several groups have successfully replaced fibroblast feeder cells with different 
extracellular matrix components such as fibronectin, laminin, collagens, or 
Matrigel™ (Klimanskaya et al., 2005; Rosier et al., 2004; Xu et al., 2001).
The feeders not only provide the stem cells with an adequate substrate to adhere 
to, but also secrete soluble factors to the media that may be important to maintain 
stem cells properties (Xu et al., 2001). When fibroblast feeders are substituted for 
deoxycholate treated fibroblast feeder cells or extracellular matrix proteins, the
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essential factors released by the feeders can be supplied using conditioned 
medium collected from fibroblasts (Rosier et al., 2004; Xu et al., 2001).
1.7.1 Substrates 
Matrigel
Matrigel™ is a soluble mix of extracellular matrix components produced by BD 
Biosciences (Franklin Lakes, New Jersey). The main components of Matrigel™ 
are laminin followed by collagen IV, heparan sulfate proteoglycan and entactin 
(Ohashi K. et al., 2006; Xu et al., 2001). Xu et al. (2001) demonstrated that 
human embryonic stem cells can be grown undifferentiated on Matrigel™ coated 
dishes.
Feeder cells
It is possible to grow embryonic stem cells (ES) in the absence of feeder cells, 
however, most of the research groups working with stem cells rely on the feeders 
to provide factors that promote proliferation and support the undifferentiated 
status of the stem cells.
The most commonly used feeders in stem cell cultures are primary cultures of 
mouse embryonic fibroblast (MEFs) or STO mouse fibroblast cell line. MEFs are 
a reliable and a potent source of feeders, however, as primary cells they have a 
limited life span and they need to be continuously replaced with fresh stocks 
(Hogan et al., 1994; Park et al., 2004; Wang et al., 2005).
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STO are a thioguanine- and oubain-resistant subline of SIM mouse fibroblast 
isolated by Dr. Bernstein (Martin and Evans, 1975). STO cell lines have been 
used as feeders to grow ES cells (Hogan et al., 1994).
Sodium deoxycholate treated STO feeders
Fibroblasts grown in vitro secrete a pericellular matrix that is rich in 
glycosaminoglycans such as hyaluronic acid, heparan sulphate, fibronectin, and 
procollagen types I and III. These components of the matrix are involved in cell 
adhesion (Hedman et al., 1978).
Hedman et al. (1979) developed a method to isolate the pericellular matrix of 
cultured fibroblast by treating the fibroblast with a sodium deoxycholate 
detergent solution. Klimanskaya et al. (2005) used this technique to remove 
fibroblast from culture and retain the extracellular matrix in order to use it as a 
substrate to grow stem cells. Human embryonic stem cells (hES) grown in 
deoxycholate treated feeders maintained normal karyotype, and expression of 
pluripotency markers such as Oct-4, SSEA-3, SSEA-4, Tra-1-60, and alkaline 
phosphatase (Klimanskaya et al., 2005). After six months undifferentiated in 
culture, the hES were able to give rise to cells from the three different germ 
layers. This method provides a substrate that allows the growing of stem cells 




The extracellular matrix (ECM) lies in the intercellular space providing physical 
support to tissues and organs (Ghajar and Bissell, 2008). The ECM is formed by a 
heterogeneous mix of water, saccharides, and protein components that can be 
classified into four groups: collagens, proteoglycans, non-collagenous 
glycoproteins and elastins. The ECM not only provides support for the cells in 
tissues, but it also affects cell functions by two mechanisms. Firstly, ECM 
functions as storage for molecules such as growth factors, cytokines, chemokines, 
and enzymes. Secondly, ECM proteins affect cell adhesion and migration by 
interacting with cellular receptors (Aszodi et al., 2006).
Fibronectin is an adhesive glycoprotein of high molecular weight present in the 
extracellular matrix. Fibronectin regulates some cell functions by interacting with 
other ECM molecules, integrins, and syndecans (Aszodi et al., 2006).
Most of the groups that isolated kidney stem cells plated the cells onto fibronectin 
after isolation of the cells (Bussolati et al., 2005; Gupta et al., 2006; Oliver et al., 
2004; Sagrinati et al., 2006).
1.7.2 Culture medium for expanding stem cells
The basal medium that have been used by most groups to grow embryonic stem 
cells consists of Dulbecco’s modified Eagle’s medium (DMEM) with high 
glucose (4500 mg/1) and addition of 1 mM of sodium pyruvate, 1 mM glutamine, 
0.1 mM P-mercaptethanol and 1% non-essential aminoacids (Bussolati et al., 
2005; Gupta et al., 2006; Peister et al., 2004; Sagrinati et al., 2006). Foetal calf 
serum is also added to this basal medium in a range of 10-20% (Hogan et al.,
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1994). However, to culture tissue stem cells various different basal media have 
been used containing a-modified minimum essential medium (aMEM), 
Dulbecco’s modified Eagle’s medium (DMEM), IMDM, RPMI-1640, DMEM- 
LG, or MCDB-201, and a standard protocol has not become established 
(Bussolati et al., 2005; Gupta et al., 2006; Peister et al., 2004; Sagrinati et al., 
2006).
1.8 Aims
The possibility of treating kidney disease with a regenerative or repair therapy 
based on adult stem cells taken from the patient promises a valuable alternative to 
transplant. Recent developments have shown that this is feasible for organs such 
as the bladder and lungs. The kidney represents a fundamentally more complex 
situation. The first step in developing such a therapy would be to isolate a 
population of stem cells capable of giving rise to the wide variety of cell types 
required to generate a functional nephron.
Recent studies have indicated that the existence of an extant population of kidney 
stem cells in adult human kidney is a possibility. Unfortunately working with 
human kidney samples is problematic and in the first instance an alternative 
model species is preferred. The mouse provides a suitable alternative, and has the 
advantage that nephrogenesis continues after birth, meaning that accessing tissue 
that is undergoing kidney development is relatively simple.
The following study was aimed, in the first instance, at investigating the existence 
of stem cells in postnatal mouse kidney. Firstly, to study how their prevalence
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and location alters during kidney development and later to determine whether or 
not it would be possible to identify a population of stem cells in mature kidney.
Following identification of stem cells in the post-natal kidney, the next step in the 
study was to isolate these kidney stem cells in order to further study their 
properties. Magnetic-activated cell sorting (MACS) was the preferred technique 
to separate the population of stem cells from the rest of the cells in the kidney. A 
series of lectins was screened in order to identify a suitable cell surface marker to 
bind the stem cells and separation using MACS was also performed.
As a variety of substrates and media have been successfully used to culture stem 
cells a study was undertaken, following isolation of the cells, to optimize the 
culture condition to promote expansion and self-renewal. Under these optimized 
conditions the putative stem cells were then assessed to determine whether they 
exhibited other properties of stem cells, such as the ability to form clones and the 
ability differentiate to specific renal or extrarenal cell types.
\
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Chapter 2: Materials and Methods
2.1 WTl-Cre/ROSA26 transgenic mice
Mice that were transgenic for the construct Rosa26R-lox-STOP-lox-LacZ were 
crossed with transgenic mice that expressed Cre recombinase under control of the 
WT1 promoter (Figure 2-1) (Wilm et al., 2005). In offspring that were transgenic 
for both constructs the activation of the WT1 promoter would result in the 
expression of Cre recombinase, which would then permanently remove the stop 
sequence between the lox sites in the Rosa26R-lox-STOP-lox-LacZ construct. 
This would cause transcription of the LacZ reporter gene resulting in expression 
of (3-galactosidase. The expression of P-galactosidase would continue even after 
WT1 expression had ceased allowing cells that had previously, but no longer, 
expressed WT1 to be identified. Offspring transgenic for both constructs were 
selected and their kidneys were isolated 7 days after birth. Transgenic mice 
strains were created by Bettina Wilm, University of Vanderbilt, who then 
supplied the 7 day old kidneys (Wilm et al., 2005).
2.2 Kidney Dissection
2.2.1 Embryonic kidney rudiment
Pregnant CD-I mice (Charles River, UK) were sacrificed at 11.5 days following 
timed mating with CO2 and/or cervical dislocation. Embryos were removed from 
uteri of pregnant mice at embryonic day 11.5. Embryos were placed in a dish 
containing dissecting media (see Kidney rudiment culture medium, page 81). 
Using a 25 gauge hypodermic needle (Becton Dickinson, New Jersey, USA) the
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Figure 2-1 Schematic illustrating WTl-Cre/ROSA26R transgenic strategy. Mice transgenic 
for R26Rosa-lox-STOP-Lox-LacZ in which a stop sequence is separating the reporter gene LacZ 
from the Rosa26 promoter were crossed with mice transgenic for WTl-Cre recombinase. 
Offspring carrying both constructs were selected. In cells that express WT1, cre-recombinaseis 
expressed, causing recombination of the lox sites and removal of thestop sequence. The 
recombination event is irreversible and thus the WT1 expressing cells and their descendants 
permanently express LacZ. Lox sites in the diagram are represented by green triangles (Diagram 
provided by Bettina Wilm).
embryos were decapitated. Embryos were dissected under a Nikon SMZ1000 
zoom stereomicroscope (Nikon Instruments Inc, Melville, USA). Transverse 
incisions were made caudally and rostrally to the hind limb bud using the 
hypodermic needles. A sagittal section was then made through the spinal cord of 
the isolated hind limb region to separate the left and right sides. Finally, the limb 
was removed from the base of each side and the kidney rudiments were exposed. 
The hypodermic needles were use to tease the surrounding tissue away from the 
kidney rudiment, thus freeing it.
2.2.2 Neonatal and adult kidney
CD-1 mice (Charles River) were sacrificed with CO2 and/or cervical dislocation. 
The mice were laid on their back and sprayed with 70% ethanol in order to reduce
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the contamination with hair during the dissection. The skin was removed and the 
abdominal cavity was opened using surgical scissors (Sigma) and watchmaker 
forceps (Sigma). The internal organs were removed and the kidneys extracted.
2.3 Preparation of frozen mouse kidney sections
Whole kidneys were surgically removed from CD1 mice (Charles River) at 
different ages: 1 day old, 6 days old, 2 weeks old, three weeks old, and adult. At 
least three mice, from different litters, were analysed per time point. Mice were 
sacrificed with CO2 and/or cervical dislocation.
2.3.1 Fixation and mounting of kidneys
The kidneys were fixed in 4% (w/v) paraformaldehyde (PFA) (Sigma, Poole, 
UK) in phosphate buffered saline (PBS) (see “Buffer recipes”, page 82) for 1 
hour at room temperature in the dark. In the case of adult kidneys, the kidneys 
were cut into 3 parts and left in PFA for 4 hours. The kidneys were then washed 
three times in PBS and mounted on a Peel-A-Way® embedding mould 
(Polysciences Europe GmbH, Eppelheim, Germany) using cryo-embedding 
solution (cryo-M-bed, Bright Instruments Company Ltd. Huntingdon, UK), and 
were then frozen in liquid nitrogen-chilled isopentane (Sigma). Transverse 
sections of the frozen kidneys were cut at 7 pm using a cryostat set at -20 °C 
(HM505N, Microm International, Walldorf, Germany) and C35 Feather 
microtome blades (VWR. Lutterworth, UK). The sections were placed on 
gelatine/CrKS0 4  subbed (see Preparation of subbed slides, page 58) twinfrost
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glass microscope slides (76x26x0.8 mm) (VWR). Frozen sections were stored at 
-80 °C.
Seven day old WTl/Cre recombinase P-galactosidase transgenic mice kidneys 
were received in PBS already fixed in 4% PFA. The same protocol for 
embedding was followed as described above.
2.3.2 Preparation of subbed slides
Slides were soaked for 10-15 minutes in absolute ethanol (University of 
Liverpool solvents service) and washed five times in reverse osmosis water. The 
slides were then immersed for 25 seconds in a solution of 0.5% (w/v) gelatin 
from porcine skin type A (Sigma) and 0.05% (w/v) of CrKSCL (Sigma) in reverse 
osmosis water.
2.4 Immunostaining
2.4.1 Immunostaining of frozen sections
After being removed from the -80 °C freezer, the sections were left for 5 minutes 
at room temperature to defrost. The position of the sections on the slide was 
marked by circling them with a hydrophobic pen (DAKO, Copenhagen, 
Denmark) to delineate the area of tissue to be stained. The samples were blocked 
for one hour at room temperature with 0.1% Triton X-100 (Sigma) and 10% (v/v) 
serum (Sigma) in PBS. The serum used in the blocking, primary antibody, and 
secondary antibody solutions was goat, bovine, or chicken serum (Sigma) 
depending on the antibody used. When possible, the serum used for blocking was 
from the species in which the secondary antibody was raised.
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After one hour the blocking solution was removed, and the sections were 
incubated with the primary antibody solution, which contained the primary 
antibody, or for dual staining two primary antibodies, in 0.1% (v/v) Triton X-100 
and 1% (v/v) serum in PBS. The section was then left overnight at 4 °C in a 
humidified chamber. Details of the different primary antibodies used are given in 
Table 2-1. The next day the slides were washed three times in PBS at room 
temperature, before being incubated with the secondary antibody in 0.1% Triton 
X-100 and 1% (v/v) serum in PBS for two hours at room temperature in a 
humidified chamber in the dark. Details of the different secondary antibodies 
used are given in Table 2-2. The sections were then washed three times in PBS at 
room temperature. The blocking solution and the primary and secondary antibody 
solutions were centrifuged prior to use at 13400x g for 6 minutes in a 
Microcentaur centrifuge (Sanyo Electric Co., Ltd, Osaka, Japan).
Finally, to visualize the nuclei of the cells, the sections were incubated with DAPI 
(4',6-diamidino-2-phenylindole, dihydrochloride) (Invitrogen, Paisley, UK) 
1:100,000 in PBS for 3 minutes at room temperature. The sections were then 
washed three times in PBS at room temperature, and mounted in Dakocytomation 
fluorescent mounting medium (DAKO). Clear nail polish was then applied to seal 
the slides. The sections were observed under a Leica DM2500 fluorescence 
microscope (Leica, Heidelberg, Germany), and images were captured using a 
DFC350FX camera. Samples were also observed under LEICA AOBS SP2 
confocal microscope.
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Table 2-1 Primary antibodies used in this study.
Antibody Host Isotype Concentration Supplier
Pax-2 Rabbit Polyclonal IgG 1:200 Covance
P-Galactosidase Rabbit Polyclonal IgG 1:5000 Cappel/ICN
(3-Galactosidase Chicken Polyclonal IgG 1:750 Abeam
WT1 clone 6F- 




WT1 Rabbit Polyclonal IgG 1:500 Sigma
pan Cytokeratin Mouse MonoclonallgG1/lgG2a
1:500 Sigma
AQP1 Goat Polyclonal IgG 1:200 Santa Cruz
AQP2 Goat Polyclonal IgG 1:200 Santa Cruz
PECAM-1
(CD31)
Rat Monoclonal lgG2a 1:100 BD Pharmingen
vW F Rabbit Polyclonal IgG 1:100 Sigma
aSM A Mouse Monoclonal lgG2a 1:500 Sigma
Synaptopodin Mouse Monoclonal lgG1 ready to use Fitzgerald
Podocin Rabbit Polyclonal IgG 1:500 Alpha D iagnostic
Calbindin Rabbit Polyclonal IgG 1:200 Chemicon
Table 2-2 Secondary antibodies used in this study.
Antibody Host Isotype Concentration Supplier
anti-m ouse AlexaFluor® 488 Goat i g d 1:500 Invitrogen
anti-m ouse AlexaFluor® 488 Goat lgG2a 1:500 Invitrogen
anti-m ouse AlexaFluor® 594 Donkey IgG 1:500 Invitrogen
anti-goat AlexaFluor® 488 Donkey IgG 1:500 Invitrogen
anti-rabbit AlexaFluor® 594 Chicken IgG 1:500 Invitrogen
anti-rabbit AlexaFluor® 594 Goat IgG 1:500 Invitrogen
anti-chicken AlexaFluor® 488 Goat IgG 1:400 Invitrogen
anti-rat AlexaFluor®488 Chicken IgG 1:1000 Invitrogen
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In every staining a negative control, in which the primary antibody was omitted, 
was included in order to ensure that non-specific binding of the secondary 
antibody was not occurring.
Wild-type mouse kidneys were used as controls for p-galactosidase 
immunostaining in experiments using transgenic mouse kidneys.
2.4.2 Immunostaining of cultured cells
Before the cells were stained, the culture medium was aspirated from the dishes 
and the cells were fixed for 10 minutes in 4% (w/v) PFA (Sigma) in PBS at room 
temperature and in the dark. After fixation the dishes were washed three times in 
PBS at room temperature and a ring was drawn with the hydrophobic pen 
(DAKO) around the area of cells. The cells were immunostained as described 
above.
2.4.3 Immunostaining of kidney rudiments
In order to stain kidney rudiments, the kidneys from El 1.5 embryos were 
dissected and plated in a tissue culture petri dish (Sigma) for 48 hours in kidney 
rudiment culture medium. Then the rudiments were fixed for 20 minutes in 4% 
(w/v) PFA. The dishes were then washed three times in PBS at room temperature. 
The kidney rudiments were double stained for Pax-2 and WT1 as described 
above. The rudiments were then mounted in Dakocytomation fluorescent 
mounting medium (DAKO) and observed under LEICA AOBS SP2 confocal 
microscope.
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2.5 Quantification of Pax-2 during kidney development
To quantify Pax-2 expression at different stages of kidney development kidneys 
were collected from mice at 3, 7, 14, and 21 days after birth. Three different 
kidneys were analysed per time point, and three different sections per kidney 
were studied. Kidneys were stained for Pax-2 (Covance) and nuclei were 
counterstained with DAPI. Images of the cortex-medulla and the papilla at 20x 
magnification were taken with a Leica DM2500 microscope using a DFC350FX 
camera.
Image J software (Rasband, 2008) was used to quantify the fluorescence intensity 
of Pax-2 and DAPI. Grayscale tiff images for each stain were thresholded at 30 to 
255, and the number of selected pixels and signal intensities were measured 
(Figure 2-2). The ratio of total Pax-2 intensity to total DAPI intensity for each 
field of view was calculated. The mean Pax-2:DAPI ratios for the four time 
points were compared using an ANOVA, and a Tukey HSD post hoc test was 
applied to identify significantly different time points.
2.6 Lectin staining
The frozen sections were thawed at room temperature for 5 min. The kidney 
sections were co-stained with Pax-2 and a lectin. The sections were washed three 
times in Tris buffered saline (TBS) (see Buffer recipes, page 82), and incubated 
with the lectin at a concentration of 10 pg/ml (v/v) in TBS for 2 hours at room 
temperature. After the incubation time the lectins were washed three times in 
TBS.
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Figure 2-2 Pax-2 and DAPI levels in kidney sections were measured using Image J.
(a) Micrograph showing immunostaining of a section of 3 day old mouse kidney for Pax-2 (red).
(b) Grayscale equivalent of (a); the intensity of Pax-2 staining is represented by the whiteness of 
each pixel, which can be measured on a scale of 0 (black) to 255 (white), (c) Histogram of the 
intensity of all pixels in the micrograph. The red region represents the “thresholded” pixels, in this 
case those with a signal intensity of 30 or greater. The integral of this area gives a measure of the 
total level of signal from Pax-2 staining on the slide, (d) A visual representation of the 
thresholding applied in (c), all pixels selected using this thresholding are coloured red.
The sections were then blocked with 0.1% (v/v) Triton X (Sigma) and 10% (v/v) 
chicken serum (Sigma) in PBS for one hour at room temperature. After 
incubation time the blocking solution was aspirated and immunostained for Pax-2 
and DAPI as described previously. Pax-2 was visualized with a secondary 
antibody conjugated with AlexaFluor® 594.
The lectins used were taken from the Fluorescein Lectin Kit I, the Fluorescein 
Lectin Kit II, and the Fluorescein Lectin Kit III (Vector Laboratories Ltd., 
Peterborough, UK). All the lectins were directly conjugated with fluorescein.
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The lectins contained in the kits were concanavalin A (Con A), Dolichos btflorus 
Agglutinin (DBA), peanut agglutinin (PNA), Ricinus communis Agglutinin I 
(RCA 120) , soybean agglutinin (SBA), Ulex europaeus Agglutinin I (UEA I), 
Wheat germ Agglutinin (WGA), Griffonia (Bandeiraea) simplicifolia Lectin I 
(GSL I), Lens culinaris Agglutinin (LCA), Phaseolus vulgaris Agglutinin (PHA- 
E), Phaseolus vulgaris Agglutinin (PHA-L), Pisum sativum Agglutinin (PSA), 
Succinylated WGA (sWGA), Sophora japonica Agglutinin (SJA), Datura 
stramonium Lectin (DSL), Erythrina cristagalli Lectin (ECL), Griffonia 
(Bandeiraea) simplicifolia Lectin II (GSL II), Jacalin, Lycopersicon esculentum 
(Tomato) Lectin (LEL), Solanum tuberosum (Potato) Lectin (STL), Vicia villosa 
Lectin (VVL).
2.7 Alkaline phosphatase staining
The medium was aspirated from the cells and they were washed once in Tris-HCl 
pH 9.2. Tris-HCl was aspirated and the alkaline phosphatase solution was added 
to the cells and incubated at room temperature for 5-20 min. The alkaline 
phosphatase staining solution was prepared by adding 2 mg of naphthol AS-MX 
phosphate (Sigma) and 10 mg of Fast Red TR (Sigma) to 10 ml Tris-HCl pH 9.2. 
The alkaline phosphatase staining solution was removed from the cells and they 
were then rinsed once in Tris-HCl.
2.8 Disaggregation of neonatal mouse kidneys
The following disaggregation protocol was based on those described by Cook et 
al. (1987) and Vielhauer et al. (2003).
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The kidneys were surgically removed from 2-6 days old CD-I mice immediately 
after killing the animals by CO2 and/or cervical dislocation. The kidneys were 
placed in cold Paris Buffer (see Buffer recipes, page 82). The kidneys were cut 
into small pieces of <1 mm in ice-cold Paris Buffer, transferred to a 15 ml 
centrifuge tube (Falcon), and left for a few minutes for the tissue pieces to settle 
under gravity. The Paris buffer was removed and the kidneys were washed three 
times by re-suspending them in Hank’s buffered saline solution (HBSS) with 
calcium and magnesium (Gibco), leaving them for a few minutes to settle under 
gravity, and then removing the supematant.The kidneys were then immersed for 
20 min at 37 °C in the enzymatic solution containing 1 mg/ml of collagenase 
type I (Sigma) and 0.1 mg/ml of deoxyribonuclease I (DNase I) (Sigma) in HBSS 
containing calcium and magnesium (Invitrogen).
The cell suspension was washed two times with HBSS containing calcium and 
magnesium at room temperature. Between washes the cells were left to settle for 
a few minutes under gravity.
The tissue was incubated in 0.5 mM EDTA (Sigma) for 20 minutes at 37 °C. The 
supernatant, containing isolated individual cells, was then removed and kept on 
ice.
The remaining pellet was incubated with 5 ml of 1 mg/ml collagenase I in HBSS 
containing calcium and magnesium for 20 minutes at 37°C.
After the incubation, the whole suspension was passed twice through a 21-gauge 
needle and then twice through a 23-gauge hypodermic needle, and left to settle on 
ice for 5-10 min. Both supernatants were pooled and centrifuged for 2.5 minutes
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at 200x g and washed twice in HBSS (containing calcium and magnesium) at 
room temperature, after which, the pellet was re-suspended in 1 ml of the HBSS. 
The cell suspension was then poured gently into a 15 ml falcon tube containing 
7 ml of HBSS containing calcium and magnesium, so that the cell clumps settled 
at the bottom of the tube, whilst individual cells remained in suspension. After 
1 0  minutes the supernatant containing individual cells was collected and the 
pellet discarded.
The whole cell suspension was passed through a 30 pm pre-separation filter, 
centrifuged for 2.5 min at 2 0 0 x g and re-suspended in MACS® separation buffer 
(10% BSA) (Miltenyi biotec) for MACS isolation of the cells, or in normal 
culture medium if the cells were to be plated without MACS separation.
2.9 Isolation of cells using magnetic cell sorting (MACS®)
Six kidneys were disaggregated as described above to obtain a total of 2.5x106 
cells. Cells were counted in a Neubauer haemocytometer (Hausser Scientific, 
Horsham PA, USA). Disaggregated kidney cells were divided into three equal 
fractions. One fraction was used as a control, and no isolation procedure was 
performed on it. The second fraction was incubated with magnetic beads coated 
with PNA lectin (LodeStars™ 2.7 Carboxyl. Polymer laboratories) for 1.5 h at 
37 °C under agitation, and the third fraction was incubated with uncoated beads 
under the same conditions.
Cells incubated with magnetic beads were passed through a MS column (Miltenyi 
Biotec) that was placed in a magnetic field (MiniMACS™ separator, Miltenyi
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Biotec). The column was then washed through with MACS separation buffer and 
the washed fraction, containing the cells that were not retained by the magnetic 
field, was collected; hereafter referred to as the unselected fraction. The cells 
bound to the magnetic beads (PNA-coated and control) were retained in the 
column.
The magnetic field was then removed, and the fraction of cells retained by the 
magnetic field was collected by washing the column with MACS separation 
buffer; hereafter referred to as the selected fraction. The selected fraction was 
seeded onto 3.5 cm tissue culture dishes coated with a monolayer of STO feeder 
cells and Advanced DMEM serum free medium. Two dishes were cultured per 
fraction. One dish was fixed in 4% (w/v) PFA after 24 h, and the other was 
expanded in culture for further analysis. This experiment was performed three 
times.
The dishes fixed 24 h after plating were stained for Pax-2 and PNA lectin. Ten 
different fields of view at 2 0 x magnification were analysed per fraction. The total 
number of cells was established by counting the number of cells stained with 
DAPI, and the number of cells positive for Pax-2 was also counted. The 
percentage of Pax-2 positive cells was then established.
Cells were analysed after two weeks in culture. They were fixed in 4% PFA and 
stained for Pax-2. The number of colonies on each dish was counted, and the 
colonies were classified as Pax-2 positive or Pax-2 negative. When more than 
50% of the cells in a colony were positive the colony was considered Pax-2
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positive, and when less than 50% of the cells in the colony were negative, the 
colony was considered negative.
2.9.1 Removal of magnetic beads
The following disaggregation protocol was based on the protocol described by 
Gomez et al. (1998). After MACS, the fractions of cells selected with PNA were 
resuspended in 1 ml of Hank’s buffer saline solution (HBSS) containing 5% fetal 
calf serum (FCS) and 200 mM D-galactose (Vector laboratories), and incubated 
for 10 min at room temperature with rotation. The suspension was passed through 
the columns placed in the magnetic field, and was then washed 5 times with 
HBSS with 5% FCS. The cells were centrifuged at 2 0 0 x g for 5 min and 
resuspended in the adequate growth media.
2.10 Cell culture
All the cells used in this study were kept in a cell incubator at 37 °C and 5% CO2 
(Sanyo). Along the study, the cells were grown on different substrates with 
different culture media. All the protocols for coating the culture dishes and media 
recipes are listed below; however, details on how particular cells were cultured 
and the conditions used are explained in the relevant chapters.
2.10.1 Routine subculture
During this study all the cells were subcultured using the following protocol. The 
cell culture medium was removed and the cells were washed two times in PBS 
without calcium and magnesium (Invitrogen) that had been pre-warmed to 37 °C. 
The cells were detached from the dishes using a mixture of trypsin and EDTA
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(Sigma) in PBS without calcium and magnesium to a final concentration of 
0.05% trypsin/0.02% EDTA. The cells were incubated in the trypsin/EDTA for 
approximately 5 min at 37 °C, and gently shaken to detach the cells. Then the 
trypsin/EDTA was neutralized by adding Dulbecco’s modified Eagle medium (D- 
MEM) (Invitrogen) supplemented with 10% (v/v) FCS (PAA. Pasching, Austria). 
The suspension containing the cells was then centrifuged at 200x g for 2.5 min. 
The supernatant was aspirated, and the pellet containing the cells was 
resuspended in the growth medium.
2.10.2 Preparation of culture substrates 
Preparation of Matrigel coated dishes
Matrigel® (Becton Dickinson, Oxford, UK) was thawed at 4 °C overnight on ice. 
Glass and plastic pipettes, pipette tips, tissue culture plates and microcentrifuge 
tubes (Eppendorf, Hamburg, Germany) were kept at -20 C until they were 
needed. The Matrigel® stock was diluted 1:2 (v/v) in cold Knockout™ DMEM 
(Invitrogen) and stored in aliquots at -20 °C.
To prepare Matrigel® coated plates, the aliquots were thawed slowly at 4 °C and 
diluted at 1:15 (v/v) in cold Knockout™ DMEM (Invitrogen) (for a final dilution 
of 1:30). The diluted Matrigel® was added to 3.5 cm cell culture dishes (Nunc, 
Rochester, NY). The dishes containing Matrigel® were kept at 4 °C for up to a 
week before they were used. The Matrigel® solution was removed immediately 
before use.
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Gelatinisation o f  cell culture dishes
Cell culture dishes (Nunc) were coated with 0.1 % (w/v) porcine gelatin solution 
(Sigma) in distilled water for 30 min at room temperature.
Routine subculture o f  STO cells
The STO (Sandoz inbred mouse embryo-derived thioguanine and ouabain- 
resistant) fibroblast cell line was a gift from Neil Smyth (University of 
Southampton, UK). STO cells were thawed from frozen stocks and cultured in 
DMEM with 10% added serum (see Culture media, page 78) in 10 cm cell culture 
dishes (Coming. NY, USA).
After 3 days, when the cells were confluent, the cells were detached from the 
tissue culture dish using trypsin/EDTA as described above. After trypsinization 
the cells were resuspended in DMEM with 10% added serum and re-plated onto 
fresh gelatinized culture dishes (Coming).
Preparation o f  STO feeder cell layers
When STO cells were confluent, they were treated with 20 pg/ml of mitomycin-C 
(Sigma) in DMEM with 10% added serum, and incubated at 37 °C in a 
humidified incubator in an atmosphere of 5% CO2 for 2.5 h. After the incubation 
time, the mitomycin-C was aspirated and the cells were washed two times in 
10 ml PBS (calcium and magnesium free) pre-warmed to 37 °C. The cells were 
then trypsinized, as previously described, and split into 3.5 cm gelatinized tissue 
culture dishes (Nunc). Every 10 cm dish with confluent STO cells was split into 
sixteen 3.5 cm STO feeder cell dishes.
Preparation of STO feeder cell layers
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Culture medium was removed from STO feeder dishes and the cells were washed 
three times in warm PBS (Invitrogen). The PBS was aspirated and a solution 
containing 0.5% sodium deoxycholate and 1 mM phenylmethyl sulfonylfluoride 
in 10 mM Tris-Cl buffered saline at pH 8.0 was added to the cells. The cells were 
incubated in this solution for thirty minutes at 4 °C on a rocking platform 
(Hedman et al., 1979). The deoxycholate solution was removed and the dishes 
were washed 5 times in PBS. The cells were kept at 4 °C until use.
Fibronectin coated dishes
Cell culture dishes (Nunc) were coated with a 50 pg/ml solution of fibronectin 
(Chemicon) in PBS without calcium and magnesium, and incubated for 1 h at 
37 °C. The fibronectin solution was aspirated immediately before plating the 
cells.
Sodium deoxycholate treated STO feeders
2.11 Differentiation of kidney stem cells
2.11.1 In vitro differentiation of KSC
Putative kidney stem cells (pKSC) (see Chapter 6 , Characterisation and 
differentiation of putative KSC) were plated onto uncoated plastic culture dishes 
(Nunc). The media used was DMEM with 10 % added serum (see Culture media, 
page 78). The media was changed every two days and the cells were subcultured 
when confluent.
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2.11.2 Extrarenal differentiation: Adipogenesis
For adipogenic differentiation, pKSC and differentiated putative kidney stem 
cells (dpKSC) were incubated for 2-3 weeks in adipogenic medium (see 
Adipogenic medium, page 81). The cells were fixed as described above and were 
stained for 20 min with 0.5% (w/v) oil red O (Sigma) in isopropanol (Sigma). 
The cells were washed three times in distilled water to remove excess dye, 
mounted in 80% (v/v) glycerol in water (Sigma) and were observed under a Leica 
DM2500 microscope (Leica). Images were captured using a DFC350FX camera.
2.12 Integration of kidney stem cells into developing 
kidney rudiments
A pregnant CD-I mouse (Charles River) was sacrificed at 11.5 days following 
timed mating by cervical dislocation, and the embryos were isolated. Twelve 
kidney rudiments were dissected from El 1.5 mouse embryos and placed in a 
1.5 ml microcentrifuge tube containing 100 pi of kidney rudiment culture 
medium (see Kidney rudiment culture medium, page 81).
Twelve kidney rudiments were dissected from 11.5 day mouse embryos as 
described above. Kidney rudiments were transferred into a 3.5 cm dishes 
containing 2x trypsin/EDTA (Sigma), and incubated for five minutes at 37 °C 
and 5% CO2. After the trypsin incubation step, the kidneys were transferred to a 
fresh dish containing the kidney rudiment culture medium, and left for 15 minutes 
at 37 °C to inhibit the trypsin.
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The kidneys were transferred to a fresh 1.5 ml microcentrifuge tube containing 
100 ¡0.1 of kidney rudiment culture medium, and were dissociated by gentle 
pipetting in order to disrupt cell aggregates.
Putative kidney stem cells (pKSC) were labelled with 
Vybrant® carboxyfluorescein diacetate, succinimidyl ester cell tracer kit 
(Invitrogen). A 3.5 cm confluent culture dish containing pKSC was trypsinized as 
described before (see routine subculture section) and incubated in 1 ml of cell 
tracker staining solution (0.5 pM of cell tracker in Advanced DMEM medium). 
The cells were incubated at 37 °C 5% CO2 for 45 minutes. The cells were then 
washed three times by adding 3 ml of Advanced DMEM medium at room 
temperature and centrifuging at 1400x g  for 3 minutes. The cells were 
resuspended in 1 ml of Advanced DMEM and they were counted using a 
haemocytometer (Hausser Scientific).
The 100 pi solution containing disaggregated cells was mixed by gentle pipetting 
with 100 pi of Vybrant®-labelled kidney stem cells in a ratio of 2:1 (two parts 
kidney cells to one part labelled KSC). The cell suspension was then centrifuged 
at 1,400x g  for 3 min in order to obtain a compact pellet.
The pellet was then collected with a pipette and placed on a 1.2 pm isopore 
membrane filter (Millipore; Sigma). The filter was then placed on a stainless steel 
metal grid inside a culture dish containing the culture medium which reached the 





Filter m em brane
Figure 2-3 Diagram showing transfilter culture of kidney aggregate.
The cells were cultured for 24 h in kidney rudiment culture medium with 20 pM 
of the Rho-kinase inhibitor Y27632 (Calbiochem). The media was then replaced 
with kidney rudiment culture medium without Y27632. The kidney rudiment was 
fixed after 4 days in 4 % (w/v) PFA for 45 minutes in the dark at room 
temperature. After fixation the kidney rudiments were washed three times in PBS 
and stained for Calbindin as described in the immunostaining section (page 58).
This protocol to integrate kidney stem cells into developing kidney rudiments 
was kindly provided by Mathieu Unbekandt from the University of Edinburgh.
2.13 Cell growth curves
In order to compare the growth rates of pKSC and dpKSC the proliferation rates 
were measured and growth curves were established. The cells in both conditions 
were subcultured when they were confluent, approximately every 2-3 days, and 
the number of cells counted over seven passages. Three different replicates were 
performed per condition. A linear regression analysis was performed to determine 
the rate of proliferation as a function of time. From the results of the regression 
the time required for a doubling of the population was calculated for each group.
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2.14 Clonogenic assay
In the first attempt cells were trypsinized and single cells were pipetted with a 
mouth pipette (Sigma) and plated in a 96 well plate (Nunc). The experiment was 
repeated twice. The cells were cultured in STO conditioned medium 2.5% FCS. 
In the second experiment the cells were trypsinised, and were resuspended in 
DMEM with 10% FCS at a final density of 1 cell per 50 pi. Cells were plated in 
96 well plates (Coming® Costar® Sigma) at 50 pi per well, in order obtain one 
cell per well. All the wells were examined, and wells containing no cells or more 
than one cell were discarded. Three replicates of this experiment were performed.
2.15 RT-PCR
2.15.1 RNA extraction
To isolate RNA from cultured cells, first the cell medium was removed from the 
culture dishes containing the isolated kidney cells, and 1 ml of TRIzol® Reagant 
(Invitrogen) was added. The TRIzol was left for a few minutes, and then the cells 
were lysed by pipetting. The TRIzol/cell solution was then transferred to a 1.5 ml 
microcentrifuge tube.
When embryonic kidney rudiments were collected for RNA extraction, five 
kidney rudiments were place in a microcentrifuge tube containing 1 ml of TRIzol, 
and they were homogenized using a pellet pestle motor and a polypropylene 
pestle (Sigma).
RNA extraction for both cells and kidney rudiments then proceeded as follows. 
2 0 0  pi of chloroform were added, and the samples were mixed by inversion for
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15 seconds. The samples were then centrifuged at 4 °C for 15 minutes at 
1 2 ,0 0 0 x g, which separated the mixture into three distinct phases.
The upper aqueous phase, containing RNA, was transferred to a fresh 
microcentrifuge tube containing 1 pi of glycogen (1 pg/pl) (Boehringer 
Mannheim GmbH, Mannheim, Germany) and 0.5 ml of isopropanol (Sigma). The 
contents of the tube were then mixed by inverting five or six times. The samples 
were incubated overnight at -20 °C.
The chilled samples were centrifuged at 4 °C for 10 minutes at 12,000x g. The 
supernatant was discarded and 1 ml of 75% ethanol (diluting ethanol absolute for 
molecular biology (Sigma) in nuclease-free water (Sigma) was added to wash the 
pellet. The pellet was washed by vortexing, and was then settled by centrifugation 
at 4 °C for 5 min at 4,400x g. The ethanol was removed from the RNA samples 
by pipetting, and the pellets were left to air dry for a few minutes. The RNA 
pellets were finally dissolved in 15 pi of nuclease-free water (Sigma).
2.15.2 DNase treatment
For DNAse treatment 8 pi of RNA solution was incubated with 1 pi of RQ1 
DNase buffer (Promega, Madison, WI, USA) and 1 pi of DNase (Promega) for 
30 min at 37 °C. After the incubation, 1 pi of Stop Buffer (Promega) was added 
and the solution was incubated for a further 15 minutes at 60 °C.
The concentration and quality of the extracted RNA were measured using a 
NanoDrop™ 1000 Spectrophotometer (NanoDrop Technologies, Wilmington, 
USA). RNA quality was assessed using the 280/260 nm and 280/230 nm
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absorbance ratios. The former ratio provides an assessment of RNA integrity, 
while the latter provides an indication of contamination of the sample with salts 
or organic compounds. Sample with either ratio less than 1.8 were discarded.
2.15.3 cDNA synthesis
For cDNA synthesis, 5 pi of nuclease-free water and 2 pi of a 100 ng/pl stock 
solution of random hexamers (Abgene, Portsmouth, USA) were added to 5 pi of 
DNase treated RNA, and the samples were incubated at 80 °C for 3 min. The 
samples were chilled briefly on ice and the tubes were pulse centrifuged to collect 
the contents. In the next step, 4 pi 5 x 1st strand buffer (Invitrogen), 2 pi of 
100 mM DTT (dithiothreitol) (Invitrogen), and 1 pi 10 mM dNTP mix (Bioline 
Ltd, London, UK) were added to the sample. The reaction mixture was mixed 
gently, and then incubated at 42 °C for 2 min. After 2 minutes, 1 pi of Superscript 
III™ reverse transcriptase (Invitrogen) was added. The samples were then 
incubated for 60 minutes at 50 °C, followed by a final incubation step at 70 °C 
for 15 min to inactivate the enzyme. The samples were stored at -20 °C until they 
were used.
2.15.4 Oligonucleotide primers
All primers were obtained from Sigma. The primers were resuspended in 1 x TE 
buffer (Cambrex, Rutherford, NJ) to a final concentration of 100 pM. Working 
dilutions of 5 pM were prepared in nuclease-free water (Sigma) and kept at 
-20 °C until they were needed. All the primers were used at 0.2 pM.
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2.15.5 PCR
The 20 pi PCR reaction consisted of 2 pi of 10x NH4 Buffer (Mg2+ free), 0.5 pi of 
MgCb Solution (50 mM), 0.5 pi dNTP mix (10 mM stock), 0.5 pi Taq DNA 
polymerase (all from Bioline), 0.8 pi of the forward and reverse primers 
(0.5 pM), 14.4 pi of nuclease-free water (Sigma), and 0.5 pi of cDNA 
( 2 0 0  ng/pl).
The cycling conditions were as followed: An initial step of 3 minutes at 94 °C, 
followed by 38 cycles of 94 °C for 30 seconds, 62 °C for 30 seconds and 72 °C 
for 45 seconds, followed by a final extension of 72 °C for 10 min.
The PCR products were detected by gel electrophoresis on a 1.5% (w/v) agarose 
gel (Bioline) in lx TAE, with ethidium bromide solution (Sigma) added to the gel 
at the concentration 0.5 pg/ml. 2 pi of 6 x loading buffer (see Buffer recipes, page 
82) was added per 5 pi of sample, and the samples were run for 30 minutes at 
100 V. The gel was visualized with a UV transilluminator (Chemilmager 4400, 
Alpha Innotech Corporation, San Leandro, CA, USA).
In all PCR reactions Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was 
used as reference gene.
2.16 Culture media
DMEM with 10% added fetal calf serum
• High glucose Dulbecco’s Modified Eagle medium (DMEM) (without sodium
pyruvate, with 4,500 mg/1 Glucose) (Invitrogen)
• 10% FCS (PAA)
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Table 2-3 Table showing the primers used in this study. The specificity of 
primers designed in-house was determined by sequencing of PCR products 
(University of Dundee sequencing service). F -  forward primer; R -  reverse 
primer.
Prim er Sequence Produ  ct size
Source
Pax-2 F: G CG TCCTTCCTATCCCGATG 
R: TTG CCTG AG AACTCG CTCCC
303 bp in-house
WT1 F: CCAG TG TAAAACTTG TCAG CG A 234 bp
(Yam am oto
R: TGGGATG CTG G ACTG TCT e t  a/., 2006)
GDNF
F: TG CCAG CCCAG AG AATTCCA 
R: AG CCTTCTACTCCG AG ACAG
176 bp in-house
Sall1
F: G CACATG G G AG G CCAG ATCC 
R: G G AAG CG TCCG CTG ACTTG G
141 bp in-house
Podocalyxin
F: CACG G G AG TCCCATTAG AG A 179 bp
(K ram er e t
R: T G ACAT GG AAGCCC ACT AC A at., 2006)
Synaptopodin
F: GCC AGGG ACC AGCC AG AT A
73 bp
(Orth e t al.,
R: AG G AG CCCAG G CCTTCTCT 2005)
ZO-1
F: CTCATAG TTCAACACAG CCT 
R: TCATCTTCATCTTCTTCCACAG
148 bp (O safune e t  
al., 2006)
Desmin
F: CTCAAGG CCAAACTACAG G A 
R: CAGAATCGAATCCCTCAACG 133 bp in-house
Megalin F: CCTTGCCAAACCCTCTG AAAAT 562 bp
(Erranz e t
R: CACAAG G TTTG CG G TG TCTTTA al., 2004)
CD2AP F: TG AG G TAG G G CCAG TCAAAG 504 bp (K ram er e tR: CG AG TT GGGG AAAT CAT CAG al., 2006)
THP F: CTAACCCATCCTTG CCTTT 250 bp
(K ram er e t
R: TCACACACCAG CCCATCAC al., 2006)
Ksp-cadherin F: G CCG TG G CT ACTTT ACCT CT CT GTT A R: TG ATAG G ACAATG TG G CCTTCATCTC 165 bp
(K ram er e t  
al., 2006)
N eph l F: G TG G CCTG G CATG TAAAAAT 167 bp (K ram er e tR: CTAG ACATTG G CCG CG TATT al., 2006)
V im entin F: TCTTG ACCTTGAACGGAAAGTG R: CACATCG ATCTG G ACATG CT 123 bp in-house
Cytokeratin8
F: AG G AGCTTATGAACGTCAAG
161 bp
(O safune e t
R: CCCATAGGATGAACTCAGTC al., 2006)
VEGF F: GAG AT AG AG T AC AT CTT C AAGCC R: TTTCTTTGGTCTGCATTCAC 201 bp in-house
GAPDH F: T  G AAGCAGGC AT CT GAGGG R: CTTTGGTCCGGATG ATCCTG 110 bp in-house
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• 2 mM L-glutamine (Invitrogen)
• 1:100 (v/v) 1 OOx non-essential amino acids (Invitrogen)
Advanced DMEM
• Advanced DMEM (Invitrogen)
• 2 mM L-glutamine (Invitrogen)
• 5 (iM P-mercaptoethanol (Invitrogen)
• 1:100 (v/v) penicillin/streptomycin (Gibco) was added to the medium during 
the first 2-3 weeks after kidney isolation to prevent infections and omitted 
later on.
Advanced DMEM with growth factors
• Advanced DMEM (Invitrogen)
• 2 mM L-glutamine (Invitrogen)
• 5 pM P-mercaptoethanol (Invitrogen)
• 100 ng/ml of FGF-2 (Sigma)
• 50 ng/ml and BMP-7 (Abnova, Taiwan)
STO-conditioned medium with 2.5% FCS
STO-conditioned medium was Advanced DMEM in which STO cells had been 
grown for two days, according to the following protocol.
When STO cells became confluent DMEM with 10% FCS medium was removed 
from the cells and replaced with Advanced DMEM. The STO cells were gown in 
Advance DMEM for a further two days and then treated with mitomycin C. The
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STO feeder cells were then subcultured and grown in Advanced DMEM. The 
conditioned media was collected after two days and replaced with fresh 
Advanced DMEM. After two more days the conditioned media was collected and 
the STO feeder cells were discarded. Collected media was either stored at 4 °C 
for immediate use or at -20 °C for up to 2 weeks.
Prior to use STO conditioned media was centrifuged at high speed, and only the 
supernatant was collected in order to exclude unwanted STO cells and debris. 
Conditioned medium was then mixed in a 1:1 ratio with fresh Advanced DMEM 
contained 5% FCS.
Kidney rudiment culture medium
• Minimum Essential Medium (MEM) (Invitrogen)
• 2 mM L-glutamine (Invitrogen)
• 1:100 (v/v) penicillin/streptomycin (Invitrogen)
Adipogenic medium
From Peister et al. (2004):
• DMEM (Invitrogen)
• 10% FCS
• 1 x 106 M dexamethasone (Sigma)
• 5 pg/ml insulin (Sigma)
• 50 pM indomethacin (Sigma)




From Cook et al. (1987):
• 20 mM Tris/HCl (Sigma)
• 125 mM NaCl (Sigma)
• 10 mM KC1 (Sigma)
• 10 mM sodium acetate (Sigma)
• 5 mM glucose (Sigma)
2.17.2 Phosphate buffered saline (PBS)
From Hogan et al. (1994):
• 0.137 M NaCl (Sigma)
• 2 mM KC1 (Sigma)
• 6 mM, Na2HP0 4  (Sigma) 
pH adjusted to 7.4-7.6
2.17.3 Tris buffered saline (TBS) lOx
From IHC world (IHC world, 2007):
• 0.5 M Tris base (Sigma)
• 9% NaCl (Sigma) 
pH adjusted to 7.6
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2.17.4 Tris-acetate-EDTA (TAE) 50x
• 242 g Tris base (Sigma)
• 57.1 ml glacial acetic acid (Sigma)
• 100 ml 0.5 MEDTA (Sigma) 
pH adjusted to 8.0
2.17.5 Gel-loading buffer 6x
From CSH protocols (Cold Spring Harbor laboratory, 2006):
• 3 ml glycerol (Sigma)
• 25 mg bromophenol blue (Sigma)
• 10 ml of distilled H2O (Sigma)
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Chapter 3: The location, prevalence and origin of 
Pax-2 positive cells in the postnatal mouse kidney
3.1 Introduction
Several approaches have been attempted, during the past few years, to identify 
and isolate renal stem cells in humans and rodents. These have included isolation 
of low cycling cells (Maeshima et al., 2003; Maeshima et al., 2006; Oliver et al.,
2004), the identification of side populations using FACS (Challen et al., 2006; 
Hishikawa et al., 2005; Iwatani et al., 2004), the use of specific culture conditions 
that favoured the proliferation of stem cells over differentiated cells (Gupta et al., 
2006; Kitamura et al., 2005), and the use of specific stem cell markers (Bussolati 
et al., 2005; Dekel et al., 2006; Sagrinati et al., 2006). Cells isolated using these 
techniques have presented various characteristics indicative of stem cells, such as 
clonogenicity and the expression of markers characteristic of undifferentiated 
cells (Bussolati et al., 2005; Challen et al., 2006; Dekel et al., 2006; Gupta et al., 
2006; Hishikawa et al., 2005; Kitamura et al., 2005; Maeshima et al., 2006; 
Oliver et al., 2004; Sagrinati et al., 2006). Furthermore, they have been shown to 
be capable of differentiation to a variety of specialised cell types (Bussolati et al., 
2005; Challen et al., 2006; Dekel et al., 2006; Gupta et al., 2006; Kitamura et al., 
2005; Maeshima et al., 2006; Oliver et al., 2004; Sagrinati et al., 2006), and 
integration into developing kidney structures (Maeshima et al., 2006). They have 
also been indicated as having a role in renal regeneration following acute injury 
(Challen et al., 2006; Dekel et al., 2006; Hishikawa et al., 2005; Kitamura et al., 
2005; Oliver et al., 2004; Sagrinati et al., 2006).
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The cell surface antigen CD 133 has been successfully used to isolate progenitor 
cells from human tissue (Florek et al., 2005; Yin et al., 1997). CD133, also 
known as prominin-1 , is a glycoprotein containing five transmembrane domains 
with an extracellular N-terminus and a cytoplasmic C-residue. It has a molecular 
weight of 120 kDa in humans and 115 kDa in mice (Shmelkov et al., 2005; 
Weigmann et al., 1997).
CD 133 polyclonal antibody detects prominin-1 in epithelial cells; in the case of 
the kidney this includes the brush border of the proximal tubular cells both in 
humans and mice (Florek et al., 2005). The monoclonal antibody AC 133 binds a 
glycosylation-dependent epitope of CD 133. The AC 133 antigen is down- 
regulated when cell differentiation occurs, and it is therefore this antibody that 
has been identified as being specific to human progenitor cells (Florek et al., 
2005; Yin et al., 1997). The marker is a reliable indicator of progenitor cells as its 
expression is generally restricted to stem cells and progenitor populations, such as 
hematopoietic stem cells (Miraglia et al., 1997; Yin et al., 1997), endothelial 
progenitor cells (Peichev et al., 2000), human central nervous system stem cells 
(Uchida et al., 2000), and human embryonic epithelia (Corbeil et al., 2000; 
Weigmann et al., 1997). However, the monoclonal antibody AC 133 was raised in 
mice (Bussolati et al., 2005; Cai et al., 2005; Corbeil et al., 2000; Yin et al., 
1997), and does not react with mouse protein (Prof. Giovanni Camussi, 
University of Turin, pers. comm.).
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Bussolati et al. (2005) showed that a population of CD133 expressing cells is 
resident in adult human kidney, and that these cells, when isolated, demonstrated 
properties that suggested that they may be renal stem cells.
Human and mouse prominin-1 are highly related proteins that share 
approximately 60% amino acid-sequence identity (Corbeil et al., 1998), and they 
are both widely expressed in embryonic and adult tissue (Weigmann et al., 1997; 
Yin et al., 1997).
Cells expressing the marker CD 133 have been successfully isolated from adult 
human kidney, and have furthermore been shown to possess stem cell like 
properties (Bussolati et al., 2005; Sagrinati et al., 2006). The cells identified by 
Bussolati et al. (2005) using CD 133 were found in the interstitium of the renal 
cortex and co-expressed the transcription factor Pax-2. The lack of expression of 
hematopoietic markers CD34 and CD45 excluded the possibility that they 
originated from circulating hematopoietic stem cells that had become resident in 
the kidney and further supported the inference that the expression of Pax-2 
suggested a renal origin. Pax-2 is essential in normal kidney development and is 
expressed in a similar pattern during kidney development in mice and humans 
(Dressier et al., 1990; Eccles et al., 1992; Ryan et al., 1995).
All of these findings suggest the possibility of the existence of a progenitor 
population in mice similar to that previously described in humans. However, 
while these cells would be expected to express Pax-2, they would not express the 
AC 133 epitope recognised by the CD 133 monocolonal antibody. Pax-2 therefore
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is more likely than CD 133 to be an amenable marker for putative kidney stem 
cells in murine kidney.
Both metanephric mesenchyme and ureteric bud express Pax-2 in the early stages 
of kidney development (Ryan et al., 1995). The ureteric bud is responsible for the 
formation of the collecting ducts, and only the cells from metanephric 
mesenchyme form the nephrons (Saxen, 1987). Therefore it would be necessary 
to determine the origin of Pax-2 positive cells found in postnatal mouse kidney to 
ensure they have nephrogenic potential. While both cell populations express 
Pax-2, only metanephric mesenchyme expresses the transcription factor WT1 
(Figure 3-1) (Yize et al., 2003).
To determine the origin of Pax-2 cells, WTl-Cre/Rosa26R mice were used 
(supplied by Dr Bettina Wilm, University of Liverpool). WTl-Cre is a transgenic 
line with Cre recombinase under the control of the WT1 promoter. Rosa26R is a 
transgenic line in which Cre-mediated recombination activates expression of the 
P-galactosidase reporter gene. When cells in WTl-Cre/Rosa26R mice express 
WT1, they also express Cre recombinase, which activates P-galactosidase, this 
recombination event is irreversible. In these transgenic mice WT1 expressing 
cells and their progeny will permanently express p-galactosidase (Figure 2-1).
In conclusion, it would be very important to determine whether a population of 
Pax-2 positive cells, as found in humans, is also present in mice. Furthermore, if 
such a population is present, it would also be necessary to establish the 
embryonic origin of the Pax-2 positive cells present in postnatal mouse. If these 
Pax-2 cells had a ureteric bud origin it would mean that they would be unlikely to
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have any nephrogenic potential, in contrast, proving a metanephric mesenchymal 
origin would indicate that these cells could potentially form nephrons.
Figure 3-1 Fluorescence micrographs showing immunostaining of cultured kidney 
rudiments and 1 day old mouse kidney for Pax-2 and WT1. (a) Kidney rudiments of El 1.5 
embryo cultured for two days showing Pax-2 expression in ureteric bud (arrow) and metanephric 
mesenchyme (arrowhead) and WT1 expression in metanephric mesenchyme (arrowhead), (b) 
Cortex of 1 day old mouse kidney showing Pax-2 positive cells in the nephrogenic area (arrow) 
and WT1 in some cells of the nephrogenic area (arrow) and developing glomerular epithelium 
(arrowhead), (c) Papilla of 1 day old mouse showing Pax-2 positive cells and absence of WT1 
expression. Scale bars 100pm.
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3.1.1 Aims
In order to investigate if postnatal mouse kidney contains a population of Pax-2 
positive cells equivalent to the Pax-2 population found in human kidney, 
immunostaining for Pax-2 was performed at different stages of kidney 
development.
To trace the lineage derivatives of metanephric mesenchyme and determine 
where Pax-2 positive cells originate, transgenic mice were used to permanently 
label WT1 expressing metanephric mesenchyme cells and their descendants.
3.2 Results
3.2.1 The location of Pax-2 positive cells in the postnatal mouse 
kidney
Pax-2 expression in day 1 mouse kidney
In neonatal mice at day 1 (dl), the expression of Pax-2 appeared very similar to 
the expression observed in late embryonic kidney by Dressier et al. (1992). Pax-2 
was found to be expressed in the nephrogenic area in the outer cortex, 
specifically, in the condensed mesenchyme surrounding the ureteric bud, in the 
comma-shaped bodies, the S-shaped bodies, and in the tips of the ureteric bud 
(Figure 3-2). Pax-2 positive cells were also present in some of the tubular 
structures in the cortex and outer and inner medulla. A high number of Pax-2 
positive cells were found in the renal papilla at this stage. Some cells appeared to 
express higher levels of Pax-2 than others. Most of the Pax-2 positive cells in the 






Figure 3-2 Confocal micrographs showing Pax-2 expression in frozen sections of 1 day old 
neonatal mouse kidney. An image of the cortex from a control staining in which the primary 
antibody was omitted is also shown. The images are representative of five individual kidneys, me 
-  medulla, ex -  calyx, pa -  papilla. Scale bars: 100 pm.
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in the interstitial space. No staining was observed when the primary antibody was 
omitted.
Pax-2 expression in day 7 mouse kidney
By day 7 (d7), the number of Pax-2 positive cells in the cortex had dramatically 
decreased, with only a few small condensates of five or six cells and some tubular 
structures still displaying expression (Figure 3-3). In the medulla, Pax-2 positive 
cells were observed in some tubules of the inner medulla close to the calyces. 
Although the number of Pax-2 positive cells in the cortex was much lower than at 
d l, in the papilla of d7 mice the number of Pax-2 positive cells appeared 
comparable to that at dl (Figure 3-3). No staining was observed when the 
primary antibody was omitted even though a higher reddish background was 
detected compared with control in which the primary antibody had been omitted 
at day one.
Pax-2 expression in day 14 mouse kidney
When the kidneys of day 14 (dl4) mice were analysed, the pattern of expression 
was found to be similar to that of d7 mice. In the cortex and medulla there were 
clearly fewer Pax-2 positive cells than at dl, but some Pax-2 positive cells were 
observed in tubular structures (Figure 3-4). In the papilla, on the other hand, the 
number of Pax-2 positive cells remained high and appeared comparable to that at 






Figure 3-3 Confocal micrographs showing Pax-2 expression in frozen sections of 7 day old 
neonatal mouse kidney. An image of the cortex from a control staining in which the primary 
antibody was omitted is also shown. The images are representative of five individual kidneys. 





Figure 3-4 Confocal micrographs showing Pax-2 expression in frozen sections of 14 day old 
neonatal mouse kidney. The images are representative of five individual kidneys. Scale bar: 
100 pm.
Pax-2 expression in adult mouse kidney
In adult mouse kidney very few Pax-2 positive cells were observed in the cortex 
and medulla (Figure 3-5). Some Pax-2 positive cells were present in the papilla, 
but the numbers were significantly diminished in comparison with all the 
previous time points. No staining was observed in a slide in which the primary
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Figure 3-5 Confocal micrographs showing Pax-2 expression in frozen sections of adult 
mouse kidney. The images are representative of five individual kidneys, co -  cortex, pa -  papilla. 
Scale bars: 100 pm.
3.2.2 The prevalence of Pax-2 positive cells in the postnatal mouse 
kidney
In order to study the prevalence of Pax-2 cells in postnatal mice, the ratio of all 
the cells (DAPI) compared with the cells expressing Pax-2 was compared 
between kidneys of mice at different ages. Levels of Pax-2 were studied in two 
different regions: the cortex-medulla and the papilla.
In the cortex-medulla (Figure 3-6), analysis of variance (ANOVA) showed a 
significant difference in Pax-2:DAPI ratio between the time points {p = 0.017). A 
Tukey's honest significant difference post hoc test was then applied to determine
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which time points were significantly different to one another. This showed a 
significant difference in Pax-2 levels between days 3 and 7 (p = 0.025), when 
there was almost a 6 fold decrease in the mean ratio. The data also shows 
significant differences in cortex-medulla between day 3 and days 14 (p = 0.031) 
and 21 (p = 0.042). While the latter two time points showed less of a decrease in 
Pax-2 expression relative to day 3 than did day 7, there was no significant 
difference between days 7, 14, and 21 (p > 0.9).
In papilla (Figure 3-7), ANOVA showed no significant difference in Pax-2 
expression levels between any time points (p > 0.05).
(a) (b)
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Day 7 0.025 - -
(N ’ Day 14 0.031 0.998 -






Q_ T - Mean a
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* Day 14 0.262 0.14
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Days After Birth
Figure 3-6 Comparison of Pax-2:DAPI signal ratios in the cortex and medulla of kidney 
from mice at days 3, 7, 14, and 21. Three different slides were analysed for each kidney and 
three different kidneys were analysed per time point. Images were captured at 20x magnification, 
(a) Mean Pax-2:DAPI ratio for each kidney at each time point, (b) p  values for comparison of 
Pax-2:DAPI ratio using Tukey's Honest Significant Difference test subsequent to significant 






Day 3 1.2 0.616
Day 7 1.221 0.485
Day 14 0.888 0.651
Day 21 0.19__________0.109
3 7 14 21
Days After Birth
Figure 3-7 Comparison of Pax-2:DAPI signal ratios in the papilla of kidney from mice at 
days 3, 7, 14, and 21. Three different slides were analysed for each kidney and three different 
kidneys were analysed per time point. Images were captured at 20x magnification, (a) Mean Pax- 
2:DAPI ratio for each kidney at each time point. No significant differences between time points 
found with ANOVA p  =  0.121. (b) Mean Pax-2:DAPI ratio for each time point and standard 
deviations (a).
3.2.3 The origin of Pax-2 positive cells in the postnatal mouse 
kidney
WTl-Cre positive metanephric mesenchyme cells were permanently labelled 
with the expression of LacZ transgene and they were detected with staining for 
P-galactosidase. The transgenic kidneys were co-stained for P-galactosidase and 
Pax-2 to determine whether any of the p-galactosidase positive cells in the papilla 
were also expressing Pax-2. The results showed that many of the Pax-2 positive 
cells found in papilla in d7 mice also expressed P-galactosidase (Figure 3-8c and 
d). No P*galactosidase+/ Pax-2- cells were found in papilla.
In the cortex some P-galactosidase positive cells were found in the renal 
corpuscle, these cells were negative for Pax-2 (Figure 3-8a). Surprisingly, very 
few P-galactosidase positive cells were found in the renal tubules. Due to the 
metanephric mesenchymal origin of the nephron, all the renal tubules were
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expected to express P-galactosidase. However, some cells contained in tubular 
structures in the renal cortex were Pax-2 positive even if they did not present 
P-galactosidase staining. Some P-galactosidase positive cells were found in 
tubular structures of the medulla (Figure 3-8b).
Wild type kidneys were stained for P-galactosidase to rule out any endogenous 
activity of the enzyme and some background was observed, however, it did not 
seem to be due to specific staining (Figure 3-9a). Also, staining in which the 
primary antibody had been omitted was performed on the transgenic kidney 
sections and no specific staining was observed (Figure 3-9b).
To estimate the proportion of Pax-2 positive cells expressing P-galactosidase, 
cells in four different fields of view using the 40x objective were counted. It was 
found that between 40-49% of the cells expressing Pax-2 in papilla were also 
expressing P-galactosidase (Table 3-1).
Table 3-1 Table summarising the proportion of Pax-2 positive cells 
expressing p-galactosidase in papilla. The results collected in the table were 
from four different fields of view on the same slide, the images were taken with a 
confocal microscope using the 40x immersion oil objective. In column one, the 
different fields of view are shown. In column 2, the number of Pax-2 positive 
cells counted in the field. In column three the number of P-galactosidase positive 
cells in the fields. In the last row, percentage of co-expression is shown.
Field of view Pax-2 +ve Beta gal +ve Co-expression (%)
1 45 18 40%
2 74 36 49%
3 108 53 49%








































































































































































































































































































































Figure 3-9 Confocal micrographs showing control slides for Pax-2 and fl-galactosidase 
immunostainings. (a) Cortex of wild type kidney section stained for Pax-2 (red) and 0- 
galactosidase (green), (b) Cortex of WTl-Cre transgenic mouse kidney where primary antibodies 
were omitted from staining; the sections were incubated with Alexa Fluor® 594 chicken anti­
rabbit IgG, and AlexaFluor® 488 goat anti-chicken IgG antibodies. Scale bars 100 pm.
3.3 Discussion
In this chapter, it has been shown that a population of Pax-2 positive cells is 
present in the papilla of postnatal mouse kidney following the completion of 
nephrogenesis. It was found that the number of Pax-2 positive cells in the papilla 
remained constant up to three weeks following birth, but appeared to decrease in 
adult mice. Lineage tracing studies showed that at least half of the Pax-2 positive 
cells in the papilla were derived from WT1 positive cells, suggesting that their 
origin was the metanephric mesenchyme.
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Pax-2+ cells are located in the papilla of the postnatal mouse 
kidney
In mature human kidney, Pax-2 was found to be expressed in a stem cell 
population within the renal cortex (Bussolati et al., 2005). In contrast, this study 
showed that in mature mouse kidney, Pax-2 positive cells were almost 
exclusively present in the renal papilla. Although this seems to suggest that the 
distribution of Pax-2 positive cells in mature human and mouse kidney is 
different, however, the papilla of human kidney has not yet been analysed for the 
presence of Pax-2 positive cells. Furthermore, the human kidney samples 
analysed in the Bussolati study comprised regions of apparently ‘normal’ tissue 
excised from kidneys afflicted with renal carcinoma. It is therefore possible that 
Pax-2 positive stem cells present in the cortex of these human kidneys might have 
arisen from the renal carcinoma, for it has been shown that Pax-2 is expressed in 
the majority of clear cell renal carcinomas, which is the most common form of 
renal cancer (Mazal et al., 2005). It is difficult to perform a detailed study of the 
distribution of Pax-2 positive cells in normal human kidney because of the high 
demand of such organs for transplantation. In future, it would be interesting to 
investigate the distribution of Pax-2 positive cells in non-human primate and 
porcine kidney to determine if the expression profile of this protein in mouse is 
similar to that of other mammals.
A hypothesis of the current study is that the Pax-2 positive cells present in the 
papilla of the postnatal mouse kidney represent a stem cell population. Oliver et 
al. (2004) found a population of low rate cycling cells in the renal papilla, which 
they suggested were possible stem cells. In contrast with the present findings the
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majority of these cells were located in the interstitium, with some in tubular 
epithelial cells. On the other hand, Maeshima et al. (2006; 2003) identified a 
similar population of low rate cycling cells present in different fractions of renal 
tubules, rather than in the interstitium. The difference in location between these 
papers could be explained by the differences in the protocol used for BrdU 
labelling, by the age of the animals, or even by the species.
Among the Pax-2 positive cells in the papilla, different levels of expression were 
observed. A previous report had shown that Pax-2 is re-expressed in proximal 
tubules after damage, and these Pax-2 expressing cells have the potential to 
dedifferentiate and proliferate in order to replace the damaged tubular cells 
(Imgrund et al, 1999). Therefore, one possible explanation for the differences in 
Pax-2 levels in the papilla is that expression levels could be related to the 
differentiation state of the cells. Cells with higher levels of Pax-2 expression may 
be in a less differentiated state than those presenting lower expression, and could 
therefore have more differentiation potential.
The number of Pax-2 positive cells in the mouse papilla is 
decreased in the adult
In this study, the number of Pax-2 positive cells in the papilla appeared to be 
reduced compared with 3 week old adolescent mice. If the Pax-2 positive cells 
are indeed stem cells, the reduced numbers in the adult might suggest that the 
number of stem cells reduces with age. The adults used in this study were young 
adults of about 8-10 weeks. Although beyond the scope to this study, it would be 
interesting in future to determine the number of Pax-2 positive cells at 6 months
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and 12 months to investigate the effect of ageing on the number of Pax-2 positive 
cells. However, it is interesting to note that Cai et al. (2005) showed that a high 
number of Pax-2 positive cells were present in the papilla of adult mouse kidney. 
Therefore, it is possible that the reduced number of Pax-2 positive cells observed 
here could have been due to technical problems related to the fixation procedure, 
given the fact that the size of the kidneys was significantly bigger than at the 
earlier time points and so penetrability of the fixating agent could have had an 
adverse effect on subsequent staining.
Lineage tracing of Pax-2 positive cells
The renal papilla is the region of the kidney where the collecting tubules empty 
urine into the renal pelvis. Therefore, although this region contains the tips of the 
some of the loop of Henle, most of the tubules are collecting tubules derived from 
the UB. In early kidney development, Pax-2 is expressed in both MM and in the 
UB. Although MM cells can give rise to UB cells and their derivatives, it has 
been established that UB cells have a more limited potential and cannot give rise 
to the cells of the nephron (Qiao et al., 1995). It was therefore important to 
confirm that at least some of the Pax-2 positive cells in the papilla were derived 
from MM rather than UB. The results showed that 40-50% of Pax-2 positive cells 
were derived from WT1-expressing cells. Given that in the developing kidney, 
the MM but not the UB expresses WT1, this result shows that the Pax-2+/p- 
galactosidase+ cells cannot be derived from UB. The most likely interpretation is 
that the Pax-2+/p-galactosidase+ cells are derived from MM, although it is also
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possible that they could be derived from a non-renal population of WT1- 
expressing cells that populates the kidney during its development.
Approximately half of the Pax-2 positive cells found in papilla did not express p- 
galactosidase. This may suggest that these cells had a UB origin, or it may have 
been that they were expressing p-galactosidase below detection levels. However, 
in the cortex, although p-galactosidase positive cells were found in the renal 
corpuscle, few positive cells were observed in the renal tubules of the nephron. 
This result was unexpected because the whole nephron is derived from WT1 
positive MM cells. The absence of P-galactosidase staining in all parts of the 
nephron is most likely due to incomplete Cre penetrability.
In this chapter, a population of Pax-2 positive cells was identified in the papilla of 
postnatal mouse kidney; a region that has been postulated to be a niche for rodent 
renal stem cells Oliver et al. (2004). A hypothesis of this thesis is that these Pax-2 
positive cells are a population of kidney stem cells. To test this hypothesis, it is 
necessary to show that the Pax-2 positive cells have the ability to self-renew and 
differentiate to renal-specific cell types. In order for these properties to be 
assessed, the cells must be isolated from the kidney and expanded in vitro. In the 
following chapter, a method is developed to enable the Pax-2 positive cells to be 
identified using a cell surface marker and isolated using Magnetic Activated Cell 
Sorting.
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Chapter 4: Isolation of putative KSC using MACS
4.1 Introduction
In the previous chapter a population of Pax-2 expressing cells was identified in 
the papilla of postnatal mouse kidney. To further study these Pax-2 positive cells 
and evaluate whether or not they exhibited properties consistent with stem cells, it 
was necessary to first separate them from the rest of the kidney. A variety of 
different techniques can be used for cell sorting and separation of a particular 
population of cells from a tissue, however, two of the most commonly used 
techniques are fluorescence-activated cell sorting (FACS) and magnetic-activated 
cell sorting (MACS) (Pappas and Wang, 2007).
FACS has been used for many years to identify and separate rare cells. However, 
as FACS individually sorts each cell within the population the number of cells 
that can be processed is limited. This means that it is inefficient at isolating very 
rare cells from a large population of cells (Radbruch and Recktenwald, 1995). 
MACS can be used to process a high number of cells obtaining significant 
numbers of the population of interest (Radbruch and Recktenwald, 1995). MACS 
is therefore the more appropriate technique for the isolation of rare cells within a 
population, and thus is the preferred technique for the isolation of stem cells, 
which typically represent a small fraction of the cells within a tissue (Buageaw et 
a l, 2005; Pappas and Wang, 2007). MACS has been successfully used to isolate 
amniotic fluid stem cells (De Coppi et al., 2007), liver progenitor cells (Qin et al.,
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2004), epithelial stem cells (Collins et al., 2001), and human kidney progenitor 
cells (Bussolati et al., 2005; Sagrinati et al., 2006).
As with FACS, the MACS strategy separates cells using specific markers, 
however in contrast to FACS, which sorts cells one-by-one, MACS separation 
can be performed on large number of cells simultaneously. Briefly, the whole 
population of cells from which a specific fraction is to be isolated is typically 
incubated with magnetic beads that have an antibody or a lectin bound to their 
surfaces, which will tag the cell population of interest. The cells are then passed 
through a column placed in a magnetic field and the cells tagged with magnetic 
beads are retained in the column while unlabelled cells pass through (Lanza et al., 
2006). While this technique allows for the more rapid processing than FACS, 
MACS specifically requires cell surface markers unlike FACS, which can use any 
cellular marker- surface markers or intracellular markers, such as transcription 
factors -  that can be fluorescently tagged.
The selection of a particular fraction of cells by magnetic cell sorting can be 
achieved in two ways. The first one is positive selection, in which the population 
of interest is labelled with magnetic beads. When the unlabelled cells have passed 
through the magnetic field, the column is removed from the magnetic field and 
the cells of interest are collected.
The alternative approach is a negative selection, which uses an antibody that tags 
the unwanted cells causing them to be retained in the column and allowing only 
the desired cell fraction to pass through. The advantage of negative selection is 
that the cells of interest are not bound to magnetic beads. A combination of
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positive and negative selection is very effective for enriching stem cells from a 
mixed population, and facilitates the isolation of a pure population (Lanza et al., 
2006).
Using the stem cell marker CD 133 two different groups have been able to isolate 
a multipotent population of cells from human kidney with MACS positive 
selection (Bussolati et al., 2005; Sagrinati et al., 2006). Other groups have 
performed MACS negative selection in order to enrich a population of 
mesenchymal stem cells from bone marrow by depleting unwanted hematopoietic 
cells (Morigi et al., 2004; Rombouts and Ploemacher, 2003).
The cell population of interest in this study expressed the nuclear transcription 
factor Pax-2. However, Pax-2 is unsuitable for MACS given its nuclear location 
and the stem cell marker CD 133, as used by Camussi and Romagnani groups 
(Bussolati et al., 2005; Sagrinati et al., 2006), is not suitable in mice as they lack 
the antigen recognized by the AC 133 monoclonal antibody. Therefore, in order to 
separate these cells from the total population of the kidney using MACS, it would 
be necessary to identify an alternative cell surface antigen specific to this cell 
population.
Complex carbohydrates are present on the surfaces of all cells, where they are 
essential components of glycoproteins, glycolipids and proteoglycans (Sharon 
and Lis, 1989). Cell surface carbohydrates play important roles in cell-cell 
recognition and cell adhesion (Brandley and Schnaar, 1986). Lectins are a group 
of glycoproteins that are involved in a wide range of biological processes
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including cell adhesion and immune function. Lectins specifically bind to 
particular cell surface carbohydrates (Scarpino et al., 1998).
Based on their properties for binding carbohydrate residues, lectins can be used 
for cell isolation (Scarpino et al., 1998). Lectins have been used to isolate 
different cell types such as liver endothelial cells using MACS (Rodes and 
Milton, 1998) or Sertoli cells using lectin coated dishes (Scarpino et al., 1998). 
Lectins have also been used for enriching hematopoietic progenitors from bone 
marrow using lectin coated devices (Rodes and Milton, 1998).
Several groups have studied lectin binding patterns in developing and adult 
mouse kidney using immunostaining (Hanai et al., 1994; Holthofer, 1983; 
Laitinen et al., 1987; Schulte and Spicer, 1983). Changes in glycoconjugate 
composition have been observed during mouse kidney development using lectins 
(Hanai et al., 1994). However, there is a specific regional distribution of 
glycoconjugates in adult mammalian kidney, which shows the functional 
compartmentalization of the organ (Laitinen et al., 1987).
Hanai et al. (1994) studied the binding pattern of some lectins during mouse 
kidney development. This group showed that peanut agglutinin lectin (PNA) did 
not bind any structures in prenatal mouse kidney and in postnatal mouse, and that 
from newborn to senescent mouse, PNA binding was restricted to proximal 
tubules. They also showed that Dolichos biflorus agglutinin (DBA) lectin is 
expressed in collecting duct in prenatal mouse and newborn, but is absent in adult 
and senescent mouse. When they studied Phaseolus vulgaris leucoagglutinin
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(PHA-L), there was no lectin binding in prenatal mouse and the lectin bound the 
proximal tubules and glomeruli from newborn onwards.
Laitinen et al. (1987) performed a lectin binding study in embryonic and in adult 
mouse kidney. PNA binding in adult kidney showed similar results to the study 
performed by Hanai et al. (1994). PNA bound mainly to proximal tubules, and 
some staining was also observed in collecting ducts. In embryonic kidney, PNA 
was found to bind most of the structures in developing kidney, including the 
ureteric bud, primary cell condensates, and the S-shaped body. However 
uninduced mesenchyme and maturing glomeruli later in development did not 
show PNA lectin binding. In this study, DBA lectin was also found to bind 
collecting duct during early development and in adult kidneys (Hanai et al., 
1994).
Laitinen et al. (1987) also studied succinylated wheat germ agglutinin (sWGA) 
and Griffonia simplicifolia lectins (GSL-I). sWGA lectin was found to bind all 
structures in developing kidney, but in adult was largely restricted to proximal 
tubules with some binding also detected in distal tubules and collecting ducts. 
GSL-I was found to bind endothelial structures in the kidney.
As a number of lectins have already been shown to bind to specific cell 
populations within the rodent kidney, it was decided that a lectin, rather than 
antibody-based screening approach, would be more likely to yield a suitable cell 
surface marker for the Pax-2 positive cells in the papilla.
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4.1.1 Aims
In this chapter, the isolation of Pax-2 positive cells from neonatal mouse kidney 
using MACS is reported. In order to facilitate this isolation it was necessary to 
identify a suitable a cell surface marker co-expressed with the nuclear marker 
Pax-2.
The first aim was to co-stain postnatal mouse kidney with Pax-2 and a panel of 21 
lectins. Following identification of a lectin that bound specifically to the Pax-2 
positive cells, the next aim was to investigate whether magnetic beads conjugated 
to the lectin could be used to isolate the Pax-2 positive cell population.
4.2 Results
4.2.1 Lectin binding study in neonatal kidneys during 
development
Some of the 21 lectins screened at different stages of kidney development did not 
show specific staining patterns in the kidney and were discarded (Table 4-1).
Nine lectins were selected for further study because they appeared to bind 
specific structures in the kidney. However, only six appeared as good candidates 
for Pax-2 positive cell isolation and were therefore further analysed. The lectins 
selected for deeper analysis were PNA, DBA, sWGA, PHA-L, GSL-I and 
Solanum tuberosum lectin (STL).
Some of these lectins bound the surface of Pax-2 positive cells in the developing 
kidney while others bound the surface of cells negative for Pax-2. PNA, DBA and 
STL lectins seemed to bind the surface of some Pax-2 positive aggregates and 
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of most of the cells in cortex negative for Pax-2. GSL-I presented a different 
pattern, binding glomeruli and endothelial structures. All these lectins bound the 
surface of most of the Pax-2 positive cells in the papilla with the exception of 
PHA-L where no lectin binding was observed. PNA was the only lectin that 
specifically bound most of the Pax-2 positive cells at all life stages tested, 
therefore, this lectin was bound to magnetic beads in order to isolate renal cells 
using MACS.
Peanut agglutinin lectin (PNA)
In the renal cortex and medulla of one day old mice PNA lectin clearly bound 
tubular structures, some of which contained Pax-2 positive cells (Figure 4-la). 
However, the PNA lectin also bound the surface of tubular structures that did not 
contain Pax-2 positive cells. PNA also bound the surface of some of Pax-2 
positive cells in the comma- and S-shaped bodies, and Pax-2 positive cells that 
were condensed around the tips of the lectin binding tubules, but in these cases 
staining was considerably weaker than in tubular structures.
PNA lectin bound the surface of most of the cells expressing Pax-2 present in the 
renal papilla (Figure 4-la). The lectin seemed to bind the surface of the tubules 
expressing Pax-2 and the surface of one or two cells or small clusters of cells.
In 7 day (Figure 4-2a), 14 day, and adult mice the amount of PNA binding 
apparent in the cortex decreased significantly with only a few tubules still binding 
PNA (Data not shown). In contrast the numbers of cells still binding PNA in the 
























































































































































































































































































































































































































































































































Figure 4-3 Micrographs showing the expression of Pax-2 (red) and the binding of PNA, 
DBA, and sWGA (green) in the cortex and papilla of kidneys from 14 day old mice. Scale 
bars: 100 pm
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Figure 4-4 Micrographs showing the expression of Pax-2 (red) and the binding of PNA, and 
sWGA (green) in the cortex and papilla of kidneys from adult mice. Scale bars: 20 pm.
positive cells, predominantly those in tubules (Figure 4-2a, Figure 4-3 and Figure
4-4).
Dolichos biflorus agglutinin (DBA)
DBA lectin was found to bind the surface of some Pax-2 positive cells in the 
cortex and medulla at day 1 (Figure 4-la). However, only a few tubules 
expressing Pax-2 in the cortex and medulla were found to have lectin staining. In 
7 day old mice some DBA binding was still seen in the cortex and medulla 
(Figure 4-2a), however, by day 14 and in adult mice there was no DBA binding 
(Data not shown).
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In the renal papilla of one day old mice, the lectin appeared to bind the surface of 
many tubules containing Pax-2 positive cells (Figure 4-la). By visual analysis 
there seemed to be fewer tubules in the papilla positive for DBA binding than 
there were for PNA. Very little DBA binding was evident in the papilla of day 7 
(Figure 4-2a), day 14 (Figure 4-3), and adult mice (Data not shown).
Succinylated wheat germ agglutinin (sWGA)
When kidneys of one day old mouse were stained with sWGA strong staining 
was observed in some tubular structures of the cortex (Figure 4-lb). These 
tubules did not contain Pax-2 positive cells. No lectin staining was observed in 
renal corpuscles, comma- and S-shaped bodies, or any Pax-2 expressing cells in 
the nephrogenic area. In the medulla the sWGA lectin bound many tubules, and 
some of these tubules contained Pax-2 positive cells. At days 7 (Figure 4-2b) and 
14 and in adult sWGA bound the majority of tubules in the cortex but these 
showed very little Pax-2 expression (Data not shown).
When renal papilla was analysed it was found that the lectin bound the surface of 
the majority of tubules present in papilla containing cells expressing Pax-2 at all 
time points (Figure 4-2b, Figure 4-3 and Figure 4-4).
Phaseolus vulgaris leucoagglutinin (PHA-L)
The lectin PHA-L in one day old neonates appeared to bind the sugars on the 
surface of some tubules and glomerular and developing glomerular structures 
(Figure 4-lb). However, the lectin binding seemed to be absent in the 
nephrogenic zone, where Pax-2 was expressed. Some tubules in the inner medulla
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presented lectin staining, but they did not contain Pax-2 positive cells. At later 
time points the lectin bound the majority of structures in the cortex and medulla, 
but, again, none of these structures contained significant numbers of Pax-2 
positive cells (Figure 4-2b).
The lectin did not bind the surface of any of the Pax-2 positive cells in the papilla 
at any time point (Figure 4-lb and Figure 4-2b).
Griffonia simplicifolia lectin I (GSL-I)
When one day old (Figure 4-lc), seven day old (Figure 4-2c) and 14 day old 
(Data not shown) kidneys were stained with GSL-I, it was found that in the cortex 
the lectin bound what appeared to be the capillary loop in the renal corpuscle, 
endothelial structures, and some tubules. Also, in some tubules in the medulla co­
expression was found with Pax-2 and the lectin binding sites.
In renal papilla of one day old mice, the lectin stained the surface of most tubular 
structures containing Pax-2 positive cells (Figure 4-lc). However, later, in days 7 
and 14, the lectin bound the surface of few tubules containing Pax-2 positive cells 
(Data not shown).
No GSL-I staining was observed in cortex or renal papilla of adult mice (Data not 
shown).
Solan um tuberosum lectin (STL)
When one day old kidneys were stained with STL lectin there was a weak lectin 
staining on the surface of the aggregates and S-shaped bodies in the nephrogenic 
zone (Figure 4-lc). STL lectin was also found to bind the surface of some tubular
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structures in the cortex, and seemed to bind the renal corpuscle, but with lower 
intensity. In the renal medulla the lectin bound most of the tubules containing 
Pax-2 positive cells.
In day 7 (Figure 4-2c), day 14, and adult kidneys the lectin bound a few tubular 
structures in the cortex, but these tubules did not contained Pax-2 positive cells.
In renal papilla the lectin bound the surface of most of Pax-2 positive cells at all 
four time points (Figure 4-lc and Figure 4-2c).
4.2.2 Kidney stem cell isolation using magnetic-activated cell 
sorting (MACS®)
PNA was selected as the best lectin to enrich Pax-2 population in kidney using 
MACS. To determine whether PNA-coated magnetic beads could be used to 
isolate Pax-2 positive cells from mouse postnatal kidney, a single cell suspension 
of disaggregated kidney cells was incubated with PNA-coated beads, and the 
percentage of Pax-2 positive cells in the MACS-selected population was 
compared to that in the unselected population. Uncoated beads were included as 
controls.
No magnetic beads were observed in the unselected fractions obtained from 
PNA-coated and uncoated beads (Figure 4-5). Further analysis showed that while 
many of the cells in the unselected fraction obtained from control beads bound 
PNA, very few cells in the unselected fraction obtained from the PNA-coated 
beads bound PNA (Figure 4-5).
To determine the efficiency of the procedure, 24 hours following MACS, selected 












Figure 4-5 Micrographs showing the expression of Pax-2 (red) and lectin binding (green) in 
cells from the wash fractions from cells incubated with PNA-coated beads (a) and control 
beads (b). The cells from the control unselected fraction show significant levels of Pax-2 
expression while those from the PNA selected fraction do not, indicating that the PNA-binding 





immunostained for Pax-2 to determine the proportion of Pax-2 positive cells in 
each fraction. The proportion of Pax-2 positive cells in the MACS-selected 
populations was then compared to that in a disaggregated kidney that had not 
been subjected to MACS.
It was found that 79% of cells selected with PNA-coated beads were Pax-2 
positive, whereas only -34% of cells in the unselected fraction were 
Pax-2positive (Figure 4-6). With the uncoated beads, ~30% of cells in the 
selected fraction were Pax-2 positive compared to -65% in the unselected 
fraction.
Analysis of the disaggregated kidney not subjected to MACS, showed that 
following 24h in culture, 57% of the cells were Pax-2 positive.
PNA PNA Control Control Disaggregated
Selected Unselected Selected Unselected Kidney
Fraction
Figure 4-6 Proportions of cells from different cell fractions presenting Pax-2 expression 
after 24 hours in culture. The red portions of the bars represent the percentage of cells in the 
cultures that were Pax-2 positive.
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Following plating of the MACS-selected cells, it was found that many of the cells 
were heavily loaded with beads (Figure 4-7). It has been shown previously that 
lectin binding can have effects on cellular processes such as proliferation, 
migration, and in some cases, can have a toxic effect on cells (Dodeur et al., 
1980; Ryder S., 1998; Schwarz et al., 1999). Therefore, to avoid any potential 
problems arising from lectin binding to the kidney cells, attempts were made to 
remove the lectin-coated beads immediately after MACS selection by incubating
Figure 4-7 Micrographs of cell fraction selected with PNA coated beads. The left-hand image 
shows cells selected with PNA beads at 10* magnification. The right-hand side picture shows a 
higher magnification of cell in detail overloaded with magnetic beads. Scale bars: 100 pm.
the cells with the competing sugar, galactose. However, it was found that this 
strategy was not successful and the beads remained attached to the cells.
To determine whether the lectin-coated beads had any noticeable effect on cell 
viability, morphology or Pax-2 expression, the selected fractions of lectin-coated 
and uncoated beads, along with disaggregated kidney not subjected to MACS, 
were cultured for 2 weeks. After this period the cells were fixed and 






Figure 4-8 Micrographs showing cells from different ceil fractions selected by MACS after 
14 days in culture, and their Pax-2 expression. When cells separated with PNA beads (a & b) 
were cultured, the cells originating from the unselected fraction (b) showed depletion of Pax-2 
positive cells while the selected fraction (a) showed enrichment of Pax-2 positive cells. When 
cells separated with control beads were cultured, the cells originating from the selected fraction 
(c) showed many cells expressing Pax-2 and cells from the unselected fraction (d) showed many 
Pax-2 positive cells as well. Ph -  Phase contrast. Scale bars: 100 pm.
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It was found that the PNA-selected cells and the cells from the disaggregated 
kidney showed little difference in cellular morphology or colony expansion. The 
cells selected with the unbound beads on the other hand displayed a lower 
number of colonies.
When the cells were studied for Pax-2 expression, colonies in which more than 
half of cells were Pax-2 positive were referred to as positive colonies, while 
colonies in which less than half were positive for Pax-2 were considered negative. 
Pax-2 analysis showed that in the cells selected with PNA-coated beads, 68% 
ofthe colonies were Pax-2 positive, while in those selected with uncoated beads 
only 14% of the colonies were Pax-2 positive. However, in the cells expanded 
from disaggregated kidney, 61% of the colonies were Pax-2 positive.
4.3 Discussion
In this chapter the isolation of Pax-2 positive cells from postnatal mouse kidney 
was attempted using MACS. In order to find a surface marker to isolate Pax-2 
positive cells, a screening of lectins was performed in order to find a lectin that 
specifically bound the surface of the Pax-2 expressing cells in the papilla. It was 
found that high levels of the PNA lectin bound to the Pax-2 positive cells in the 
papilla, and PNA-coated magnetic beads could be used to enrich the Pax-2 
positive population using MACS. However, it was found that even without 
MACS selection, the majority of isolated cells were Pax-2 positive following two 
weeks in culture.
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Pax-2+ cells in the postnatal mouse kidney express binding sites 
for PNA lectin
PNA, which is specific for D-galactose or N-acetyl-D-galactosamine (Laitinen et 
a l, 1987; Young et al, 1984), seemed to be the most suitable lectin among those 
tested for Pax-2 positive cell enrichment, as it bound the surface of most of the 
Pax-2 positive cells in the papilla at different stages of development. Hanai et al 
(1994) showed that PNA bound proximal tubules in mouse kidney during 
development, from postnatal (including newborn, suckling, and weanling) to 
adult and senescent mice. Laitinen et al (1987) also studied binding of PNA in 
mouse kidney and found that in late embryo and early neonates PNA bound the
S-shaped body, the capillary loop, the proximal tubules, and the collecting ducts, 
and with less intensity, the primary cell condensates, primary vesicles, and distal 
tubules. Later on in development, when kidneys are matured, Laitinen et al 
(1987) showed that PNA binding was restricted to proximal tubules and 
collecting ducts whereas Hanai et al. (1994) only found lectin binding to 
proximal tubular cells and not collecting ducts. The results of this study, which 
demonstrated that in early neonates strong lectin binding was observed in some 
tubular structures that may be proximal tubules and collecting ducts, are more 
consistent with the findings of Laitinen (Laitinen et a l, 1987). Weaker PNA 
binding was observed in other structures in the cortex such as early condensates 
and developing glomeruli.
In mature kidney, both groups found the lectin binding to be restricted to tubular 
structures, which is also consistent with the findings of this study that showed 
that after one week, PNA seemed to bind tubular structures in the cortex,
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medulla, and papilla that may correspond to proximal tubules and collecting 
ducts.
However, in this study it was not possible to determine which type of tubules the 
lectin was binding to, and in order to determine this, immunostaining using 
specific tubular markers and the lectin would need to be done.
Enrichment of Pax-2+ cells using MACS
The magnetic separation using PNA coated beads seemed to enrich the 
population of Pax-2 expressing cells, however, a high percentage of Pax-2 cells 
was also obtained in whole plated kidney with no isolation procedure. The 
percentage of cells expressing Pax-2 was only 20% higher in the fraction of cells 
selected with PNA coated beads than in disaggregated kidney without isolation. 
Furthermore, after two weeks in culture, the percentage of colonies expressing 
Pax-2 was very similar in the cells selected with PNA beads and in the cells 
plated with no selection.
Following the hypothesis that Pax-2 positive cells may be a stem cell population, 
these cells may have a proliferation advantage in vitro compared with the rest of 
the cells. If this is the case, it may be possible that the percentage of Pax-2 
positive cells present in plated kidneys with no isolation procedure is enough to 
proliferate and expand a stem cell population without MACS, or any particular 
cell separation procedure.
Magnetic cell isolation is an expensive technique and it is also time consuming, 
so overall it may be that isolation of cells using PNA coated beads is not the most
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convenient method to isolate and enrich Pax-2 expressing cells. In previous 
attempts to isolate stem cells using MACS, cells have been isolated using 
particular surface markers that are expressed by the cell population of interest, 
such as CD133 (Bussolati et al., 2005; Sagrinati et al., 2006). The lack of a cell 
surface marker to isolate Pax-2 expressing cells makes the isolation difficult. The 
use of PNA binding to isolate the cells as opposed to the actual marker, Pax-2, for 
the cells of interest reduced the efficiency of the procedure, given the fact that 
PNA was not fully specific for Pax-2.
Another approach could have been to isolate cells not expressing Pax-2 in order 
to deplete Pax-2 negative cells from the total population and leave Pax-2 positive 
cells in the wash fraction. A third possibility could have been the combination of 
positive and negative selection using PNA and PHA-L to further enrich 
population of Pax-2 positive cells. PHA-L lectin seemed to be ideal for negative 
selection. PHA-L showed a constant pattern during development of not binding 
Pax-2 positive cells.
In conclusion, although the MACS technique did isolate high numbers of Pax-2 
positive cells from kidney, it appeared that plating the cells from disaggregated 
kidney was equally effective for obtaining high numbers of Pax-2 expressing 
cells in vitro. After six weeks in culture there was no observable difference in the 
numbers of Pax-2 positive colonies in cultures from the two techniques, therefore, 
it was decided that the simpler option of using whole kidney disaggregates was a 
more efficient means of proceeding. However, further optimisation of the culture 
conditions might offer the possibility of encouraging greater proliferation of the
132
Pax-2 positive cells relative to the other cells in the kidney should they prove to 
be stem cells. In the next chapter, culture conditions to expand Pax-2 positive 
cells from disaggregated kidney were optimized.
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Chapter 5: In vitro expansion of putative stem cells
5.1 Introduction
In order to work with stem cells it is necessary to have the correct conditions to 
culture them for two different cellular states. First, stem cells need to be 
maintained in a self-renewing state of undifferentiating proliferation. Second, 
when it is required, stem cells need to be differentiated under the right stimulus to 
a particular cell type. A crucial factor is the substrate on which the cells are 
grown, which influences proliferation, differentiation, and phenotype of the cells. 
Mouse embryonic stem cells can be maintained undifferentiated in vitro in the 
presence of a feeder layer of fibroblasts (Evans and Kaufman, 1981a; Evans and 
Kaufman, 1981b; Martin, 1981) or, alternatively, on gelatin-coated plates with 
the addition of leukemia inhibitory factor (LIF) (Williams et al., 1988). The 
fibroblast feeders provide not only a substrate on which to grow the stem cells, 
but also supply the stem cells with growth factors essential for survival (Smith 
and Hooper, 1983; Talbot et al., 1994). Although it is possible to maintain the 
cells undifferentiated with no feeders and using media supplemented with LIF, 
most groups still culture the cells on feeders to provide the necessary factors to 
promote proliferation of the cells in an undifferentiated state.
The most common types of fibroblast used as feeder layers to grow embryonic 
stem cells are mouse embryo fibroblasts (MEFs) and STO mouse fibroblast cell 
line (STO). STO cells are thioguanine- and ouabain-resistant subline of SIM 
mouse fibroblast isolated by Dr. A. Bernstein (Martin and Evans, 1975). STO are
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an established cell line so they can be grown in the lab easily. MEFs, by contrast, 
need to be continuously replenished from frozen stocks.
Several problems can arise from the use of feeders. A major problem of using 
feeders to grow stem cells arises when analysing the cells. Given the cellular 
nature of the feeders, they can interfere with the results by giving background 
staining and signals in immunostainings and polymerase chain reaction (PCR) 
analyses. In addition, it is impossible to know the influence that feeders have on 
the stem cells behaviour.
When fibroblasts are grown in vitro they produce a pericellular matrix that 
contains fibronectin (Hedman et al., 1978; Hedman et al., 1979), procollagen 
types I and III and glycosaminoglycans (Hedman et al., 1979). This pericellular 
matrix can be isolated by removing the fibroblasts using a 0.5% sodium 
deoxycholate solution leaving a substrate suitable for culture without the presence 
of unwanted cells (Hedman et al., 1979). This could provide a solution to the 
problems associated with the presence of the fibroblasts themselves. However, it 
would then be necessary to replace the factors that feeders release into the 
medium. Some groups have used conditioned media from STO cells in order to 
supplement stem cells with factors normally released by the feeders (Ouyang et 
al., 2007).
Another approach to growing kidney cells is to coat the dishes with extracellular 
matrix (ECM) components in order to mimic the in vivo process. Different 
components of the ECM have been used to grow and expand KSC such as 
Matrigel™, Type I, and Type IV collagen, laminin and fibronectin (Draper et al.,
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2004; Maeshima et al., 2006). Fibronectin, which is an adhesive ECM protein, 
seems to be the ECM component of choice for KSC expansion (Bussolati et al., 
2005; Gupta et al., 2006; Oliver et al., 2004; Sagrinati et al., 2006). Fibronectin- 
rich matrices support and influence cell proliferation, survival, migration, and 
differentiation (George et al., 1993; McCarthy et al., 2003). ECM plays an 
important role in kidney development and also repair, and is involved in 
processes such as ureteric bud branching morphogenesis and metanephric 
mesenchyme condensation. It also has an influence on the differentiation of the 
renal tubes, and the assembly of the glomerular basement membrane (Lelongt and 
Ronco, 2003).
The most frequently used media for culturing stem cells is Dulbecco’s modified 
Eagle’s medium (DMEM) containing 4500 mg/1 of glucose with the addition of 
1 mM sodium pyruvate and a high concentration of serum (10-20%) (Hogan et 
al., 1994).
In order to reduce the concentration of serum added to the culture media there are 
some commercially available media that allow reduction of serum without 
resulting in a changing in the morphology of the cells or cell growth rate. For 
example, Advanced DMEM has been used by various groups in to promote 
growth and proliferation of stem cells in a low serum concentration (Boucher et 
al., 2006).
It has been also shown by Dudley et al. (1999) that the addition of FGF-2 and 
BMP-7 to the culture media promote survival and proliferation of metanephric 
mesenchyme cells. Potentially the addition of these two factors to the medium
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could increase the chances of survival and proliferation of KSC or metanephric 
mesenchyme-like cells.
5.1.1 Aims
The aim of this chapter was to test different substrates and cell culture media for 
their suitability in culturing the isolated population of putative kidney stem cells 
(pKSC). The culture dishes were coated with different substrates, and each 
substrate was assessed for its ability to promote attachment, proliferation and 
expansion of pKSC, while maintaining the “undifferentiated” state of the pKSC 
characterised by the expression metanephric mesenchyme markers.
5.2 Results
5.2.1 Establishing the optimal culture medium for expansion of 
putative KSC
To test which culture medium was most suitable for expansion of the KSC, the 
cells were plated on dishes coated with fibronectin with two different media: 
Advance DMEM with no added serum and STO-conditioned medium with 2.5% 
FCS added (STO-CM). When the cells were grown on Advanced DMEM with no 
added serum, the cells attached to the dish and proliferated. After a week to ten 
days the proliferation slowed down and it was difficult to subculture them 
successfully (Figure 5-1). When the cells plated on fibronectin coated dishes were 
grown on STO-CM the cells attached and proliferated continuously, and it was 
possible to subculture the cells every few days. Cells in these conditions could be 




Figure 5-1 Phase contrast micrograph showing cells isolated from 3 days old mouse kidney 
after 10 days in culture. Cells were plated on fibronectin coated dishes with two different media 
-  Advanced DMEM with no serum and STO-CM. Scale bars:200pm.
BMP-7 and FGF-2 in combination have been shown to encourage the growth and 
maintenance of MM cells in vitro (Dudley et al., 1999). In order to evaluate their 
effects on expansion and proliferation of the pKSC, the cells were cultured on 
substrates of fibronectin or dSTO with one of two different media. The first was 
STO-CM and the second was STO-CM to which BMP-7 and FGF-2 had been 
added.
The cells were cultured under each of the four different conditions for two weeks. 
No differences were observed in the morphology or the growth rate of the cells 
between the four conditions (Figure 5-2). After two weeks in culture, cells were 
collected from each condition and RNA was extracted for RT-PCR analysis of 
MM markers.
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Figure 5-2 Phase contrast images of cells grown on dSTO and fibronectin coated dishes for 5 
days with without or with added growth factors, (a) Cells grown on dSTO for 5 days with 
STO-CM. (b) Cells grown on dSTO for 5 days with STO-CM plus FGF-2 and BMP-7, (c) Cells 
grown on fibronectin coated dishes for 5 days with STO-CM. (d) Cells grown on fibronectin 
coated dishes for 5 days with STO-CM plus FGF-2 and BMP-7. Scale bars: 100 pm.
A band of the specific size of Pax-2 (303 bp) was observed in the RNA extracted 
from a whole 5 day old mouse kidney; this was used as a positive control for 
Pax-2. No Pax-2 band appeared on heart and liver of five days old mouse; this 
was used as negative controls for Pax-2 expression. Pax-2 was expressed by the 
cells grown in all four conditions. There was no obvious difference in the 
intensity of the Pax-2 bands between the four conditions. No band for Pax-2 was 
observed on the reaction where no template was added. The results of RT-PCR 
for Pax-2, WT1 and GDNF are shown in Figure 5-3.
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Figure 5-3 Reverse transcription-polymerase chain reaction for Pax-2, WTI, GDNF and 
GAPDH from RNA extracted from cultured kidney cells with whole kidney, heart and liver 
from 5 day old mouse as controls. Kid -  whole kidney; Hrt -  whole heart; Liv -  liver; DxNF -  
cells grown on dSTO with no added factors; DxF -  cells grown on dSTO with FGF-2 and BMP-7 
added to the medium; FNNF -  cells grown on fibronectin with no factors added; FNF -  cells 
grown on fibronectin with FGF-2 and BMP-7 added to the media; NT -  no template control.
A band corresponding to WTI (234 bp) was observed on the whole 5 days old 
mouse kidney and also another band on the whole heart from five days old 
mouse; both bands presented similar intensity. A weaker band appeared for WTI 
expression on the five day old liver sample. Cells from all four conditions 
presented a band of similar intensity corresponding to WTI expression. No band 
was observed when no template was added.
The next marker analyzed was GDNF (176 bp). Weak bands were observed on 
the samples from five days old heart and kidney. No band for GDNF was 
observed on the five days old neonate liver. GDNF was expressed on cells grown
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on dSTO and on fibronectin with or without added factors, all four bands had 
similar intensity. No GDNF band was observed on the reaction with no added 
template.
The reference gene GAPDH (llObp) showed a similar level of expression in all 
the samples.
5.2.2 Establishing the optimal culture substrate for expansion of 
putative KSC
To determine the optimal culture conditions for expansion of putative KSC, 
disaggregated cells from 3 days old neonatal mouse kidneys were plated onto the 
following four culture substrate: Matrigel, STO feeders, deoxycholate-treated 
STO feeders (dSTO) and fibronectin. Matrigel did not support the growth and 
expansion of the renal cells so it was discard in early experiments (Data not 
shown).
5.2.3 Short term culture of renal cells on three substrates
As a preliminary test to investigate whether the plated cells from neonatal
kidneys had a KSC-like phenotype after short term culture, the cells were fixed 
and stained for Pax-2 on the 1st and 7th day after plating.
After one day in culture, the cells plated onto STO feeders had formed many 
colonies of different sizes, and most of the cells in these colonies were Pax-2 
positive (Figure 5-4 a). The colonies were not very large, with between 80-90%
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(a)
Figure 5-4 Micrographs showing immunostaining for Pax-2 and DAPI, and phase contrast 
of cells from whole disaggregated kidney of 3 days old neonatal mice plated on STO feeder 
cells, (a) Cells grown on STO feeders and fixed after one day in culture stained, (b) Cells grown 
on STO feeders and fixed after one week in culture. Ph -  phase contrast. Scale bars: 100 pm.
of the colonies containing less than 15 cells. After one week, the colonies 
appeared considerably bigger and still expressed Pax-2 (Figure 5-4 b). The cells 
grew as a monolayer and presented mainly an epithelial morphology. 
Approximately half of the colonies now contained more than 15 cells.
When the renal cells were plated onto dishes coated with deoxycholate-treated 
STO (dSTO), after one day in culture the cells were found to attach to the dish 
forming a monolayer of colonies of different sizes (Figure 5-5 a). Again the 
colonies were relatively small, with about 80-90% of them containing fewer than 
15 cells. Some single cells were found between the colonies or close to the 
periphery of the colonies. Cells of different morphology were observed, with
142
(a)
Pax-2 DAPI Ph *
(b)
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Figure 5-5 Micrographs showing immunostaining for Pax-2 and DAPI, with phase contrast 
of cells from whole disaggregated kidney of 3 days old neonatal mice plated on dSTO feeder 
cells, (a) Cells grown on dSTO feeders and fixed after one day in culture, (b) Cells grown on 
dSTO feeders and fixed after one week in culture. Ph -  phase contrast. Scale bars: 100 pm.
some of the cells being elongated whilst others were more rounded. Some of the 
cells seemed to form epithelial-like colonies of thin flat layers. When the cells 
were left for a week under this condition they proliferated and spread over the 
surface of the dish, coating most of it (Figure 5-5 b). Most of the cells still 
expressed Pax-2.
Cells were plated onto fibronectin coated dishes expressed Pax-2 after one day in 
culture. At this point colonies of different sizes were found and a similar 
morphology was observed if they were compared with the cells plated on feeders 
and dSTO (Figure 5-6 a). It was also possible to observe some single cells 








Figure 5-6 Micrographs showing immunostaining forPax-2 and DAPI, with phase contrast, 
of cells from whole disaggregated kidney of 3 days old neonatal mice plated on fibronectin 
coated dishes, (a) Cells grown on fibronectin and fixed after one day in cultura. (b) Cells grown 
on fibronectin and fixed after one week in cultura. Ph- phase contrast. Scale bars: 100 pm.
colonies. In this condition, as the previous two, 80-90% of the colonies were 
smaller than 15 cells. When the cells were left for a week on fibronectin coated 
dishes, it was possible to observe proliferation, and the cells were found to spread 
along the surface of the dish, coating most of it after one week (Figure 5-6 b). 
Nearly all still maintained Pax-2 expression. Some cells formed epithelial-like 
colonies, whilst other cells, with more elongated morphology, covered the rest of 
the dish and surrounded these colonies.
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5.2.4 Long term culture of renal cells on three substrates 
Cells grown for one month
The cells were grown for a month on STO feeders and were checked for Pax-2 
expression (Figure 5-7). After this time many cells still expressed Pax-2, but 
some cells started to lose Pax-2 expression. In some colonies pairs of cells were 
observed with closely adjacent nuclei, suggestive of daughter cells that had arisen 
from a recent cell division. In many cases, one daughter was Pax-2 positive and 
the other Pax-2 negative. It was found that after a few passages the cells on feeder 





Figure 5-7 Micrographs showing immunostaining for Pax-2 and DAPI, merge of both 
markers, and phase contrast of cells from whole disaggregated kidney of 3 days old neonatal 
mice plated onto STO feeder cells and cultured for one month. Ph -  phase contrast. Scale 
bars: 100 pm.
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Cells grown on dSTO and on fibronectin were also grown for a month in culture, 
however, no changes were observed in these two conditions and the expression of 
Pax-2 and WT1 was maintained, therefore the cells were cultured for a further 4 
months.
Cells grown for four and eleven passages
At this point, STO feeders were discarded as a substrate as they did not support 
the expansion of renal cells and resulted in the loss of the expression of Pax-2 in 
most of the surviving cells.
Cells grown for four and eleven passages (approximately two and five months in 
culture respectively) on deoxycholate treated STO and on fibronectin were fixed 
and immunostained for Pax-2 and WT1. When the cells grown for four passages 
on dSTO were analysed, the majority of the cells were found to express Pax-2 
and WT1 (Figure 5-8). Among the cells expressing Pax-2 and WT1 different 
levels of expression were observed. When the cells were grown on dSTO for 
eleven passages there was a decrease in the number of cells expressing Pax-2, 
however, WT1 was still expressed in most of the cells (Figure 5-8).
When the cells were grown for four passages on fibronectin coated dishes, a 
similar staining pattern to the cells grown on dSTO was observed (Figure 5-9). 
Most of the cells were positive for Pax-2 and also WT1. The cells grown on 
fibronectin for eleven passages also presented similar staining than cells grown 
on fibronectin for four passages with most of the cells Pax-2 positive and also 














































































































































The cells grown on dSTO and fibronectin for four and eleven passages were also 
analysed by RT-PCR (Figure 5-10). At passage four, the cells presented a specific 
band with similar intensity for Pax-2 expression on both conditions. Pax-2 bands 
were also observed on the controls: whole kidney rudiments of El 1.5 embryos 
and whole kidney of five day old neonate. The cells grown on both substrates 
presented WT1 expression at passage four with similar levels. All the controls 
presented some level of WT1 expression, stronger in the case of neonatal kidney 
and heart and slightly weaker on the El 1.5 whole rudiment. An even weaker 





Figure 5-10 Reverse transcription-polymerase chain reaction for Pax-2, WT1, GDNF and 
GAPDH from RNA extracted from cells cultured for four passages on dSTO and 
fibronectin, with STO feeder cells, kidney rudiments, whole kidney, liver and heart of 5 day 
old mouse as controls. Emb -  El 1.5 kidney rudiment; STOc -  STO feeder cells; Kid -  whole 
kidney; Liv -  liver; Hrt -  whole heart; FN -  fibronectin; NT -  no template control.
S 3g Emb Kid Liv Hrt STOc dSTO FN NT
Emb Kid Liv Hrt STOc dSTO FN NT
Emb Kid Liv Hrt STOc dSTO FN NT
Emb Kid Liv Hrt STOc dSTO FN NT
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A band appeared confirming the presence of GDNF at passage four on the cells 
grown on both substrates. Also the STO cells presented a clear band of GDNF 
expression, and weaker bands were observed in whole kidney rudiments of El 1.5 
embryos and whole kidney of five day old neonate. A weak band appeared in the 
heart sample.
The next time point analysed was passage eleven (Figure 5-11). Pax-2 was 
expressed in the kidney of five day old neonate, which was used as a positive 
control. There was a very weak band of Pax-2 in the STO cells. There was no 
Pax-2 expression in the heart. There was Pax-2 expression in the cells plated on 
deoxycholate treated STO, but the expression seemed weaker than in passage 
four.
Pax-2 expression was maintained at passage eleven in cells grown on fibronectin, 
and Pax-2 levels were clearly lower on the cells grown on dSTO than in cells 
grown on fibronectin (Figure 5-11). WT1 was expressed in kidney and heart of 
five day old neonate, and by STO feeder cells. Similar levels of WT1 expression 
were found on cells grown on both substrates, and the levels appeared to be 
maintained from passage four. GDNF was found to be expressed in the kidney of 
five day old neonate, STO feeder cells, and very weakly in heart. GDNF was also 
expressed in the cells grown on both substrates although the levels seemed to be 
higher on the cells grown on fibronectin. Sail 1 was not expressed by any of the 
controls or the cells grown on dSTO, but was expressed in the cells that were 
grown on fibronectin for eleven passages. Similar levels of expression of the 
reference gene, GAPDH, were found in all samples.
150




Kid STOc Hrt dSTO FN NT
WT1
( 9 | Kid STOc Hrt dSTO FN NT
GDNF
m m m m





Kid STOc Hrt dSTO FN NT mm
* »
GAPDH
m an m m 'iK I
Figure 5-11 Reverse transcription-polymerase chain reaction for Pax-2, WT1, GDNF, Salll, 
and GAPDH from RNA extracted from cells cultured for eleven passages on dSTO and 
fibronectin and also whole kidney, STO feeder cells, and heart of 5 dayl old mouse as 
controls. Kid -  whole kidney; STOc -  STO feeder cells; Hrt -  whole heart; FN -  fibronectin; NT 
-  no template control.
5.3 Discussion
In this chapter, culture conditions were optimized for expanding the Pax-2 
positive cells isolated from disaggregated kidney. By culturing on a substrate of 
fibronectin in medium conditioned by the STO mouse embryonic fibroblast cell 
line, it was found that the cells could be expanded, and could maintain expression 
of metanephric mesenchyme markers.
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STO-conditioned medium (STO-CM) supports expansion of 
Pax-2+ cells
Cells grown in conditioned medium fared better than cells in Advanced DMEM 
medium without serum. This could be due to the factors present in the medium 
that were previously released by the STO feeders, and that provided the cells with 
the necessary factors to proliferate. For instance, it was found that the STO cells 
expressed high levels of GDNF, which apart from playing an important role in 
kidney development, has been shown to promote the proliferation and survival of 
several types of stem and progenitor cell types, including spermatogonial stem 
cells, enteric neuron and glial progenitors (He et al., 2008; Heuckeroth et al., 
1998).
However, it is also possible that the FCS (2.5 %) contained in the STO-CM was 
responsible for the improvement in survival and proliferation of the cells grown 
in this condition.
The addition of the growth factors BMP-7 and FGF-2 to the STO-CM did not 
affect the expression of the MM markers Pax-2, WT1, or GDNF, nor did it 
improve proliferation or expansion of the cells. This is in contrast to the 
improvement in survival and proliferation of MM cells reported by Dudley et al. 
(1999). Dudley et al. (1999) used MM cells in their study, while the cells used in 
this study were derived from neonatal kidneys. It could be that the cells used in 
this study were originally derived from MM, however, they may have a different 
level of renal commitment or differentiation and this may explain their lack of 
response to BMP-7 and FGF-2.
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Fibronectin culture substrate supports expansion of Pax-2+ cells
The kidney cells plated on STO feeders, dSTO, or fibronectin were isolated from
disaggregated neonatal mouse kidney (three to five days old). It was shown in 
chapter 3 that at this neonatal stage, only two areas in the kidney contained a high 
number of Pax-2 positive cells, the nephrogenic zone in the cortex and the 
papilla. It is therefore surprising that following two weeks of in vitro culture, 
most of the cells on all three culture substrates expressed Pax-2, considering that 
they were isolated from whole kidney. One possible explanation could be that 
Pax-2 positive cells have an advantage compared with Pax-2 negative cells. They 
may have a better capacity to attach to the dishes and to survive in culture than 
cells not expressing Pax-2. Another explanation could be that the in vitro 
conditions change the cell phenotype and induce them to express Pax-2. 
However, further experiments would need to be done to determine which was the 
case.
Following long term culture, it was found that STO cells and dSTO did not 
support the expansion of kidney cells expressing MM markers such as Pax-2.
Many adjacent cells with close nuclei, probably derived from a recent cell 
division, were observed among the cells growing on STO. Interestingly, in some 
cases one daughter cell was Pax-2 positive and the other had lost Pax-2 
expression. This phenomenon could be due to the cells undergoing asymmetric 
division. Asymmetric division is a frequent feature of stem cells that allows them 
to maintain their numbers (self-renew) whilst also generating progenitor cells or 
more differentiated cells (Morrison and Kimble, 2006). This suggests that the
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cells maintained long-term on STO feeders started to undergo a differentiation 
process and were differentiating to a more mature phenotype.
Pax-2 and WT1 are co-expressed in MM in early kidney development. During 
kidney development Pax-2 is expressed in condensing mesenchyme and comma- 
shaped bodies, but starts to decrease in the proximal part of the S-shaped bodies 
as WT1 expression begins to increase (Ryan et al., 1995). It could be that the 
cells cultured on STO and dSTO for longer periods were starting to differentiate 
and to acquire a more mature renal phenotype and therefore, started to lose Pax-2 
expression.
It appears that kidney cells plated on fibronectin coated dishes and in STO 
conditioned medium were best able to proliferate and expand in culture in the 
long term whilst maintaining expression of MM markers, such as Pax-2, WT1, 
GDNF, and Salll.
In conclusion, in this chapter the conditions for expanding the Pax-2 cell 
population in vitro were optimized. Based on their expression of the metanephric 
mesenchyme markers Pax-2, WT1, Salll, and GDNF it was hypothesised that 
these cells might represent a population of stem cells. In the next chapter these 
MM-like cells were further characterized in order to determine if these renal cells 
were kidney stem cells.
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Chapter 6: Characterization and differentiation of 
expanded KSC
6.1 Introduction
The previous chapters described the identification, isolation and culture of a 
putative stem cell population isolated from neonatal mouse kidney. These cells 
were found to express a number of MM-specific genes, raising the possibility that 
they could be MM-like cells that remain in the kidney following nephrogenesis. 
In order to establish whether these cells were stem cells, it was necessary to 
determine their characteristics. It is well established that the defining property of 
a stem cell is that it should be able to self-renew, giving rise to more stem cells, 
and differentiate into specific cell types (Morrison and Kimble, 2006). Therefore, 
stem cells can be identified on the basis of their properties of self-renewal, 
clonogenicity, and also differentiation potential and/or expression of specific 
markers (Sagrinati et al., 2006).
In this chapter putative kidney stem cells were differentiated to specific renal and 
non-renal cells.
Stem cells have been shown to be present in most adult tissues, such as skin 
(Gambardella and Barrandon, 2003; Tumbar et al., 2004; Watt and Hogan, 2000), 
intestinal epithelium and bone marrow (Moore and Lemischka, 2006; Pittenger et 
al., 1999), central nervous system (Reynolds and Weiss, 1992), retina (Tropepe et 
al., 2000), skeletal muscle (Jackson et al., 1999), liver (Alison and Sarraf, 1998), 
and kidney (Bussolati et al., 2005; Challen et al., 2006; Gupta et al., 2006;
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Hishikawa et al., 2005; Iwatani et al., 2004; Kitamura et al., 2005; Maeshima et
al., 2006; Oliver et al., 2004; Sagrinati et al., 2006).
Tissue-specific stem cells were originally considered to be capable of only giving 
rise to the cell types that form their tissue of origin, however, it has been proved 
that at least some adult stem cells, such as mesenchymal stem cells, can generate 
cell types from a variety of tissues, such as bone, cartilage and fat (Herzog et al., 
2003; Jiang et al., 2002).
This has also been shown to be the case with kidney stem cells. Sagrinati et al. 
(2006) isolated a population of progenitor cells from human kidney and were able 
to generate not only renal cell types, but also extrarenal cell types such as 
osteoblasts and adipocytes.
The nephron is the structural and functional unit of the kidney. Each nephron is 
formed by the renal corpuscle (Bowman’s capsule and glomerulus) and the renal 
tubule. The Bowman’s capsule is the initial portion of the nephron and it is 
invaded by the vascular tuft, which is the glomerulus. The renal corpuscle 
contains the filtration apparatus of the kidney, which is comprises three 
components: the vascular endothelial cell layer, an outer epithelial cell layer that 
contains specialised cells called podocytes, and an intermediate layer of basement 
membrane called glomerular basement membrane (GBM). (Vize et al., 2003).
Podocytes stabilize glomerular architecture and form a crucial component of the 
glomerular filtration barrier (Pavenstadt, 2000). Podocytes are highly specialised 
cells that can be divided into three structurally and functionally different
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segments: the cell body, the major processes, and foot processes interlinked by 
slit diaphragms.
In addition to podocytes the renal corpuscle contains mesangial cells, which are 
responsible for phagocytosis, in order to maintain a clean GBM, structural 
support of the podocytes, and secretion of a variety of molecules (Martini and 
Bartholomew, 1997). These cells are located between the individual capillaries of 
the glomerular tuft.
The rest of the nephron is composed of the renal tubule that from the Bowman’s 
capsule can be divided into four sections: the proximal tubule (including 
convoluted and straight parts), the thin limbs of the loop of Henle, the distal 
tubule (including convoluted and straight portions), and finally the connecting 
segment that empties into the collecting duct (Vize et al., 2003).
The different cell types of the kidney express specific proteins that can serve as 
markers for their identification.
Synaptopodin is an actin-associated protein that is characteristic of differentiated 
podocytes (Mundel et al., 1997a). WT1, which is expressed in MM and in MM 
derivatives at different stages of maturation, is also upregulated in mature 
podocytes. It is expected that mature podocytes would therefore present a high 
expression level of WT1 (Dressier and Douglass, 1992). Podocalyxin is highly 
synthesized in differentiating podocytes and is restricted to apical surfaces of foot 
processes and to the luminal membrane domain of endothelial cells (Schnabel et 
al., 1989; Vize et al., 2003), but it is not specific for podocytes because it is also 
expressed by endothelial cells (Shankland et al., 2007). Nephl expression is
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restricted to lateral margins of podocyte foot processes at the insertion of the slit 
diaphragm (Barletta et al., 2003).
CD2-associated protein (CD2AP) is expressed in mature kidney in podocytes, 
however, it is also expressed in proximal tubule, and collecting duct and therefore 
cannot be considered podocyte specific (Akilesh et al., 2007).
Vascular endothelial growth factor (VEGF) is involved in migration, 
proliferation, and differentiation of the vasculature of the kidney (Vize et al., 
2003). In kidney development VEGF is expressed in condensed mesenchyme and 
portions of the S-shaped body, and with kidney maturation becomes restricted to 
the glomerular epithelium and tubular cells (Simon et al., 1995; Tufro et al., 
1999; Vize et al., 2003). Developing podocytes also secrete VEGF, which guides 
endothelial cells towards developing glomeruli (Guan et al., 2006) and even after 
glomeruli are fully mature podocytes continue to synthesize VEGF (Vize et al., 
2003).
Vimentin, an intermediate filament protein of the cytoskeleton, is expressed in 
early kidney development in the undifferentiated metanephric mesenchyme, 
however, as the meschymal cells begin to differentiate its expression is lost. 
Later, the developing podocytes begin to express vimentin again, and as they 
develop its expression becomes restricted finally to their bodies and major 
processes (Vize et al., 2003). Podocytes can also be identified morphologically 
when cultured in vitro. Differentiated podocytes in vitro are large cells with a 
large cytoplasmic to nuclear volume ratio, arborized and often binucleated 
(Saleem et al., 2002; Shankland et al., 2007).
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The mesgangial cells of the glomerulus can be identified by their expression of 
the markers a smooth muscle actin (aSMA) and desmin. aSMA is a marker of 
smooth muscle cells that it is expressed in mesangial cells during kidney 
development and is also present in high amounts in vascular smooth muscle cells 
(Skalli et al., 1989; Stephenson et al., 1998). Similarly, Desmin is also expressed 
in mesangial cells as well as in vascular smooth muscle cells (Zou et al., 2006).
Some general epithelial markers, such as Kidney specific cadherin (Ksp-cad) and 
cytokeratins, can be used to identify cells of the tubular epithelium. KSP-cad is 
expressed in renal tubular epithelial cells, and is the only member of the cadherin 
family that it is exclusively found in the kidney. Cytokeratins are cytoskeletal 
proteins that form part of the intermediate filament group, and are characteristic 
of epithelial cells (Fleming and Symes, 1987). Cytokeratin 8 is expressed in all 
parts of the developing nephron and in adult tissue is expressed in all tubule 
epithelial cells (Oosterwijk et al., 1990).
Other markers are specifc for certain portions of the nephron. Aquaporin 1 
(AQP1) is expressed in kidney proximal tubules and descending thin limbs (Jenq 
et al., 1999), and megalin (Oliver et al., 2002) and alkaline phosphotase (AP) are 
known to be expressed in proximal renal epithelial cells (Baer et al., 1999; 
Bussolati et al., 2005; Sagrinati et al., 2006). Meanwhile, Tamm-Horsfall protein 
(THP) is localized in the thick ascending limb of the loop of Henle and the early 
distal convoluted tubule (Chakraborty et al., 2004). The collecting ducts can be 
identified by their expression of aquaporin 2 (AQP2) (Cai et al., 2005).
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Zonula Occludens 1 (ZO-1) is expressed in the tight junctions of epithelial cells 
and in the kidney can be found in the epithelial foot processes, in particular being 
concentrated at the points of insertion of the slit diaphragms into the lateral cell 
membrane (Schnabel et al., 1990). While its expression is not specific to a 
particular portion of the tubular structure of the kidney its relative expression 
levels can be used to identify certain portions. ZO-1 is in epithelia throughout the 
tubular fractions of the kidney but stronger expression is observed in the distal 
segments (Gonzalez-Mariscal et al., 2000).
Endothelial markers as platelet endothelial cell adhesion molecule (PECAM) 
(Redick and Bautch, 1999) and von Willebrand factor (vWF) (Pusztaszeri et al., 
2006) were also studied on the cells.
A number of groups have attempted to integrate embryonic stem cells or kidney 
stem cells into developing kidneys in order to evaluate whether the developing 
kidneys can provide an adequate environment and the signals required for the 
stem cells to differentiate into renal cells or even integrate into the developing 
structures (Kim and Dressier, 2005; Maeshima et al., 2006; Steenhard et al.,
2005).
When injected into developing kidneys ex vivo, embryonic stem cells have 
successfully formed tubular epithelial structures (Kim and Dressier, 2005; 
Steenhard et al., 2005). Maeshima et al. (2006) isolated renal progenitors from rat 
kidney and injected them into embryonic kidney ex vivo and found that 40% of 
the injected cells integrated into various parts of the developing kidneys.
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Differentiation protocols for kidney stem cells commonly include animal serum 
(foetal bovine serum, foetal calf serum or horse serum) in the differentiation 
medium, and it appears that serum has some role in promoting differentiation 
(Bussolati et al., 2005; Challen et al., 2006; Kruse and Tseng, 1993; Sagrinati et 
al., 2006).
6.1.1 Aims
The aim of this chapter was to clarify whether the expanded population of Pax-2 
positive renal cells were kidney stem cells. The putative stem cells were tested for 
their ability to differentiate into specific kidney cell types, and the resulting cells 
were investigated for cell marker expression in order to characterise them. The 
differentiated cells were also tested for their clonogencity. Finally, the cells were 
tested for their ability to integrate into a developing kidney, in order to evaluate 
their nephrogenic potential.
6.2 Results
6.2.1 In vitro differentiation of KSC
In order to promote differentiation of KSC into renal-specific cell types, cells 
grown on fibronectin for eleven passages were plated into uncoated plastic dishes 
and STO-CM was changed to DMEM containing serum (10% FCS). The cells 
were grown for five passages (one month) under these conditions. The cells were 
then analysed for MM and renal-specific markers by immunostaining and 
RT-PCR, and changes in their morphology were evaluated. Hereafter cells that 
had been cultured under the differentiating conditions will be referred to as
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‘differentiated putative kidney stem cells’ (dpKSC) to distinguish them from 
those maintained under the original conditions (pKSC).
Morphological analysis
When in culture the pKSC appeared as a relatively homogeneous population, 
however, the dpKSC population became more heterogeneous and cells with 
different morphologies were observed (Figure 6-1). Some cells formed layers of 
epithelial-like cells, some became spindle shaped or mesangial-like cells with 
their characteristic stellate morphology (Cortes-Hemandez et a l, 2002). Others 
displayed a cobblestone morphology characteristic of immature podocytes in 
culture (Shankland et a l, 2007). Arborized, binucleated cells, which are 
characteristic of differentiated podocytes, were also observed. However, in the 
colonies some cells with morphology similar to undifferentiated pKSC were 
observed.
Investigation of MM-specific marker expression
It has been demonstrated that the pKSC maintained expression of the metanephric 
mesenchymal markers Pax-2 and WT1 when cultured through a number of 
passages, indicating that they may have been stem cells. In order to determine 
whether the cells differentiated under the new culture conditions, the expression 
of these markers was tested in dpKSC. After five passages in the differentiating 
conditions, the cells were immunostained for Pax-2 and WT1. While pKSC 
maintained expression of Pax-2 and WT1, dpKSC continued to express WT1, but 
the majority of the cells lost Pax-2 expression (Figure 6-2).
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RT-PCR was performed to detect expression of Pax-2, WT1 GDNF and Salll. 
The results showed that WT1 and GDNF expression was maintained following 
differentiation but, as expected from the immunostaining results, there was no 
Pax-2 expression (Figure 6-3). This experiment was repeated and the results of 
both immunostaining and RT-PCR were shown to be reproducible.
Pax-2 WT1 GDNF GAPDH
dpK Neo NT dpK Neo NT dpK Neo NT dpK Neo NT
SalM GAPDH
Figure 6-3 RT-PCR analysis of dpKSC for Pax-2, WT1, Salll, GDNF and GAPDH. dpKSC 
(dpK) did not express Pax-2 or Salll, but were positive for WTl and GDNF. Positive control in 
each case was 5 day old kidney (Neo); no template control (NT) also shown.
Investigation of renal-specific marker expression
To determine whether the cells were differentiating to renal-specific cell types a 
variety of renal-specific markers were investigated using RT-PCR and 
immunostaining.
Expression of the specific renal marker synaptopodin was investigated to 
determine whether the dpKSC were assuming podocyte commitment. 
Furthermore, WTl expression levels were evaluated as it is known that WTl is
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more highly expressed in mature podocytes than in MM cells (Ryan et al., 1995). 
When dpKSC were stained for synaptopodin and WT1 clusters of cells could be 
observed that showed higher levels of WT1 expression and higher levels of 
synaptopodin expression (Figure 6-4a). These cells also presented cytoplasmic 
synaptopodin.
Among the dpKSC some binucleated cells were present. These binucleated cells 
also had a higher cytoplasmic volume compared with the rest of the cells in 
culture. WT1 expression in these cells was higher than in neighbouring cells; this 
would be consistent with them being podocytes (Figure 6-4c). Both pKSC and 
dpKSC were positive for synaptopodin when they were analysed by RT-PCR 
(Figure 6-5). Other podocyte markers such as podocalyxin, nephl and CD2AP 
were positive in pKSC and dpKSC when they were analysed by RT-PCR (Figure
6-5).
In order to check whether mesangial cells were founded among the differentiated 
cells, the mesangial marker aSMA (alpha smooth muscle actin) was used to stain 
dpKCS. When pKSC were stained for aSMA most of the cells appeared negative 
for aSMA with no staining observable above background levels (Figure 6-6a). 
However, many dpKSC were found to be aSMA positive (Figure 6-6b and c). No 
positive staining was found in the dishes where the primary antibody had been 
omitted (Figure 6-6d).
The mesangial marker Desmin was expressed in pKSC and dpKSC in RT-PCR. 
Another cytoskeletal protein studied by RT-PCR was vimentin which was 





































































































































































































































































































































































































































































































































































































































































































In order to determine whether there were epithelial cells among the dpKSC, the 
cells were stained for cytokeratin expression. Very few pKSC cells presented 
cytokeratin expression, however, clusters of the dpKSC were positive for 
cytokeratin (Figure 6-7). No specific staining was observed in samples where 






Figure 6-7 Immunostaining of pKSC and dpKSC for the epithelial marker cytokeratin. (a)
pKSC were not shown to express cytokeratin. (b) Cytokeratin staining of dpKSC showed some 
clusters positive for the marker. Scale bars: 100pm. Ph -  phase contrast.
The epithelial marker cytokeratin-8 was not expressed in pKSC, but was 
expressed in dpKSC. The kidney specific cadherin, ksp-cadherin, was expressed 
in pKSC but not in dpKSC (Figure 6-5).
Based on the morphology it was hypothesised that the epithelial-like cells present 
in the differentiated cultures could be proximal or distal tubular cells of the
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nephron. To determine whether proximal tubular cells were present, cultures were 
stained for the presence alkaline phosphatase. While no alkaline phosphatase 
activity was detected in the pKSC, the dpKSC showed clusters of cells showing 
AP activity (Figure 6-8). The cells showing AP staining presented an epithelial- 
like morphology. Some of the cells with no AP activity showed morphology 
characteristic of podocytes.
Figure 6-8 Alkaline phosphatase staining of dpKSC. (a) dpKSC formed layers of epithelial-like 
cells that were positive for alkaline phosphatase (arrow), while cells negative for AP did not 
exhibit epithelial-like morphologies (arrowhead), (b) Some dpKSC that were negative for AP 
exhibited binucleated podocyte-like morphologies (arrowhead); arrow indicates AP positive 
epithelial-like cells, (c) pKSC were negative for AP expression. Scale bars: 100 pm.
To confirm that proximal tubular cells were present, the cells were 
immunostained for the water channel Aquaporin 1 (AQP1). pKSC and dpKSC 
were negative for AQP1 staining (Figure 6-9). Staining for AQP1 was found in 
the one day old neonatal kidney included as a positive control. No staining was 
observed in the cells where the primary antibodies were omitted.




Figure 6-9 Immunostaining of dpKSC for aquaporin 1 (AQP1). (a) dpKSC did not express 
AQP1. Ph -  Phase contrast, (b) Positive control -  one day old kidney, (c) Negative control in 
which primary anitbody was omitted from stain -  one day old kidney. Scale bars: 100 pm
Other tubular markers were analysed by RT-PCR such as ZO-1 and THP, which 
are mostly expressed in distal portion of the nephrons (Figure 6-5). pKSC and 
dpKSC expressed ZO-1.
RT-PCR also showed that pKSC expressed THP, while dpKSC did not.
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The cells were also immunostained for the water channel AQP2 expressed in 
collecting ducts. pKSC and dpKSC were negative for AQP2 staining (Figure 
6-10). Staining for AQP2 was found in one day old neonatal kidney, which was 
included as a positive control. No staining was observed in the cells where the 
primary antibodies were omitted.
(a)
Figure 6-10 Immunostaining of dpKSC for aquaporin 2 (AQP2). (a) dpKSC did not express 
AQP2. Ph -  Phase contrast, (b) Positive control -  one day old kidney, (c) Negative control in 
which primary anitbody was omitted from stain -  one day old kidney. Scale bars: 100 pm.
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The dpKSC were also tested for the expression of two endothelial markers vWF 
and PECAM. No PECAM staining was found in pKSC. dpKSC showed no 
positive staining for either vWF or PECAM (Figure 6-11 and Figure 6-12).No 
staining was found in the samples in which the primary antibody had been 
omitted.
The last of the endothelial marker analysed by RT-PCR was VEGF, which was 
expressed in pKSC and in dpKSC (Figure 6-5). Table 6-1 summarise the 
RT-PCR results for all sixteen markers tested.
Reverting the Phenotype of differentiated pKSC
In order to test whether the dpKSC could regain Pax-2 expression, the cells were 
replated under the original culture conditions of fibronectin and STO-conditioned 
medium and analysed after 6 passages in culture. RT-PCR and immunostaining 
showed that the cells did not recover Pax-2 expression when the conditions were 
reverted (Figure 6-13 and Figure 6-14).
6.2.2 Extrarenal differentiation
In order to determine whether pKSC or dpKSC had the potential to differentiate 
to any cell type other than renal, adipogenic differentiation was induced. After a 
week fat droplets, characteristic of adipocytes, were identified by eye in the 
cytoplasm of many of cells in all the dishes. In the controls a few isolated 
vacuoles were also identified (Figure 6-15).
After two weeks and three weeks the presence of the fat droplets in the majority 
of the cells was confirmed using oil red O staining (Figure 6-15). There was no
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Figure 6-11 Immunostaining of dpKSC for von Willebrand Factor (vWF). (a)
Immunostianing showed the absence of vWF in dpKSC. (b) Expression of vWF in neonatal 
mouse kidney was used as a positive control. Scale bars: 100 pm. Ph -  Phase contrast.
Table 6-1 Summary of the RT-PCR results for pKSC and dpKSC.




















Figure 6-12 Immunostaining of pKSC and dpKSC for PECAM. (a) pKSC did not show any 
expression of PECAM. (b) dpKSC did not express PECAM. (c) Expression of PECAM in E14.5 
mouse embryo as positive control. Scale bars: 200 pm. Ph — phase contrast.
Pax-2 WT1 GAP NT
Figure 6-13 RT-PCR of dpKSC cells cultured for one month on fibronectin and STO-CM 
for Pax-2 and WT1. Moving the dpKSC from the differentiating conditions back to the renewal 
conditions did not result in the cells regaining expression of Pax-2; WT1 expression was 
maintained throughout.
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Figure 6-14 Immunostaining of dpKSC after reversion experiment for Pax-2 and WT1. (a)
dpKSC cultured for 1 month in original ‘renewal’ conditions of fibronectin and STO-CM did not 
regain Pax-2, but did retain WT1 expression, (b) Negative control in which primary antibody was 
omitted from the stain. Scale bars: 100 pm. Ph- phase contrast.
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Figure 6-15 Adipogénie differentiation of pKSC. pKSC cultured for two and three weeks with 
adipogénie medium and stained with oil red O. (a) pKSC cultured with adipogénie medium for 
two weeks presented lipid droplets, (b) Detail of image (a) showing lipid droplets, (c) pKSC 
cultured for three weeks with adipogénie medium presented similar numbers of adipocytes, (d) 
dpKSC cultured for three weeks with adipogénie mediumshowed scattered cells with lipid 
droplets, (e) pKSC in control medium did not develop significant numbers of lipid droplets, (f) 
dpKSC in control medium did not develop significant numbers of lipid droplets. Scale bars 
100 pm, except (b) where scale bar is 25 pm
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increase in the number of cells with droplets from two to three weeks in the 
adipogenic conditions. Nearly all pKSC presented fat droplets, while in dpKSC 
cultures there were larger areas without fat droplets.
6.2.3 Ex vivo differentiation of KSC
In order to evaluate the nephrogenic potential of the expanded putative KSC, the 
potential of the pKSC to integrate into the developing kidneys of El 1.5 mice was 
assessed. Calbindin was used to visualize ureteric bud structures. When the 
developing kidneys were stained with differentiation markers, such as 
synaptopodin or podocin, no staining was observed (data not shown). Most of the 
labelled KSC were found close to ureteric bud structures, and some were found 
condensed around the tips of the ureteric bud (Figure 6-16).
Clonogenic potential of KSC
When single cells were plated into Terasaki plates by mouth pipetting in CM- 
STO 30% attached, however, none proliferated and within 10 days all attached 
cells had died. By contrast when single cells were plated in 96 well plates by 
limiting dilution but in DMEM 10% FCS, many proliferated and formed 
colonies. From the total number of cells plated on the 96 well plates, 22 single 
cells were identified, and of these 17 formed colonies.
The clones from single cells were expanded (Figure 6-17). Differences in cellular 
morphology were observed between clones, but all the cells in an individual clone 
exhibited similar morphology (Figure 6-18a and b). Most of the clones presented
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Figure 6-16 Immunostaining for calbindin in integration experiment of KSC-vybrant dye 
into developing kidneys, (a) Immunostaining for calbindin (red) showing general view of the 
whole developing rudiment where pKSC (green) are condensed around ureteric bud structures, (b- 
c) Immunostaining for calbindin showing pKSC condensed around ureteric bud tips. Scale bars: 
(a) 200 pm, (b) and (c) 20 pm and (h) 50 pm.
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a b
Figure 6-17 Bright field images showing time course expansion of one clone (C4). (a) Bright 
field images showing a single cell one day after plating, (b) Bright field image showing cells 
proliferating two days after plating , (c) three days after plating and (d) seven days after plating. 
















































































































































a similar non differentiating morphology, however, six of the clones (C4, G10, 
H3, H9, Gl, H4) presented a spindle shaped morphology. Note that some cells in 
these spindled cultures adopted a round morphology during division; this is 
common in most adherent cell types during mitosis (Gergely and Basto, 2008).
In one clone the morphology of the cells changed during expansion. This change 
was evident after approximately six weeks. The cells originally developed the 
spindle-shaped morphology and later presented more rounded morphology with 
indented nuclei (kidney-shaped) and a nuclear-cytoplasmic ratio of about 1:1, in 
which the nuclei occupied a large volume of the cells (Figure 6-19).
Figure 6-19 Phase contrast images of clone H9 after six weeks in culture, (a) Cells from clone 
H9 after two weeks in culture presented a spindle shaped morphology, (b-c) After six weeks in 
culture cells from H9 had acquired a rounded morphology with large nuclei (arrows) and some 
indented nuclei (arrowheads). Scale bars: 100 pm.
For further characterization the clones were analysed by immunostaining and 
RT-PCR. Six of the clones were analysed by RT-PCR for Pax-2, ksp-cadherin, 
THP, vimentin, desmin, cytokeratin, and megalin expression (Table 6-2). When 
the latter four markers were analysed the cDNA from one clone, FI9, was found 
to have degenerated. One of the clones, A4, was positive for megalin, desmin, 
and vimentin but did not express cytokeratin. Another clone, Gl, was positive for
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Table 6-2 Summary of the results of the RT-PCR for the clones.
Marker E5 H3 H9 A4 G1 D7
Pax-2 X X X X X X
Ksp-Cad X X X X X X
THP X X X X X X
Vimentin X X NA ✓ X
Desmin X X NA X X
Cytokeratin v' s NA X X X
Megalin X X NA X X
vimentin, but negative for cytokeratin, megalin and desmin. Two clones, E5 and 
H3, were positive for cytokeratin (Figure 6-20).
Eight of the clones derived from single cells were stained for aSMA after one 
month in culture. Two of the clones, A4 and D7, were completely negative for 
aSMA expression. Three clones, F6, H3, and H6, presented a high expression of 
aSMA. Clones E5, FI, and H9 presented few cells positive for aSMA.
Two of the clones were further analysed. The clone H6, which presented a 
heterogeneous morphology and different cell types, seemed to be present in the 
culture and E5 where the cells presented an homogenic morphology. The results 
showed that one of the clones (H6) presented many positive cells for aSMA. 
When this clone was stained for AP, enzyme activity was detected in some 
clusters of cells. Synaptopodin staining for this clone showed many positive cells 
for the marker, with higher expression in some binucleated podocyte-like cells 
(Figure 6-2la).
The other clone analysed for these markers was E5. Some cells in this clone were 





A4 G1 D7 E5 H3 Neo NT A4 G1 D7 E5 H3 Neo NT
Vim entin Cytokeratin
A4 G1 D7 E5 H3 Neo NT
*►
A4 G1 D7 E5 H3 Neo NT
GAPDH
A4 G1 D7 E5 H3 NT
Figure 6-20 RT-PCR of cells expanded from clones from pKSC. The results of the RT-PCRs 
shown for the clones are summarised in Table 2. Kidneys from one week old neonate mice were 
used as positive controls, and reactions run with no template (NT) as negative controls.
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Figure 6-21 Micographs of clones E5 and H6 showing expression of aSMA and 
synaptopodin, and alkaline phosphatase activity, (a) Clone H6 showed expression of aSMA 
and synaptopodin and was positive for AP activity, (b) Clone E5 was postitive for aSMA but 
negative for AP and synaptopodin. Scale bars: 100 pm.
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Growth curves of KSC and dKSC
The growth rates of pKSC and dpKSC were studied and compared. The results 
showed that the pKSC proliferated slightly quicker than the dpKSC. Linear 
regressions determined that the population doubling time for pKSC was 1.3 days 
(r2 = 0.997) and the population doubling time for dpKSC was 1.5 days (r2 = 
0.990) (Figure 6-22).
Figure 6-22 Graphs showing growth rates for pKSC and dpKSC. When cells cultures were 
analysed over a period of 21 days the pKSC (black), on fibronectin, were shown to proliferate at 
higher rate than dpKSC (red), on plastic. Doubling time for pKSC was 1.3 days (r2 = 0.997) and 
for dpKSC was 1.5 days (r2 = 0.990).
6.3 Discussion
In previous chapters, it was shown that a Pax-2 positive cell population could be 
isolated and expanded in vitro from neonatal mouse kidney. Based on their 
expression of the metanephric mesenchyme markers Pax-2, WT1, Salll, and 
GDNF it was hypothesised that these cells might represent a population of kidney
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stem cells. In order to determine whether this was the case, the work presented in 
this chapter sought to demonstrate that the cells had properties characteristic of 
stem cells, such as the ability to differentiate to mature cells types with 
expression of specific cell markers (Sagrinati et al., 2006), self-renewal and 
clonogenicity.
The results showed that when cultured under conditions to promote their 
differentiation, the putative stem cell population could generate cells with the 
morphology of cultured podocoytes, and expressed some mRNAs and proteins 
characteristic of podocytes, mesangial cells and proximal tubule cells. Following 
culture under appropriate conditions, the population also showed the ability to 
generate non-renal cell types, as shown by the fact that the putative stem cells 
could give rise to adipocytes. To test their nephrogenic potential, the cells were 
combined with mouse kidney rudiment ex vivo, where it was found that the cells 
were able to condense around the UB, showing they were able to integrate into 
developing nephron-like structures. Finally, by generating single cell clones, at 
least one of which was able to give rise to multiple differentiated cell types, it 
was confirmed that the population of Pax-2 positive cells isolated from the 
neonatal mouse kidney contained true stem cells.
The differentiation potential of the putative kidney stem cell 
population
The differentiated pKSC (dpKSC) presented morphologies of more specialized 
kidney cells, including epithelial, mesenchymal, mesangial and podocyte-like 
morphologies. They also lost expression of Pax-2 and Salll, but maintained WT1
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and GDNF expression, and expressed a number of renal cell-specific markers, 
suggesting that the cells were differentiating to more specific renal cell types.
Two possible factors may have been influencing the cells in such a way as to 
cause them to differentiate: the medium and the substrate. The medium changed 
in two ways. First, the basal medium on which the pKSC were maintained was 
conditioned medium from STO feeders while the dpKSC were grown on high- 
glucose DMEM. It is well-established that embryonic stem cells can be 
maintained in an undifferentiated state when grown on a layer of fibroblast 
feeders (Evans and Kaufman, 1981a; Evans and Kaufman, 1981b). It is possible 
that the DMEM lacked certain factors released by the feeders that may maintain 
the cells in a state of self-renewal. Second, the DMEM contained a higher 
concentration of foetal calf serum, which is known to promote differentiation 
(Kruse and Tseng, 1993). Many differentiation protocols call for the use of high 
serum concentrations unless adequate cytokines are added (Lanza et al., 2006), it 
may therefore be that the serum contains cytokines that promote differentiation.
It has been proposed that interaction of the cells with the substrate, and 
consequently cell shape, influences cell proliferation and cell differentiation 
(Huang and Ingber, 2000). When the pKSC were maintained, they were plated on 
fibronectin coated dishes, but in the “differentiating conditions” the cells were 
plated on top of the plastic of the dish with no coating. Fibronectin is a 
component of the kidney ECM (Ye et al., 2004). It is possible, therefore, that 
fibronectin provides the Pax-2 positive cells from the papilla with an appropriate 
niche to support their self-renewal, which could explain why the cells lost
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expression of Pax-2 and underwent spontaneous differentiation in the absence of 
fibronectin.
One of most striking differences in phenotype observed in the dpKSC was the 
appearance of cells with podocyte-like morphologies, including characteristics 
such as large cytoplasmic volumes, interdigitating processes, and binucleation, 
consistent with the criteria given by Shankland et al. (2007). Some of these cells 
expressed the protein synaptopodin , and also expressed higher levels of WT1 
than their neighbours, which is a characteristic of podocytes (Dressier and 
Douglass, 1992).
Standard conditions for culturing podocytes in vitro result in dedifferentiation as 
indicated by the loss of processes and synaptopodin expression (Saleem et al., 
2002). These undifferentiated podocytes can be differentiated in vitro under 
certain conditions, but this results in a rapid growth arrest, preventing further 
expansion of the cells (Shankland et al., 2007). It is therefore necessary to find 
alternatives, such as the use of immortalized podocyte lines (Mundel et al., 
1997b). The results in this chapter showed that differentiation of pKSC gave rise 
to cells with podocyte-like morphology and podocyte marker expression; hence, 
the use of pKSC and the differentiating conditions described could be an 
alternative avenue for generating podocyte cultures, which could be useful for 
studying podocyte biology and for toxicological studies.
The presence of mesangial cells in the dpKSC was also suggested by the 
mesangial-like morphology of some cells in the culture. This was reinforced by 
the expression of aSMA, which was absent prior to differentiation, and desmin.
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Differentiation to tubular epithelial cells was also indicated by the presence of 
cells with an epithelial like morphology and the expression of cytokeratin 8, 
alkaline phosphatase, and megalin. However, the proximal tubule marker AQP1 
was not expressed by the dpKSC. This might reflect the level of maturation of the 
cells, it is possible that these cells are in the process of differentiating to tubular 
cells, and that AP and megalin expression appears earlier than AQP1. 
Alternatively, it is possible that the in vitro culture conditions did not provide the 
necessary cues to induce AQP1 expression. AQP1 expression is essential for 
proximal tubular cell function and it will therefore be important in the future to 
determine if the cells can express AQP1 following integration into the kidney 
rudiments.
The absence of THP expression suggested that cells from the distal portion of the 
nephron were not present among the dpKSC. It has been shown that distal tubular 
cells in culture transdifferentiate to a more proximal phenotype thereby losing 
expression of THP and starting to express proximal marker proteins (Baer et al., 
1999). It is therefore possible that any distal tubular cells in dpKSC 
dedifferentiated to proximal tubular cells losing THP expression. Alternatively it 
could be that the differentiation conditions used did not promote differentiation to 
distal tubular cells.
Collecting duct cells were also apparently absent from dpKSC, as shown by the 
lack of AQP2 and Ksp-cadherin expression. The embryonic origin of the 
collecting duct is distinct from the rest of the kidney as it originates from ureteric 
bud rather than the metanephric mesenchyme (Vize et al., 2003). The fact that
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dpKSC could only generate MM derivatives, and not UB derivatives, supports 
the lineage tracing experiments in chapter one, that suggested the cells were 
derived from MM.
It was apparent that endothelial cells were not present on dpKSC due to the 
absence of the endothelial markers vWF and PECAM. It may be that the 
differentiating conditions used did not support endothelial differentiation, or it 
may be that pKSC do not have the potential to generate endothelium. The origin 
of renal endothelial cells is not clear. Some evidence suggests that the kidney 
endothelium originates extrarenally (Oliver et al., 2002; Sariola et al., 1984). 
While cultures of embryonic kidneys ex vivo do not form capillaries, it has been 
shown that mouse embryonic kidneys grafted onto quail chorioallantoic 
membrane develop glomerular capillaries that originate from the host membrane, 
suggesting that renal endothelial cells may have an extrarenal origin (Oliver et 
al., 2002; Sariola et al., 1984). However, Robert et al. (1996) demonstrated the 
development of glomerular capillaries of renal origin in embryonic mouse 
kidneys that had been grown in vitro and then grafted into the eyes of mice, 
which suggested that embryonic kidney may contain endothelial precursors. 
Conditioned medium does not seem to be responsible for the pKSC phenotype as 
Pax-2 and Salll were not re-expressed by the cells when they were moved from 
the differentiating conditions back to fibronectin with STO-conditioned medium.
The pKSC also expressed many transcript markers of mature renal cells, despite 
displaying an homogeneous morphology lacking the characteristics of 
differentiated cell types. Although the transcripts are often reported to be markers
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of mature renal cell types, many have been found to be expressed during the early 
stages of kidney organogenesis, at a time when mature cell types have not yet 
differentiated. For instance, megalin, which is reported to be a marker of 
proximal tubule cells, is known to be strongly expressed in the metanephric 
mesenchyme of E14 embryos (Assemat et al., 2005).
As well as renal cells pKSC were also able to differentiate to adipocytes. This 
finding suggests that the pKSC might share some of the properties of 
mesenchymal stem cells, which can differentiate into multiple mesodermal cell 
types, including bone, fat, cartilage and muscle (Peister et al., 2004). Both 
mesenchymal stem cells and metanephric mesenchyme are mesodermal 
derivatives, and under the appropriate culture conditions, might be expected to 
display a similar developmental potential. For instance, it has been shown that if 
human mesenchymal stem cells are transplanted to the site of the presumptive rat 
kidney before the metanephric mesenchyme has developed, they are readily 
incorporated into the developing kidney and are able to generate renal-specific 
cell types (Yokoo et al., 2006).
The differentiation potential of single cell clones of pKSC
The pKSC were demonstrated to be highly clonogenic. Most of the clones,
according to the analysed markers, showed little evidence of differentiation. 
Clone E5, which presented a homogeneous morphology under the microscope 
and expressed aSMA, appeared to have generated only one cell type, mesangial 
cells. This suggests that the cell from which the clone originated was unipotent.
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Clone H6, in contrast, appeared to be multipotent. Cells expanded from this clone 
were able to differentiate to cells from different portions of the nephron, such as 
proximal tubules, mesangial cells and podocytes, as was shown by the expression 
of alkaline phosphatase, aSMA and synaptopodin respectively. Furthermore, cells 
from H6 presented a heterogenic morphology and different cell types were 
observed such as podocyte-like cells, mesangial-like cells and epithelial cells. 
The differentiation pattern of the clone H6 confirms that some pKSC were 
multipotent and could give rise to different cell types of the nephron.
Interestingly, one of the differentiated clones, H9, presented many cells that 
acquired indented or reniform nuclei. This nuclear morphology is not 
characteristic of any renal cell type, however, it has been observed in other cell 
types, such as cells from the islets of Langerhans (Hidaka et al., 1979) or 
monocytes (Marshall et al., 2006). To positively identify these cells a deeper 
analysis of specific markers would be required.
The nephrogenic potential of pKSC
During nephron formation in early kidney development the metanephric 
mesenchyme condenses around the ureteric bud (Ryan et al., 1995). When 
labelled pKSC were mixed with disaggregated embryonic kidneys, they were 
similarly seen to condense around ureteric bud structures suggesting some 
nephrogenic potential. However, they did not seem to integrate into ureteric bud 
structures or developing nephrons, although it is possible that any pKSC that had 
integrated and begun to proliferate had lost the labelling dye and so could not be 
detected.
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In summary, it has been shown that the population of potential KSC can be 
induced to differentiate to more specialized cell types, such as tubular epithelial 
cells or mesangial cells, by changing the culture conditions. These cells also have 
high clonogenic potential. These expanded populations also showed some 
potential to integrate in new developing kidney, but this aspect would need to be 
further studied to reach any formal conclusion. These renal cells can also be 
differentiated to extrarenal cell types such as adipocytes. In view of these 
properties, it appears that this population of cells isolated from neonatal kidney 
could be a stem cell population resident in the kidney, which can be isolated and 
manipulated in vitro.
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Chapter 7: Final Discussion
In this study putative stem cells were isolated from postnatal mouse kidney, 
expanded in vitro, and their potential to generate specific renal cell types was 
evaluated. During this project mice were used as an animal model. In some 
species, such as humans, nephrogenesis is completed before birth, but in mice the 
kidney continues to undergo nephrogenesis after birth (Pierre et al., 2008), and 
this makes it a good, accessible model. Whole kidneys were removed from the 
animal and studied, which provided a more comprehensive understanding of the 
different kidney cells populations than would have been possible analysing only 
samples from biopsies.
Adult stem cells exist in postnatal tissues and are involved in normal cell turnover 
and in regeneration after damage (Gupta and Rosenberg, 2008; Lanza et al.,
2006). However, in some organs, such as kidney or pancreas with a limited 
capacity of regeneration, the existence of adult stem cells remains controversial 
(Stanger et al., 2007). The lack of a unique kidney stem cell marker has led 
researchers to find alternatives to identify and isolate potential stem cells from 
adult kidneys. For instance, some groups have identified stem cells based on the 
theory that stem cells in tissues are slow cycling and therefore retain BrdU 
(Maeshima et al., 2006; Oliver et al., 2004). Other groups have attempted to 
isolate stem cells from kidney using markers expressed in haematopoietic and 
other tissue stem cells such as CD 133 (Bussolati et al., 2005; Sagrinati et al., 
2006) or Sca-1 (Dekel et al., 2006). A population of cells exhibiting stem cell
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properties has been isolated with MACS® from human kidneys using the marker 
CD133 (Bussolati et al., 2005; Sagrinati et al., 2006). These cells also expressed 
the transcription factor Pax-2 (Bussolati et al., 2005). During the first part of this 
study, the existence of a population of cells expressing the transcription factor 
Pax-2 in postnatal mouse kidney was investigated.
A population of Pax-2 positive cells, mainly located in tubules, was found in 
postnatal mouse renal papilla after nephrogenesis was completed. This fitted with 
the theory proposed by Oliver et al. (2004), that the renal papilla is a niche for 
kidney stem cells in rodents. This papillary Pax-2 population was a potential 
candidate for kidney stem cells with regenerative properties.
The renal papilla provides a unique environment due to the low p02 in this area 
(Oliver et al., 2004). It has been shown that low oxygen tension controls adult 
organ-specific stem cell function (Cipolleschi et al., 1993; Oliver et al., 2004). 
An hypoxic environment can promote survival, proliferation, and the 
differentiation capacity of stem cells such as bone marrow and neuronal stem 
cells (Danet et al., 2003; Morrison et al., 2000). The renal papilla seems to 
present the ideal conditions to form a stem cell niche.
Pax-2 positive cells present in papilla seem to decrease when the mouse reach 
adulthood, however some Pax-2 cells seem to be expressed in renal papilla in 
adult mice and the evidence of Pax-2 present in adult mouse renal papilla has 
been shown before (Cai et al., 2005). It would be important to test if Pax-2 
positive cells present in adult mice have the same potential that Pax-2 isolated 
from kidneys of younger mice.
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It is well established that the metanephric mesenchyme is committed to 
differentiate into nephrons whereas the ureteric bud is restricted to giving rise to 
the renal collecting system (Saxen, 1987; Vize et al., 2003). It was therefore 
important to determine the origin of Pax-2 positive cells that remained in papilla 
after nephrogenesis. The hypothesis was that if papillary Pax-2 positive cells 
were derived from MM this would mean that they could have nephrogenic 
potential, whereas if they were derived from UB, they would not. 
WTl-Cre/Rosa26R transgenic mice were used to determine the origin of Pax-2 
papillary cells, because in these mice, cells expressing WT1 at any point during 
development would be permanently labeled with LacZ expression. It was found 
that many of the Pax-2 cells in the papilla of these mice also expressed 0- 
galactosidase, and hence had expressed WT1 during development. This suggested 
that these cells had a MM origin and were therefore likely to be capable of 
forming nephrons.
The next step in the project was to isolate the Pax-2 positive cells from neonatal 
mouse kidney to later study their potential. MACS® is the preferred technique to 
isolate rare populations from tissues (Buageaw et al., 2005; Pappas and Wang,
2007), and it has been successfully used to isolate several types of stem cells, 
including human kidney stem cells (Bussolati et al., 2005; Collins et al., 2001; 
De Coppi et al., 2007; Qin et al., 2004; Sagrinati et al., 2006). Pax-2 was used to 
identify putative stem cells in murine kidneys, however, as the transcription 
factor is expressed in the nuclei of the cells it was necessary to first identify a 
surface marker to enable isolation of the Pax-2 positive cells using MACS .
201
Lectins are carbohydrate specific binding proteins, and the fact that most cells 
contain carbohydrates on their surface make them suitable for cell isolation using 
MACS®. Lectins have been shown to show specific expression patterns on 
specific cell types in the kidney (Hanai et al., 1994; Holthofer, 1983; Laitinen et 
al., 1987; Schulte and Spicer, 1983). Among the twenty-one lectins tested, PNA 
showed specific binding to most of the Pax-2 cells present in kidney during 
development. It was therefore chosen to enrich the population of Pax-2 cells from 
the whole kidney population.
PNA MACS® separation successfully enriched Pax-2 cells, however, it was also 
found to be possible to obtain high numbers of Pax-2 positive cells simply by 
plating disaggregated cells from kidney and then culturing the cells for two 
weeks. If the Pax-2 expressing cells were indeed a stem cell population, then they 
could have had a proliferation advantage over differentiated cells. This could 
explain why, after two weeks in culture, the numbers of Pax-2 expressing cells 
were very similar in cells selected with PNA and in disaggregated kidney cells on 
which no isolation procedure had been performed. MACS® is an expensive and 
time consuming technique. Overall, it seemed that enrichment of Pax-2 cells 
using PNA coated magnetic beads was not worthwhile, at least for use in early 
neonates, in which there are high numbers of cells expressing Pax-2. However, it 
is possible that the technique could be more successful in older mice, in which 
Pax-2 numbers are decreased. It may also be possible to improve the result of 
MACS® enrichment of the Pax-2 cells by performing a negative selection. The 
use of a lectin that only binds Pax-2 negative cells would remove these cells, and
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thus further enrich the Pax-2 positive cells. A possible candidate indicated by the 
results in Chapter 4 would be PHA-L.
The next step was then to explore the possibility that Pax-2 cells present in 
neonatal kidneys may be a population of stem cells. Stem cells can be maintained 
self-renewing in culture, giving rise to daughter cells that are also stem cells, or 
they can be induced to differentiate to specific cell types. In order to study stem 
cells in vitro, the culture conditions required to maintain them undifferentiated 
needed to be optimized.
Conditioned medium from STO fibroblast containing 2.5% serum proved to be a 
better medium in which to grow the cells than Advanced DMEM. STO 
fibroblasts are widely used to grow embryonic stem cells and it has been shown 
that STO fibroblasts release growth factors into the medium that may be essential 
to maintain stem cells in an undifferentiated state (Ouyang et al., 2007; Talbot et 
al., 1994; Xu et al., 2001). Factors contained in the STO-conditioned medium 
could be responsible for cell proliferation. However, the conditioned medium also 
contained 2.5% fetal calf serum, and it may be that the serum contained chemical 
signals, such as growth factors, that were responsible for promoting cell survival 
and proliferation. It is very likely that the combination of both factors was 
responsible for the improvement in cell expansion.
Adhesion to the ECM is essential for cell survival and proliferation (Xu et al., 
2001). The adhesion of putative stem cells to different substrates was studied in 
order to test which was the most suitable for promoting proliferation and cell
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survival in vitro. It was found that fibronectin supported long term proliferation 
and expansion of cells maintaining expression of MM markers.
The fact that under optimized conditions the cells were able to proliferate and 
maintain expression of MM markers supports the hypothesis that cells expanded 
from disaggregated kidneys are a potential stem cell population. This technique 
may be used as an alternative to select stem cells instead of the MACS® isolation. 
Gupta et al. (2006) previously reported a similar approach of isolating stem cells 
from kidney using optimized conditions that promoted their proliferation.
One of the properties of stem cells is that they can differentiate, acquiring 
morphological, phenotypical, and functional features of specific cell types (Lanza 
et al., 2006). The differentiation potential of the putative kidney stem cells 
(pKSC) isolated in this study needed to be assessed in order to determine whether 
they were truly stem cells.
It was hypothesised that, given the renal origin of pKSC, they would already have 
some renal commitment, and that it would be feasible to differentiate them to 
renal specific cell types. To promote differentiation of pKSC the culture 
conditions of the cells were changed. The cells were plated onto plastic dishes 
with no coating and STO-CM with 2.5% FCS was then substituted for medium 
containing 10% FCS. Under these new conditions the cells underwent 
morphological changes and lost expression of the MM markers Pax-2 and Salll. 
This change in the phenotype suggested that the cells could be differentiating to 
more specific In this study putative stem cells were isolated from postnatal mouse
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kidney, expanded in vitro, and their potential to generate specific renal cell types 
was evaluated.
Adult stem cells exist in postnatal tissues and are involved in normal cell turnover 
and in regeneration after damage (Gupta and Rosenberg, 2008; Lanza et al., 
2006). However, in some organs, such as kidney or pancreas with a limited 
capacity of regeneration, the existence of adult stem cells remains controversial 
(Stanger et al., 2007). The lack of a unique kidney stem cell marker has led 
researchers to find alternatives to identify and isolate potential stem cells from 
adult kidneys. During the first part of this study, a population of Pax-2 positive 
cells, mainly located in tubules, was found in postnatal mouse renal papilla after 
nephrogenesis was completed. This fitted with the theory proposed by Oliver et 
al. (2004), that the renal papilla is a niche for kidney stem cells in rodents. This 
papillary Pax-2 population was a potential candidate for kidney stem cells with 
regenerative properties.
It was found that many of the Pax-2 cells in the papilla of WTl-Cre transgenic 
mice also expressed P-galactosidase, and hence had expressed WT1 during 
development. This suggested that these cells had a MM origin and were therefore 
likely to be capable of forming nephrons.
PNA MACS® separation successfully enriched Pax-2 cells, however, it was also 
found to be possible to obtain high numbers of Pax-2 positive cells simply by 
plating disaggregated cells from kidney and then culturing the cells for two 
weeks. If the Pax-2 expressing cells were indeed a stem cell population, then they 
could have had a proliferation advantage over differentiated cells. This could
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explain why, after two weeks in culture, the numbers of Pax-2 expressing cells 
were very similar in cells selected with PNA and in disaggregated kidney cells on 
which no isolation procedure had been performed. MACS® is an expensive and 
time consuming technique. Overall, it seemed that enrichment of Pax-2 cells 
using PNA coated magnetic beads was not worthwhile, at least for use in early 
neonates, in which there are high numbers of cells expressing Pax-2. However, it 
is possible that the technique could be more successful in older mice, in which 
Pax-2 numbers are decreased. It may also be possible to improve the result of 
MACS® enrichment of the Pax-2 cells by performing a negative selection. The 
use of a lectin that only binds Pax-2 negative cells would remove these cells, and 
thus further enrich the Pax-2 positive cells. A possible candidate indicated by the 
results in Chapter 4 would be PHA-L.
It was found that fibronectin and STO-conditioned medium supported long term 
proliferation and expansion of cells maintaining expression of MM markers. The 
fact that under optimized conditions the cells were able to proliferate and 
maintain expression of MM markers supports the hypothesis that cells expanded 
from disaggregated kidneys are a potential stem cell population. This technique 
may be used as an alternative to select stem cells instead of the MACS® isolation. 
Gupta et al. (2006) previously reported a similar approach of isolating stem cells 
from kidney using optimized conditions that promoted their proliferation.
Standard conditions for culturing podocytes in vitro result in dedifferentiation as 
indicated by the loss of processes and synaptopodin expression (Saleem et al., 
2002). These undifferentiated podocytes can be differentiated in vitro under
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certain conditions, but this results in a rapid growth arrest challenging expansion 
of the cells (Shankland et al., 2007). It is therefore necessary to find alternatives, 
such as the use of immortalized podocyte lines (Mundel et al., 1997b). The 
results in this study showed that differentiation of pKSC gave rise to cells with 
podocyte-like morphology and podocyte marker expression, hence the use of 
pKSC and the differentiating conditions described could be an alternative avenue 
for generating podocyte cultures.
pKSC could also be differentiated into other renal cell types such as mesangial 
and proximal tubular cells. The pKSC seemed to lack the capacity to form distal 
tubular cells, collecting duct cells or endothelial cells. It may be that the 
conditions used to differentiate the cells do not promote differentiation to these 
cell types or it could be that pKSC do not have the ability to form them.
The pKSC also showed the capacity to form extrarenal cell types such as 
adipocytes. One characteristic of mesenchymal stem cells is that they have the 
potential to generate fat, cartilage, bone and muscle (Peister et a l, 2004). 
Sagrinati et al. (2006) isolated a population of cells from human kidney using 
CD133 to select them. These cells with stem cells characteristics were able to 
generate renal tubular cells, osteocytes, adipocytes, and neural cells. It may be 
that pKSC from mice are an equivalent population to those isolated by Sagrinati 
et al. (2006) in human kidneys.
It is possible that pKSC may have some nephrogenic potential ex vivo as shown 
by their condensation around UB structures, resembling early kidney 
development events. However, they did not appear to integrate into UB structures
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or nephrons. It may be that the cells do not have the potential to integrate, or it 
may be that following integration and proliferation the cells lost the tracking 
label, meaning that they could no longer be visualized. If this was the case, GFP 
expressing cells may be a solution to overcome the loss of the cell tracker after 
proliferation
The cells were also highly clonogenic and some of the clones generated from 
single cells were able to give rise to at least three different cell types. This proved 
that the pKSC population contained multipotent cells, which were able to 
generate different cell types, rather than simply being a mix of different 
progenitors with limited differentiation potentials.
Some future work will need to be done in order to assess the potential of these 
pKSC in regenerative medicine. In this study has been shown that stem cells with 
the potential to generate various renal-specific cell types are present in the 
postnatal mouse kidney. However, although these renal-specific cells have a 
similar morphology and expression profile to those present in the kidney 
neprhons, it will be important to confirm that the stem cell-derived podocytes, 
mesangial cells and proximal tubule cells also have the ability to function in the 
same way as their in vivo counterparts.The ability of the cells to integrate into 
developing kidney and form kidney structures will also need to be further studied. 
It seems very unlikely that if these cells cannot integrate into embryonic kidney 
when nephrogenesis is still occurring, that they would be able to do so in adult 
kidneys.
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Furthemore, to assess if these pKSC are likely to have a future use in the 
treatment of human kidney disease, it will be important to investigate if these 
cells have any potential to regenerate structures or improve the renal function in 
animal models, as has been previously demonstrated with other stem cells 
(Bussolati et al., 2005; Challen et al., 2006; Dekel et al., 2006; Gupta et al., 
2006; Kitamura et al., 2005; Morigi et al., 2008).
An issue with the current study is that the Pax-2 positive cells were isolated from 
neonatal mouse kidneys that were still undergoing nephrogenesis, and therefore 
contained two populations of Pax-2 positive cells: a population in the cortex that 
plays in role in the formation of new nephrons, and a population in the papilla. It 
is therefore possible that the Pax-2 positive cells isolated here were from the 
cortex. However, if the cells were from the cortex, they would have limited use in 
any future stem cell-based therapy because they are only present in the kidney 
during its development. It would thus be important in the future to investigate if a 
similar Pax-2 positive population to the one characterised here could be isolated 
from kidneys that had completed nephrogenesis, because at this stage, the only 
Pax-2 positive cells present are in the papilla.
In conclusion, the work presented in this thesis has demonstrated that neonatal 
mouse kidneys contain a population of Pax-2 expressing cells that display 
characteristics of stem cells such as the ability to self-renew long term in culture, 
the ability to differentiate, and clonogenicity, suggesting that this population is 
very likely to be kidney stem cells similar to those previously isolated in humans 
(Bussolati et al., 2005; Sagrinati et al., 2006). These cells were able to give rise to
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specific renal cell types that would be required to generate a functioning nephron. 
Furthermore, the characteristic expression of Pax-2 by these cells was also 
observed in the kidneys of 2-3 week old and, to a lesser extent, adult mice 
suggesting that this population may be resident in mature or even adult kidney.
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